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1. Introduction 
During drug development alternative in vitro cell culture models are becoming more and 
more important in order to reduce or replace in vivo or ex vivo animal experiments, in 
particular in the preclinical phase. Compared to in vivo / ex vivo experiments, in vitro cell 
culture models offer many advantages since the experimental conditions are easier to control 
and the reproducibility is usually higher. Furthermore, cell culture models are also easier to 
standardize, more cost-effective and a constant and predictable source of research material 
for continuous investigations. 
In the development of new ophthalmic medications or related studies conducted to define 
their bioequivalence, transcorneal permeation studies are usually carried out in vivo or using 
ex vivo animal cornea. Due to the poor availability of ex vivo human corneas, corneal tissue 
of rabbit origin is commonly used in such studies. Over the last 20 years, a variety of different 
in vitro cell culture based corneal models have been developed for drug permeation studies. 
However, despite the considerable progress made in this area of research, these in vitro 
corneal models also have disadvantages and aspects that need to be further evaluated and 
improved before they are suitable for wide application in the pharmaceutical industry and 
within the scope of regulatory processes. The disadvantages of these alternative models 
include, for instance, the requirement for validation, the requirement to fulfill good laboratory 
practice (GLP) regulations, the analysis of comparability of data to those achieved with 
isolated cornea regarding a wide range of substances with different physicochemical 
properties as well as ophthalmic formulations, and the proof of transferability of results to 
humans. 
Since many questions remain unclear in this context, which restricts the widespread use of 
these corneal models, the aims of the present study were, first, to perform and assess the 
transfer of standard operating procedures for the cultivation of an in vitro corneal model and 
its use for drug permeability studies from an academic research laboratory to a biotech 
laboratory (Across Barriers GmbH; ACB); secondly, to participate in a prevalidation project 
including permeation data obtained with the corneal model at ACB; and thirdly, to evaluate 
the usefulness of the corneal model in in vitro permeation studies with a wide range of 
substances and excipients for ophthalmic formulations. The corneal model that has been 
used for the current study is a three-dimensional human Hemicornea model (Hemicornea; 
HC), also known as Hemicornea construct, that has been developed by the Institut für 
Pharmazeutische Technologie, Technische Universität Braunschweig, Germany (TUBS) 
(Hahne and Reichl, 2011). The present study intended to prove the suitability of the HC 
construct as in vitro model for preclinical permeability studies during the development of new 
ophthalmic medications, and to answer the following questions:  
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1. Is it possible to transfer the standard operating procedures for the cultivation of the 
 HC construct and drug permeability studies to an industrial laboratory, and what 
 acceptance criteria need to be defined for the application of the HC construct? 
 Does the HC construct possess an acceptable degree of intra- and interlaboratory 
 reproducibility in permeability studies and can the HC construct be prevalidated for in
 vitro drug permeability studies? 
 
2. Are the barrier properties and permeability (Papp) of the HC construct with regard to 
 drugs and marker substances with a wide range of molecular attributes comparable to 
 those reported for ex vivo rabbit and human corneal tissue? 
 
3. To what extent are the epithelial integrity and permeability of the HC construct 
 influenced by physicochemical parameters of ophthalmic formulations, such as pH 
 and osmolality? 
 
4. Is the permeability of the HC construct influenced by excipients commonly used in 
 ophthalmic medications for topical application to the eye, such as EDTA and 
 preservatives, and are the data obtained in these studies with the HC construct 
 comparable to those reported for ex vivo corneal tissue?  
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2. Literature review 
2.1. Anatomy of the eye 
The human eye is one of five human sensory organs. The visible light is detected by the 
human eye and is transformed into electro-chemical signals by the optic nerve and then sent 
to the brain. This mechanism helps humans to establish a connection with their physical 
environment. The ocular globe can be divided into the anterior compartment and the 
posterior compartment. A detailed description of the anatomy and physiology of the eye is 
provided below. 
2.1.1. Anterior compartment 
The anterior compartment of the eyeball is formed by the cornea, conjunctiva, aqueous 
humor, iris, ciliary body and crystalline lens (Figure 2-1). These structures constitute almost 
one-third of the front part of the eye (Cholkar et al., 2013). 
2.1.2. Posterior compartment 
The posterior compartment is composed of the sclera, choroid, Bruch’s membrane, retinal 
pigment epithelium, neural retina and vitreous humor (Figure 2-1). 
 
 
Figure 2-1: Representation of the anatomy of the human eye (Cholkar et al., 2013) 
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2.2. Cornea 
The cornea is defined as the window of the eye to the exterior environment. It is 
characterized by its transparency and regularity (Ehlers and Hjortdal, 2005). The human 
cornea has no blood vessels (non-vascular) and consists of three cellular layers: the corneal 
epithelium, the corneal stroma and the corneal endothelium, which are separated by two fine 
layers, the Bowman’s layer and Descemet's membrane (Castro-Muñozledo, 2008). 
The cornea’s function is to facilitate the ability to see and to prevent external organisms from 
entering into the inter-neuronal membrane of the retina (Stepp, 2010). The disruption of the 
corneal barrier leads to ocular illness or ocular disorders and might lead to a loss of vision in 
the worst case (Lonsberry et al., 2008). A schematic representation of the human cornea is 
shown in Figure 2-2. 
 
Figure 2-2: Schematic representation of the structure of the human cornea: 1. corneal epithelium 
(consists of superficial cells, wing cells, basal cells), 2. Bowman's layer, 3. corneal 
stroma, 4. Descemet's membrane and 5. corneal endothelium (adapted from Cholkar 
et al., 2013) 
 
2.2.1. Corneal epithelium 
The corneal epithelium is made up of various squamous cell types, which differ in size and 
form. These squamous cells form a net structure (Lonsberry et al., 2008). Moreover, the 
epithelium is composed of three layers of flattened cells, two to three layers of wing cells and 
one layer of columnar basal cells. The epithelium is highly innervated due to its large number 
of nervous connections (Huhtala et al., 2008). The cells are divided in three compartments: 
the internal, intermediate and external epithelium. The internal epithelium consists of basal 
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cells, which are arranged in a columnar structure and closely packed. The intermediate part 
is built of two or three layers of wing cells. The external epithelium consists of two or three 
segments of squamous and flattened cells. A smooth and non-undulating basement 
membrane is located beneath the basal cells, which are attached to each other by 
hemidesmosomes. In addition, the basement membrane is a thin layer, which supports the 
corneal epithelium and has a thickness of approximately 40 - 60 nm (Ehlers and Hjortdal, 
2005).  
2.2.2. Bowman's layer 
The Bowman's layer, also called Bowman's membrane, has a thickness of approximately 8 - 
12 µm and consists of clear, randomly organized collagen fibrils (collagen type I and III) and 
proteoglycans (Reichl and Becker, 2008). This thin layer has been described as an 
extracellular matrix and impedes the direct epithelial-stromal interaction (Gabison et al., 
2009). Furthermore, it has been proposed that this membrane has a barrier function, which 
avoids the spreading of the herpex simplex and other viruses, which cause ocular diseases 
(Wilson and Hong, 2000). Moreover, it has also been suggested that this layer presumably 
acts as a biologic and physiological barrier (Obata and Tsuru, 2007). The rigidity, form and 
curvature of the anterior part of the corneal stroma are also attributed to the Bowman's layer 
(Morishige et al., 2007). 
2.2.3. Stroma 
The thickness of the cornea is approximately 500 µm to 600 µm (Funderburgh, 2010). The 
major component of the cornea is the stroma, which constitutes about 90% of the whole 
tissue (Ehlers and Hjortdal, 2005). The corneal stroma consists of water (78%) and corneal 
fibroblasts (3-5%), also known as keratocytes, and an extracellular matrix, which is largely 
composed of collagen and glycosaminoglycans (Reichl and Becker, 2008). The stroma has 
about 71% collagen by dry weight (Newsome et al., 1982).  
The collagen fibrils have a width of between 10 µm and 250 µm, possess a thickness of 
between 200 nm to 250 nm and are arranged in parallel, forming lamellae. Approximately 
258 to 290 lamellae are distributed in the stroma and lie parallel to the corneal surface, 
resulting in a total of 832 lamellae (Radner et al., 1998; Radner and Mallinger, 2002). The 
keratocyte cells are flattened and lie between the lamellae. The keratocytes are randomly 
arranged and contribute to the cornea’s stability even when the cornea is extensively 
inflamed (Müller et al., 2001). The corneal fibroblasts synthesize the extracellular matrix, 
which basically consists of collagen (Poole et al., 1993). The collagen possesses mainly a 
structural function. However, other collagen types act as chemotactic factors, antigens for the 
production of antibodies, cell attachment and cell differentiation. Collagen is considered to be 
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the protein, which is most present in the connective tissue (Knupp et al., 2009). For instance, 
collagen type I is the most abundant in the corneal stroma, whereas collagen III and V have 
been found in pepsin extracts of human cornea (Newsome et al., 1982). The presence of 
collagen IV in stromal tissue was confirmed by immunochemistry experiments (Marshall et 
al., 1990). The transparency of the cornea has been discussed for years (Funderburgh, 
2010). A mathematical model has been developed to support the assumption that the 
stromal transparency is the result of the structure of its collagen fibrils (Farrell et al., 1973). In 
addition, the specific arrangement of the lamellae is not random (McCally and Farrell, 1982). 
The most important factor for conserving the corneal transparency may be the degree of 
stromal hydration. The discovery of a new protein (crystallins) in the keratocytes and other 
types of cellular tissue of the cornea suggested that these proteins serve to alter the 
refractive index of cells. For this reason, the scattered light is diminished by corneal cells 
(Funderburgh, 2010). 
2.2.4. Descemet’s membrane 
The corneal endothelium’s basement membrane is named Descemet’s membrane. After 
birth, its thickness is almost 2.8 µm. The Descemet’s membrane does neither possess a 
cellular structure nor an internal structure (Doshi, 2004). The expression of collagen IV was 
found in bovine cornea (Tseng et al., 1982). Corneas from humans at different ages were 
observed under an electron microscopy; the data indicated that fibers form a bridge between 
the innermost parts of Descemet's membrane and might provide stability to the eye under 
mechanical stress (Binder et al., 1991). 
2.2.5. Corneal endothelium 
The corneal endothelium is formed by polygonal cells. A high proportion of these cells are 
flattened and hexagonal; each individual cell has a width of 18 µm to 20 µm and a thickness 
of 5.0 µm (Whikehart, 2010). The main function of the endothelium layers is to permit 
aqueous humor to enter in a controlled manner in order to regulate the corneal transparency. 
If this equilibrium is broken, the homeostasis could be disrupted. The endothelium has a 
higher permeability than the epithelium because it controls the transport of substances 
supplying the stroma and epithelium with nutrients. This transport is regulated by the gap 
junctions and the tight junctions on the upper side of the endothelium (Mergler and Pleyer, 
2007). The occludin and zona occludens (ZO-1) are located on the apical side of the 
endothelium (Joyce, 2003). The endothelial cell layer contains ca. 3000 cells·mm-2. The 
number of cells decreases with age (Whikehart, 2010) since the endothelial cells are not able 
to regenerate (Joyce, 2003). The alteration of the integrity of the corneal endothelium might 
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cause corneal illnesses, for instance, Fuch’s dystrophy, posterior polymorphous dystrophy or 
congenital hereditary endothelial dystrophy (Joyce, 2003). 
2.3. Cell culture models 
Corneal cell culture models are used for in vitro studies of different aspects of the ocular 
barrier that represents a major impairment for drug delivery and consequently for the 
development of pharmacological strategies in ophthalmology. These models have been 
extensively used to investigate the permeation, metabolism, toxicity and active transport of 
drugs and to predict ocular bioavailability. Cell culture models offer several advantages over 
animal testing for better controlling the experimental conditions and higher experimental 
reproducibility. Furthermore, cultured cells provide a constant and predictable source of 
research material for continuous experimental work. However, cell culture models are limited 
to simulate physiologically relevant characteristics including the precorneal drainage, blinking 
frequency as well as the lacrimal fluid composition that influence drug absorption, 
distribution, metabolism and elimination. Two types of cultures, primary cultures and 
immortalized corneal cell lines, are commonly used for establishing corneal cell models and 
are shortly described below (Kruszewski et al., 1997; Hornof et al., 2005, Reichl, 2008; 
Reichl and Becker, 2008). 
2.3.1. Primary cell cultures 
The cornea was identified as the principal barrier to ophthalmic drugs after topical application 
to the eye. Against this background, corneal epithelial cell cultures have been developed and 
served as a basis for the subsequent development of reconstructions of the complete human 
cornea. These corneal models have been developed as substitutes or supplements to animal 
models for toxicology and drug absorption studies (Castro-Muñozledo, 2008; Reichl et al., 
2011). Different explantation and culture techniques using tissues of human and animal 
origin have been improved with the aim of establishing a well-defined corneal model to be 
used for the above-mentioned purposes (Reichl et al., 2011). However, human tissue is not 
readily available since healthy donor corneas are needed for keratoplasty (Lagali et al., 2007; 
Niederer et al., 2007; Hackett et al., 2011). Consequently, primary animal corneal cells, 
mainly from rabbits (Kawazu et al., 1998) cattle and pigs (Tegtmeyer et al., 2001; Reichl and 
Müller-Goymann, 2001), are frequently used. Rabbit tissue proved to be particularly suitable 
for such studies since primary rabbit cells have a higher proliferative capacity than other 
species. They are readily available and data obtained with these models are highly 
comparable with data from in vivo studies as the majority of in vivo experiments are carried 
out with rabbits (Van Horn et al., 1977; Reichl et al., 2011). The expression of tight junctions 
in in vitro models is measured indirectly based on the transepithelial electrical resistance 
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(TEER) and the apparent permeability coefficient (Papp) of paracellular permeations markers 
(mannitol and sodium fluorescein). Both are parameters to evaluate the tightness of the 
epithelial barrier, which is an aspect that needs to be considered in drug absorption studies. 
In addition, cell culture conditions, such as cell growth media, coating materials, permeable 
supports or cultivation under Air-liquid interface (ALI) conditions, are important factors for the 
formation of tight junctions and the development of a multilayered corneal epithelium (Chang 
et al., 2000). Therefore, primary rabbit corneal cell cultures solely established with epithelial 
cells cultured on permeable supports under liquid-covered conditions do not seem to be 
suitable for drug absorption studies because these models display relatively low TEER 
values of about 150 Ohm·cm² (Kawazu et al., 1998; Kawazu et al., 1999; Sakanaka et al., 
2006) compared to the TEER values reported for excised rabbit cornea (3000 to 8000 
Ohm·cm2) (Klyce and Wong, 1977). Dey et al. also described low TEER values of about 200 
Ohm·cm² for a rabbit cell culture model (Dey et al., 2003). However, it was noted that other 
primary cell cultures based on rabbit corneal epithelial cells with improved culture conditions 
(e.g. media supplements, ALI, seeding density), which have also been established for 
investigating the in vitro absorption of hydrophilic and lipophilic drugs, form a tight epithelial 
barrier of about 2300-5000 Ohm·cm2 (Chang et al., 2000; Scholz et al., 2002; Becker et al., 
2005), which was similar to that of excised cornea. It has been described that primary 
corneal epithelial cell cultures with acceptable TEER values of about 400 Ohm·cm2 (Reichl 
and Becker, 2008) are suitable for investigating the transport of hydrophilic and moderately 
lipophilic drugs but not that of highly lipophilic drugs (Reichl 2008, Hahne and Reichl, 2011). 
Within the scope of permeation studies, primary cell culture models, which also include a 
stromal layer achieved Papp values for highly lipophilic drugs, which were better comparable 
to excised cornea. These experiments underlined the importance to include both corneal cell 
layers, the epithelial and the stromal layer, in order to obtain barrier properties similar those 
of excised animal cornea to evaluate drugs with a wide range of different physicochemical 
properties (Tegtmeyer et al., 2001; Reichl and Müller-Goymann, 2001; Reichl, 2008). 
Nevertheless, due to the low proliferative capacity and decreasing lifespan that primary cells 
display after several weeks in culture, the frequent isolation of cells is necessary. Thus, 
primary cell cultures are probably not the most adequate model to carry out larger scale 
screening test of new drugs and ophthalmic excipients or to evaluate novel ocular drug 
delivery systems (Toropainen et al., 2001; Castro-Muñozledo, 2008). As a consequence, 
immortalized cell lines based on cells of human and animal origin were developed as 
alternatives to overcome the disadvantages of primary cell cultures (Castro-Muñozledo, 
2008).  
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2.3.2. Immortalized corneal cells  
In the last few years, several immortalized corneal epithelial cell lines have been established 
using cells from rabbits (Araki et al., 1993), rats (Araki et al., 1994) and humans (Kahn et al., 
1993; Araki-Sasaki et al., 1995; Offord et al., 1999). The particular advantage of immortalized 
cell lines is that they can be maintained in culture for a long time period without any change 
in their growth and morphological characteristics. Moreover, they can be stored in liquid 
nitrogen and used at any time for research purposes (Griffith et al., 1999; Reichl and Becker, 
2008; Toropainen et al., 2001). However, only few of these cell lines have been used as an 
alternative model within the scope of in vitro drug absorption studies. The rabbit corneal 
epithelial cell line (RCE) is one example of these cell lines. A recombinant SV40-adenovirus 
vector was employed by Araki et al. to immortalize corneal epithelial cells from rabbits and 
rats (Araki et al., 1993; Araki et al., 1994). In culture, the RCE cell line displayed the 
cobblestone shape of corneal epithelial cells (Araki et al., 1993), and has been used as in 
vitro model for drug absorption studies and for investigating the fluid transport through the 
epithelial cell layers (Burgalassi et al., 2004; Yang et al., 2000). However, this cell line did not 
seem to be an appropriate option for drug transport experiments as it was not able to form a 
tight epithelial barrier (TEER values of approximately 150 Ohm·cm²). Another rabbit corneal 
cell line, which is widely used is the Statens Seruminstitut rabbit cornea (SIRC) cell line. It 
was established by M. Volkert of the Seruminstitut, Copenhagen (Niederkorn et al., 1990). In 
culture, these cells exhibit multiple elongated, epithelial-like cell layers but also a fibroblast 
phenotype (Niederkorn et al., 1990; Hutak et al., 1997). The SIRC cell line has been used for 
assessing toxicity and eye irritating effect of chemical substances, pharmaceutical excipients 
or ocular drugs (North-Root et al., 1985; Ohno et al., 1998; Tani et al., 1999; Ayaki and 
Iwasawa, 2010; Ayaki et al., 2011). This cell line has also been used for in vitro drug 
absorption studies. Goskonda et al. reported TEER values of about 2000 Ohm·cm² and 
permeability data similar to that obtained for isolated rabbit cornea (Goskonda et al., 1999). 
In contrast, other groups obtained TEER values of only about 100 - 200 Ohm·cm² and were 
thus not able to achieve a tight barrier. As a consequence of this, high Papp values were 
obtained for hydrophilic and lipophilic permeation markers compared to those obtained with 
isolated rabbit cornea (Tak et al., 2001; Burgalassi et al., 2004; Sakanaka et al., 2006). Thus, 
the SIRC model is not suitable for drug absorption studies. 
The most commonly used human corneal epithelial cell line (HCE-T) was established by 
Araki-Sasakai et al. in 1995. A SV40-simian adenovirus without the origin of SV40 viral 
replication was employed to transfect human corneal epithelial cells obtained from a 49-year-
old woman with maxillary sinus carcinoma (Araki-Sasaki et al., 1995). In culture, HCE-T cells 
possess characteristics similar to those of human corneal epithelial cells. They exhibit the 
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cobblestone-like shape and develop desmosomes and microvilli, which are typical 
morphological features of human corneal epithelial cells (Araki-Sasaki et al., 1995). 
Toropainen et al. was the first investigation group, which used these cells to establish an in 
vitro model of the corneal epithelium for drug absorption studies. HCE-T cells cultivated on 
collagen/laminin coated permeable filters under ALI conditions showed TEER values ranging 
from about 400 - 800 Ohm·cm². The cultivated in vitro corneal epithelium formed about 
seven cell layers, which were comparable to the stratified human corneal epithelium. 
Permeability assays conducted with hydrophilic and lipophilic permeation markers 
demonstrated the capacity of the in vitro HCE-T corneal model to distinguish between 
different physicochemical properties of the used substances (Toropainen et al., 2001). For 
instance, the HCE-T culture model has been used, to understand how drugs permeate 
through the corneal epithelium and to evaluate the corneal absorption and desorption rate 
constant after the topical administration of ocular drugs (Toropainen et al., 2003; Ranta et al., 
2003). Other groups used HCE-T cells in drug absorption studies in order to investigate the 
influence of formulation parameters on the permeability of the in vitro corneal epithelium and, 
furthermore, to perform comparative investigations with other in vitro corneal cell models. 
Within these investigations, the TEER values reported ranged from about 330 - 600 
Ohm·cm² (Becker et al., 2007; Becker et al., 2008). Other investigations group noted TEER 
values, which were at about 400 Ohm·cm² (Nagai et al., 2008), about 200 Ohm·cm² (Kimura 
et al., 2009; Yanai et al., 2009) or approximately 1200 Ohm·cm² (Reichl, 2008).  
Another human corneal cell line is the CEPI-17-CL 4 cell line, which was developed by 
Offord et al. (Offord et al., 1999). In culture, CEPI-17-CL 4 cells have the cobblestone shape 
of human corneal epithelial cells. Several investigation groups have used the CEPI-17-CL 4 
cell line to study the human corneal epithelium in vitro and also for drug absorption studies. 
However, CEPI-17-CL 4 based in vitro corneal models showed low TEER values of about 
100 Ohm·cm² due to, which this cell line is considered to be less suitable for drug absorption 
studies (Crider et al., 2003; Reichl et al., 2004; Reichl et al., 2005; Reichl, 2008).  
In addition to the mentioned cell lines, human corneal epithelial cell models (established 
using immortalized cell lines) are also commercially available. Examples of these models are 
the model created by Skinethic laboratories (sHCE model), the Epiocular® model by MatTek 
Corporation and the Clonetics® model (cHCE) by Lonza (Reichl et al., 2011). They have 
been used for evaluating the irritation potential of ophthalmic excipients, cosmetics and 
chemical substances to the ocular surface and, furthermore, they have been applied in 
validation studies with the aim of replacing the Draize eye test (Cotovio et al., 2007; Doucet 
et al., 2006; Van Goethem et al., 2006; Khoh-Reiter and Jessen, 2009; Cotovio et al., 2010; 
Jones et al., 2001; Barile, 2010).  
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With regard to the tightness of the epithelial barrier of these models to be used for drug 
absorption studies, the sHCE and Epiocular® model showed TEER values of about 100 - 200 
Ohm·cm², which are far below the TEER values obtained in experiments with ex vivo corneal 
epithelia (Becker et al., 2008; Reichl, 2008). Consequently, the permeability of both models 
to the hydrophilic permeation markers mannitol and sodium fluorescein was about 10 to 60 
times higher than that of excised cornea (human, rabbit and bovine cornea) (Becker et al., 
2008; Reichl, 2008). For these reasons, these in vitro corneal models are not suitable for 
drug absorption studies. In contrast, it has been observed that the cHCE model is able to 
form a tight barrier similar to that of the corneal epithelium of excised human cornea (Becker 
et al., 2008). The cHCE model showed TEER values of about 800 Ohm·cm² and the 
permeability to sodium fluorescein comparable to those observed for excised human and 
rabbit cornea (Becker et al., 2008). Other drug absorption studies conducted with 11 drugs 
have indicated that the permeability characteristic of the cHCE model is similar to that of 
excised rabbit cornea (Xiang et al., 2009).  
A short summary of the primary epithelial cells and immortalized cell lines used to establish 
in vitro corneal cell models for drug absorption studies is provided in the Table 2-1. 
 
Table 2-1: Summary of primary epithelial cells and immortalized cell lines for constructing in vitro 
corneal cell models 
Model Origin Characteristics References 
Primary 
rabbit 
corneal 
epithelium 
(1) 
Established 
by Kawazu et 
al.,1998); 
(2) 
Established 
by Chang et 
al., 2000) 
Rabbit origin; low TEER values of ≈150 
Ohm·cm² for the model of Kawazu et al. and 
TEER values > 2000 Ohm·cm² for the model 
of Chang et al.; used for drug permeation 
studies 
Kamazu et al., 1998, 
1999, 2006; Chang 
et al., 2000; Dey et 
al., 2003; Scholz et 
al., 2002; Becker et 
al., 2005; Sakanaka 
et al., 2006 
RCE 
Established 
by Araki et 
al.,1993) 
Immortalized cell line based on albino rabbit 
cornea by viral transduction (SV40); low 
TEER values of ≈ 150 Ohm·cm²; used to 
study drug permeation 
Yang et al., 2000; 
Burgalassi et al., 
2004 
SIRC 
Established 
by M. Volkert 
of 
Seruminstitut 
Copenhagen 
(Niederkorn 
et al., 1990) 
Immortalized cell line based on rabbit cornea; 
low TEER values of ≈100 - 200 Ohm·cm²; 
fibroblast phenotype; used for permeability, 
transporter, esterase activity and toxicity 
studies 
Niederkorn et al., 
1990; Hutak et al., 
1997; Tak et al., 
2001; Dey et al., 
2003; Majumdar et 
al., 2003; Becker et 
al., 2008; Goskonda 
et al., 1999; 2000; 
North-Root et al., 
1985; Ohno et al., 
1998; Tani et al., 
1999; Ayaki and 
Iwasawa, 2010; 
Ayaki et al., 2011 
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HCE-T 
Established 
by Araki-
Sasaki et al., 
1995) 
 
Immortalized human cell line developed by 
viral transduction (SV40); tight multilayered 
epithelium with TEER values of 400 - 800 
Ohm·cm² for the model of Toropainen et al.; 
TEER values of 330 - 600 Ohm·cm² for the 
model of Becker et al. TEER values of 1200 
Ohm·cm² for the model of Reichl. and 200 
Ohm·cm² for the model of Kimura et al.; used 
to study drug transport, transporter 
expression  
Toropainen et al., 
2001, 2003; Ranta et 
al.,2003; Becker et 
al., 2007, 2008; 
Reichl, 2008; Nagai 
et al., 2008; Kimura 
et al., 2009; Yanai et 
al., 2009 
CEPI-17-
CL 4 
Established 
by Offord et 
al., 1999) 
Immortalized human cell line developed by 
viral transduction (SV40); low TEER values 
of 100 Ohm·cm² for the model of Reichl.; 
used for drug transport and toxicity 
experiments 
Offord et al., 1999; 
Crider et al., 2003; 
Reichl et al., 2004; 
Reichl et al., 2005; 
Reichl, 2008; Reichl 
and Becker, 2008 
sHCE 
Established 
at SkinEthic 
Laboratories  
Immortalized human corneal epithelial cells; 
low TEER values of ≈ 100 - 200 Ohm·cm²; 
used for drug transport and toxicity studies 
and in vitro experiments on ocular irritancy  
Nguyen et al., 2003; 
Cotovio et al., 2007, 
2010; Doucet et al., 
2006; Van Goethem 
et al., 2006; Becker 
et al., 2008; Reichl, 
2008 
Epiocular® 
Established 
at MatTek 
Corporation 
Non-corneal origin (human derived epidermal 
ketinocytes); multilayered epithelium; low 
TEER values of ≈ 100 Ohm·cm²; used for 
drug transport and toxicity experiments 
Jones et al., 2001; 
Reichl, 2008; Barile, 
2010 
cHCE 
Established 
at Cambrex 
Bio Science 
in 2006 
Immortalized human cell line developed by 
viral transduction (HPV-16 ED/E7); tight 
multilayered epithelium with TEER values of 
≈ 800 Ohm·cm²; used for drug transport 
studies 
Becker et al., 2008 
RCE: Rabbit corneal epithelial cell line; SIRC: Statens Seruminstitut rabbit corneal epithelial cell line; 
HCE: Human corneal epithelial cell line, SV-40: Simian adenovirus; HPV: Human papilloma virus 
2.3.3. Organotypic cell culture models 
When designing organotypic cell culture models, the main objective is to reconstruct corneal 
tissue, which possesses the same characteristics and mimics the functions of its in vivo 
equivalent. Such a model can be used to investigate, for example, the toxicity of 
pharmaceutical excipients and active drugs, the drug transport, the cell proliferation and the 
influence of formulation parameters. Furthermore, it can also be employed to develop and 
improve drug delivery systems. These models are prepared using primary or immortalized 
corneal cells (Reichl and Becker, 2008; Hornof et al., 2005; Barar et al., 2009). The 
reconstruction of the corneal barrier with primary corneal cells is a demanding task since the 
cells must be isolated from the animal or human tissue in order to be used to reconstruct 
layer by layer the corneal barrier (Minami et al., 1993; Germain et al., 1999). For this 
purpose, the culture conditions, such as the co-cultivation of the epithelial cells with only 
keratocytes or with both keratocytes and endothelial cells as well as the ALI conditions, are 
important for obtaining a well-defined multilayered corneal epithelium, a high expression of 
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tight junctions and TEER values similar to those achieved with in vivo tissue (Friend et al., 
1982; Chan and Hasche, 1983; Orwin and Hubel, 2000; Chang et al., 2000; Toropainen et 
al., 2001). For in vitro drug absorption studies, in vitro corneal models established only with 
epithelial cells, which achieve sufficiently high TEER values are suitable to evaluate the 
permeation of hydrophilic and moderately lipophilic drugs but not highly lipophilic drugs 
(Becker et al., 2008; Reichl, 2008). In contrast, in vitro corneal models co-cultivated with 
stromal keratocytes in stromal biomatrix can be used to investigate the transport of highly 
lipophilic drugs as their permeability characteristics better match those of in vivo tissue 
(Reichl and Müller-Goymann, 2001; Reichl and Müller-Goymann, 2003; Tegtmeyer et al., 
2004; Reichl, 2008).  
Nevertheless, there are some problems related to the use of primary cells to construct in vitro 
corneal models. For example, these problems include that the cells must frequently be 
isolated, no predefined standard protocols to establish the cornea models are available, 
which leads to a poor reproducibility of results, the transfer of these protocols between 
laboratories is difficult and the transferability of results obtained from animal-based models to 
humans is questionable (Hahne and Reichl, 2011). Immortalized human corneal cells have 
been used to overcome the above-mentioned issues (Griffith et al., 1999). Some advantages 
of immortalized cell lines have already been mentioned in section 2.3.2. Furthermore, the 
protocols to establish in vitro corneal models using the above cells (i.e. HCE-T cell line) are 
easier to standardize than those of primary cell cultures, which has been confirmed by the 
reduction in the intralaboratory variability of permeation results (Hahne and Reichl, 2011). 
2.3.4. Three-dimensional corneal models 
The corneal models are classified according to their culture complexity: a monolayer 
epithelium, a stratified epithelium, the co-culturing of epithelial and stromal layers and cornea 
equivalent systems. Within this classification, the co-culture and cornea equivalent models 
are considered to be three-dimensional (3D) corneal models (Huhtala et al., 2008).  
In vitro 3D corneal models are frequently reconstructed layer by layer: First, endothelial cells, 
keratocytes and epithelial cells are isolated from the corneal tissue. Second, cells are 
embedded in a matrix comparable to the in vivo conditions. Third, the corneal cells are co-
cultured to reconstruct the whole corneal barrier and are exposed to the ALI conditions to 
promote the formation of a multilayered corneal epithelium (Minami et al., 1993). Over time, 
the improvement of the cell culture conditions has contributed to the understanding of the 
role of corneal structures (e.g. the corneal endothelium), which promote the differentiation of 
the epithelial cells and the formation of the basement membrane. The expression of 
hemidesmosomes, anchoring fibrils and the cell-cell interaction might lead to the 
differentiation of the epithelial cells as well as the synthesis and assembly of basement 
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membrane components (Zieske et al., 1994; Schneider et al., 1999). Human corneal models 
have been reported to be able to produce α and β integrin subunits, which have been closely 
linked to the wound healing process after corneal damages, as well as laminin type VII and 
collagen (Germain et al., 1999; Germain et al., 2000). All these aforementioned (3D) corneal 
models were basically developed, firstly, to improve the cell culture techniques used to 
reconstruct in vitro corneal cell models, which are equivalent to their in vivo counterparts, 
secondly, to evaluate the eye irritation potential of chemicals in order to replace the Draize 
test and, thirdly, to demonstrate that the in vitro reconstruction of the human cornea can 
possess morphological characteristics and basement membrane components similar to its in 
vivo equivalent. However, the suitability of these (3D) corneal models for in vitro drug 
absorption studies has not yet been evaluated. Tegtmeyer et al. developed an in vitro 
corneal model exclusively from bovine primary cells, and this (3D) corneal model was the 
first to be used for drug absorption studies. The morphology of the corneal epithelium of this 
model was similar to that of the epithelium of excised bovine cornea and furthermore 
achieved similar results with regard to the permeability rates for drugs (pilocarpine 
hydrochloride and timolol maleate) in different ophthalmic formulations (Tegtmeyer et al., 
2001; Tegtmeyer et al., 2004). Similar results have been reported for a (3D) corneal model 
based on porcine primary cells (Reichl and Müller-Goymann, 2001; Reichl and Müller-
Goymann, 2003). In addition, Reichl et al. established a (3D) human corneal model, which 
consists of immortalized human endothelial cells (Bednarz et al., 2000), primary cultured 
human keratocytes and the immortalized human epithelial cell line CEPI-17-CL4 (Offord et 
al., 1999), which is also described in section 2.3.2. The morphology of the epithelium of this 
reconstructed (3D) human corneal model is similar to that of an in vivo epithelium (Reichl et 
al., 2004). This reconstructed human corneal model has been used in several drug 
absorption studies carried out with different ophthalmic formulations. With regard to 
pilocarpine hydrochloride, befunolol hydrochloride, and hydrocortisone in aqueous 
formulations, the model´s permeability to these substances was almost similar to that of 
isolated porcine cornea (Reichl et al., 2004). Other drug absorption studies demonstrated 
that the permeability of this model was similar to that observed for excised human cornea 
with regard to six different ophthalmic drugs (Reichl et al., 2005). However, in vitro corneal 
models based on CEPI-17-CL4 cells achieved similar Papp values for mannitol (highly 
hydrophilic permeation marker) and timolol maleate (moderately lipophilic drug) due to, which 
these models exhibited low TEER values (< 100 Ohm·cm²). For this reason, (3D) human 
corneal model reconstructed with CEPI-17-CL4 cells are not suitable to investigate the 
transcorneal permeation of drugs with widely differing physicochemical properties (Reichl, 
2008). In the same study, Reichl demonstrated that the corneal models based on the 
aforementioned HCE-T cell line (Araki-Sasaki et al., 1995) show barrier characteristics 
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similar to those of isolated animal cornea and thus these corneal constructs are able to 
differentiate between hydrophilic and lipophilic substances. In further studies, Reichl and co-
workers established a human Hemicornea (HC) construct (stroma-epithelium) using 
immortalized human keratocytes (Zorn-Kruppa et al., 2005), which were embedded in a 
collagen matrix (stromal equivalent) and covered with the multilayer corneal epithelium 
(HCE-T cells). At first, this HC construct was cultivated in a serum-free growth medium under 
liquid covered conditions and then under ALI conditions. The epithelium of the HC construct 
developed a morphology and tight epithelial cell layers, which were comparable to those of in 
vivo human cornea, as is illustrated in Figure 2-3 (Hahne and Reichl, 2011). With regard to 
sodium fluorescein, FD-4 and rhodamine B, the performed in vitro absorption studies 
indicated that the HC construct possesses permeability properties, which lie between those 
of excised rabbit and porcine cornea. The anatomy of porcine corneal tissue rather 
resembles that of the human cornea than that of rabbit corneal tissue. This led to the 
assumption that the permeability characteristics of the HC construct are similar to those of 
the human cornea. Consequently, the permeability values obtained for the aforementioned 
substances indicate that the actual permeability of the human cornea lies between the 
permeability of rabbit and porcine cornea. In addition, the reproducibility of the Papp values 
obtained with the above substances for the HC construct were significantly higher than those 
obtained for isolated rabbit and porcine cornea (Hahne and Reichl, 2011). However, 
additional investigations need to be carried out before the HC construct can be considered 
as an alternative to animal experimentation in preclinical studies. These investigations 
include the prevalidation of the model in order to demonstrate the interlaboratory 
reproducibility of data, permeability assays with a high number of substances covering a 
broad range of different molecular attributes for the purpose of evaluating the capacity of the 
HC construct to differentiate between hydrophilic and moderately and highly lipophilic drugs, 
the comparison of the permeability of the HC construct to that of human cornea, as well as 
the evaluation of the influence of formulation parameters (buffer solutions at different pH 
levels, the osmolality and ophthalmic adjuvants, such as EDTA, calcium and preservatives) 
on the permeability of the HC construct. Against this background, the investigations 
conducted within the scope of this thesis were based on the HC construct established by 
Reichl and co-workers. 
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Figure 2-3: A. Cross section and toluidine blue staining of the HC construct. Monolayer of HCE-T 
cells on the stromal matrix containing HCK cells after one week of cultivation under 
liquid-covered conditions. B. Formation of a stratified corneal epithelium after 3 further 
days of cultivation under ALI conditions similar to the human cornea. Scale bar = 100 
µm (Hahne et al., 2012) 
2.4. Ocular drug absorption  
A high number of ocular diseases, such as infections and disorders (e.g. glaucoma or dry 
eye syndrome), are mostly treated by means of topical administration of ophthalmic 
solutions, which are the predominant pharmaceutical form available on the market (Bourlais 
et al., 1998, Urtti, 2006). Following the instillation of the medication, ocular drug absorption 
can occur through the corneal or non-corneal route. 
2.4.1. Corneal absorption route 
The ocular bioavailability of topically applied drugs is very poor because the cornea forms a 
tight barrier and the drug is rapidly removed from the corneal surface (lacrimal drainage) 
(Järvinen and Järvinen, 1996; Urtti, 2006). The permeation of the drug through the corneal 
barrier takes place by means of passive diffusion and/or an active transport. The latter is 
dependent on the expression level of the transport proteins (Mannermaa et al., 2006). A high 
proportion of drugs undergo passive diffusion through the corneal epithelium, which involves 
the transport via the paracellular and transcellular pathway. The epithelium is the main 
corneal barrier for hydrophilic drugs (Lee, 1990). In contrast, lipophilic drugs take the 
transcellular pathway to penetrate the corneal epithelium. However, their transport is affected 
by the hydrophilic characteristics of the corneal stroma, which constitutes 90% of the cornea 
(Schoenwald and Huang, 1983; Huang et al., 1983). The corneal endothelium is a monolayer 
of cells with a thickness of 5 µm (Whikehart, 2010) and is considered to be a permeable layer 
that contributes only minor to the corneal barrier. Thus, it can be assumed that the corneal 
endothelium has larger intercellular gaps than the corneal epithelium (Huang et al., 1983). 
Beside the morphological characteristics of the cornea, the level of permeation of drugs is 
also influenced by their physicochemical properties, such as the solubility, molecular weight, 
charge and the partition coefficient, among others (Grass and Robinson, 1988; Liaw and 
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Robinson, 1992; Huang et al., 1989; Liaw et al., 1992; Rojanasakul et al., 1992; Sieg and 
Robinson, 1977; Brechue and Maren, 1993). Regardless of the tightness of the corneal 
epithelial cell layers, the transcorneal drug permeation is the predominant route, which drugs 
take in order to reach the aqueous humor (Urtti, 2006). 
2.4.2. Non-corneal absorption route 
The non-corneal absorption route includes the ocular tissue of conjunctiva and sclera, which 
are known as the conjunctival-scleral route. In contrast to the corneal route, large and 
hydrophilic drugs, e.g. peptide drugs, are mainly absorbed via the conjunctival-scleral route 
(Hornof et al., 2005; Urtti, 2006). The conjunctiva facilitates the transport of topically applied 
drugs into the blood stream but not into the intraocular tissue as it is vascularized and has a 
large surface. The conjunctiva is a fine mucous membrane, which covers approximately the 
area ranging from the anterior part of the sclera to the inner part of the eyelids, not including 
the cornea. The conjunctiva is formed by up to 15 layers of epithelial cells, which make it a 
multilayered epithelium (Andrés-Guerrero and Herrero-Vanrell, 2008; Bourlais et al., 1998). 
Nevertheless, its permeability with regard to non-lipophilic substances, even those with high 
molecular weight, is significantly higher than that of the cornea. As a consequence, the 
conjunctiva is considered a leaky tissue (Huang et al., 1989; Hämäläinen et al., 1997). The 
intercellular gap junctions, the pore density and the turnover of lacrimal fluid of the 
conjunctiva are larger than those of the cornea due to, which the drug is rapidly eliminated 
(Hämäläinen et al., 1997). The sclera is a robust fibrous connective tissue formed by 
collagen type I, possessing protective properties (Watson and Young, 2004; Rada et al., 
2006). In terms of permeability, the sclera has a higher permeability to drugs than the 
conjunctiva and cornea since the molecular size of drugs has less influence on the 
absorption through the sclera than through the cornea (Hämäläinen et al., 1997). This 
absorption route is still being investigated in order to improve the ophthalmic drug delivery to 
intraocular structures (the aqueous humor and retina). 
Despite the differences in the permeability of the cornea and conjunctiva-sclera, the majority 
of drugs that are topically administered into the eye are transported via the corneal route 
(Urtti, 2006). 
2.4.3. Formulation parameters 
2.4.3.1 pH 
The eye can tolerate ophthalmic preparations at pH values ranging from 3.5 to 9.0 (Gibson, 
2009). However, in order to ensure maximum comfort, ophthalmic preparations should have 
a pH value of about 7.4, which corresponds to the pH of lacrimal fluid (Gibson, 2009). 
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In ophthalmic preparations, the buffering capacity and the pH of ophthalmic vehicles should 
be able to maintain the stability of the active compound. For this reason, buffer solutions are 
used to avoid changes in the pH values of ophthalmic preparations (Mitra and Mikkelson, 
1987; USP 29, 2006). 
The stability of the active compound in ophthalmic formulations needs to be conserved to 
ensure that its potential effect is maintained. As a consequence, stability studies aim to 
demonstrate the effectiveness of the active compound (Cha et al., 2001). The stability and 
delivery form of active compounds are two of the most relevant parameters in the 
development of formulations (Attwood and Poust, 2009). For instance, buffering agents with 
a buffering capacity not exceeding 0.05% and at pH of between 5 and 6 were employed by 
Akram et al. to ensure the stability of 1.0% prednisolone acetate formulations (Akram et al., 
2010). Apparently, chemical reactions can lead to an increase in the formation of degradation 
products and thereby to a further decrease in the amount of the active substance in the 
pharmaceutical form. As a consequence, there is a loss in the effectiveness of the active 
compound and an increase in adverse reactions. Therefore, a degradation of active 
compounds should be avoided. Investigations have revealed that degradation products often 
produce more unwanted side effects than the active compound (Attwood and Poust, 2009). 
Substantial modifications in the physical appearance of the pharmaceutical preparation, such 
as a mottling of tablets, disruption of emulsions or caking of the suspension are also taken 
into account (Attwood and Poust, 2009). A non-complex drug molecule is indefinitely stable 
in aqueous solution. Accordingly, the stability of pharmaceutical preparations must be 
guaranteed in order to ensure that more than 90% of the labeled concentration is maintained 
under storage conditions. It has been shown that ophthalmic drugs in aqueous solutions are 
in some cases more stable in acid environments than in neutral or alkaline environments; 
particularly when the molecular form is a weak base. In order to avoid the rapid formation of 
undesirable by-products, the protonation of the active compounds is achieved by maintaining 
the molecular form at an acid pH. Moreover, the corneal surface, the pH and the buffer 
capacity of the tear fluid are factors that must be considered during the development or 
improvement of ophthalmic preparations (Fiscella, 2008). 
Most drugs are either weak acids or weak bases and they exist in ionized and unionized 
forms in aqueous solutions. The pKa indicates the ionizability of a compound. A molecule 
might lose or gain a proton when it is placed into an aqueous solution. Whether a molecule is 
protonated or deprotonated depends on its pKa and on the pH of the buffer solution. 
Therefore, the pKa is defined as the negative logarithm of the acid-ionization constant. The 
term pKa can be employed for both acids and bases (Kerns and Di, 2008).  
The lipophilicity of molecular markers and drugs is determined either by measuring the 
octanol-water partition coefficient, which is usually expressed as log P (see Equation 2-1), or 
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by measuring the so-called log D, which is the distribution coefficient of all forms of a 
molecule (non-ionized and ionized solute between octanol and water). The log D of ionizable 
molecules of molecular markers and drugs is pH-dependent, and is calculated as is shown in 
Equation 2-2. 
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A sigmoidal relationship was observed between the lipophilicity (i.e. log P) and the Papp 
values of some β-blockers (see Figure 2-4). Thus, the drug lipophilicity influences the 
passive drug diffusion through the corneal barrier (Toropainen et al., 2003). In addition, 
buffer solutions and pH may affect the lipophilicity of a drug and consequently its permeation 
through the corneal barrier (Schoenwald and Huang, 1983; Wang et al., 1991; Suhonen et 
al., 1991; Suhonen et al., 1998).  
 
Figure 2-4: Influence of drug lipophilicity expressed as log P on the permeability of the HCE-T 
model (squares) expressed as permeability coefficient and on isolated rabbit cornea 
(diamonds) with regard to eight β-blockers (Toropainen et al., 2003)  
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2.4.3.2 Osmolality 
The tonicity is important with regard to pharmaceutical preparations, which are instilled into 
the eye, since it may negatively influence the bioavailability of drugs due to excessive 
lacrimation (Conrad et al., 1978). The lacrimal fluid has a tonicity value of approximately                           
279 mOsmol·kg-1, which corresponds to that of 0.9% NaCl solution. In theory, ophthalmic 
solutions should possess this tonicity level. The eye can tolerate a wide range of tonicity 
values (from 0.5% to 1.5% NaCl equivalents) without producing any irritancy effect. 
Notwithstanding, some ophthalmic solutions are outside of this range (Gibson, 2009).  
2.4.3.3 EDTA and calcium 
The tight junctions (TJs) of the corneal epithelium (see Figure 2-2) limit the penetration of 
substances and solutes through the corneal epithelium (Ban et al., 2003a). Together with 
transmembrane proteins (claudin and occludin), membrane-associated proteins (ZO-1, ZO-2 
and ZO-3), adherence junctions and desmosomes, the TJs form the so-called “junctional 
complex” (Furuse et al., 1994; Ban et al., 2003a; Cereijido et al., 2004). TJs are laterally 
connected to each other, building strands in order to seal the intercellular spaces (Furuse et 
al., 2001) and are located on the surface of the human corneal epithelium. ZO-1 was found in 
the most apical cells of the epithelium and between the basal and wing cells. Occludin was 
only found in the lateral connections of superficial cells (cell-cell borders) but not in the apical 
membrane (Anderson et al., 1993; Ban et al., 2003a). Other kinds of associated proteins, 
such as actin, myosin and α-catenin, were found under the apical junctional complex. The 
modulation of the myosin contraction and movement is, among others, regulated by the 
entering of extracellular calcium into cells. This process occurs in the presence of ATP 
(adenosine triphosphate) and phosphorylation of the calcium/calmodulin-dependent protein 
kinases, which lead to the opening of TJs. As a consequence, the paracellular permeability is 
promoted (Salama et al., 2006). Actin cytoskeleton plays an important role in the regulation 
of calcium storage, release and store-coupled calcium entry (Lange and Gartzke, 2006). 
 
Excipients such as ethylenediaminetetraacetic acid (EDTA) are often used in ocular drug 
formulations in order to improve the antimicrobial effect of preservatives. EDTA is frequently 
combined with benzalkonium chloride (preservative agent) with the aim to increase the 
antibacterial activity against strains of Pseudomonas (Furrer et al., 2002; Heydari et al., 
2013). Moreover, EDTA is a chelator of heavy metals and able to lower the concentration of 
free calcium ions in aqueous solutions (Morrison and Khutoryanskiy, 2014). Therefore, in 
vivo permeation studies conducted in rabbits showed that EDTA increased the corneal 
permeability to hydrophilic and lipophilic substances by influencing the TJ function (Grass et 
al., 1985). Other in vitro permeation studies carried out with isolated rabbit cornea have 
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suggested that EDTA causes a disruption of the TJs, which is reflected in the depletion of 
calcium from the ocular surface resulting in an increase in the corneal permeability to 
substances (Rojanasakul and Robinson, 1991). Moreover, similar results were obtained with 
other in vitro cell culture models using oxyntic cells of gastric glands, pancreatic acinar cells 
or Caco-2 cells (Contreras et al., 1992; Ma et al., 2000). This evidence supports the 
assumption that EDTA and calcium may also affect the in vitro corneal permeability of the 
HC construct.  
2.4.4. Preservatives 
In the 1960s, there were incidents of eye ointments contaminated with Pseudomonas 
aeruginosa, as a result of, which preservatives have been used in ophthalmic medication 
thenceforth (Furrer et al., 2002). According to USP 29, multi dose packaging of ophthalmic 
preparations must contain a suitable substance or a mixture of preservatives, which prevents 
potential contamination and ensures its sterile condition after opening (USP 29, 2006). Thus, 
the main purpose of preservatives in ophthalmic preparations, artificial tears or contact lens 
solutions is to avoid the growth of microorganisms (Furrer et al., 2002). During the 
development of new ophthalmic preparations or their improvement, it is of great importance 
to investigate the influence of preservatives on the transport of active compounds through 
the cornea as well as their ocular toxicity.  
Different studies have demonstrated that the use of preservatives might alter the corneal 
permeability to drugs since a disruption of the corneal barrier was noted (Pfister and 
Burstein, 1976; Camber and Edman, 1987). Moreover, different kinds of preservatives are 
not only used in ophthalmic preparations but also nasal drops and some inhalers. It is still 
questionable whether the use of preservatives has adverse effects on the corneal and nasal 
epithelium is still questionable (Baudouin et al., 2010; Marple et al., 2004; Mallants et al., 
2007). Preservatives used at high concentrations can perhaps produce eye irritation or 
damage the ocular surface (Baudouin, 2008; Ayaki et al., 2010). The following table shows 
the preservatives and the respective concentrations, which have been used in 
pharmaceutical preparations (Furrer et al., 2002). 
Table 2-2:  Overview of ophthalmic preservatives (adapted from Furrer et al., 2002) 
Classification Preservatives Concentration 
 [%(m/v)] 
Optimal pH 
Quaternary 
amoniums 
Benzalkonium chloride 
(BAC) 
0.004 - 0.02 --- 
Cetrimide (Ce) 0.005 7 - 9 
Cetylpyridinium chloride 0.025 --- 
Benzododecinium bromide 0.012 --- 
Benzethonium chloride 0.01 - 0.02 --- 
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Classification Preservatives Concentration 
 [%(m/v)] 
Optimal pH 
Polyquaternium-1 
(Polyquad® – PQ-1) 
0.001* --- 
Mercuriales 
Phenylmercuric 
nitrate/acetate/borate 
0.002 - 0.004 4 - 10 
Thiomersal (Thio) 0.001 - 0.02 7 - 8 
Alcoholes 
Chlorobutanol 0.5  5.5 
Benzyl alcohol 0.5  5 
Phenoxyethanol 1.0  6 
Phenylethyl alcohol 0.5  5 
Carboxylic acids Sorbic acid 0.2 4.5 
Phenoles 
Methylparaben (MP)-
propylparaben 
0.1 4 - 9 
Amidines Chlorhexidine digluconate 0.005 - 0.01 5 - 8 
Miscellaneous EDTA 0.01 - 0.1 4 - 10 
Stabilized oxychloro 
complex  
Purite® (95.5% NaClO2 – 
0.05% NaClO3) 
0.005 – 0.0075** --- 
“Self-preserved” sofZia® (see section 3.1.5)*** 7.9 
*(Paimela et al., 2012); **(Rote-Liste, 2013; Kaur et al., 2009); ***(Chowhan et al., 2010) 
 
To evaluate the effect of excipients commonly used in ophthalmic formulations on the in vitro 
corneal model HC, firstly the excipients of 28 frequently prescribed ophthalmic drugs listed in 
“Rote-Liste” (Drug information for Germany) were reviewed. As a result, it was noted that two 
ophthalmic formulations contain citrate, three borate, ten phosphate and three contain citrate 
and phosphate buffers, as well as ten are unbuffered ophthalmic preparations. With regard to 
the preservative used, it was found that ten of them contain BAC, three BAC and EDTA, four 
Ce and EDTA, one Thio, four Purite, two contain Polyquad® and four are preservative-free 
ophthalmic preparations. Currently, in Germany, there are apparently no pharmaceutical 
preparations available, which contain the preservative system sofZia®. 
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3. Materials and Methods 
3.1. Materials 
3.1.1. Immortalized human cell lines 
The Table 3-1 presents the cell lines used in this study. 
Table 3-1: Cell lines used to construct the human Hemicornea model 
Cell line Description Supplier 
HCE-T 
(Araki-Sasaki et al., 1995) 
Transfected by 
recombinant SV 40-
adenovirus vector, human 
corneal epithelial cells 
TUBS (Riken Bioresource Center, Koyadai, 
Tsukuba, Ibaraki,Japan, Catalog number: 
RCB 1384) 
HCK 
(Zorn-Kruppa et al., 2005) 
Transfected by 
recombinant SV 40-
adenovirus vector, human 
corneal keratocytes 
TUBS (Dr. M. Zorn-Kruppa, Academy for 
Animal Protection - Deutscher 
Tierschutzbund e.V. 
 
3.1.2. Permeation markers and substances 
3.1.2.1 Permeation markers for the prevalidation of the HC construct 
The Table 3-2 shows physicochemical properties and concentrations of permeation markers 
used in this study. 
Table 3-2: Permeation markers used for permeability studies with the HC construct in KRB at pH 
7.4 
Substance 
Chemical 
formula 
Molecular 
weight 
[g·mol-1] 
*Log P Concentration Supplier 
Sodium 
fluorescein (Na-
FLU) 
C20H10Na2O5 376.27 -1.52 10 µg·mL-1 
Sigma-Aldrich, 
Steinheim, Germany 
Fluorescein 
isothiocyanate-
dextran (FD-4) 
C21H11NO5S-
H(C6H10O5)xOH 
4400 
-2.0 
2500 µg·mL-1 
Rhodamine B C28H31ClN2O3 479.02 1.78 50 µg·mL-1 
*Obtained from http://www.chemicalize.org (accessed at 12.07.2016), except for Na-FLU and FD-4 
(Sakai et al., 1997) 
 
3.1.2.2 Ophthalmic drugs for the prevalidation of the HC construct 
Some molecular properties of ophthalmic active compounds are depicted in Table 3-3. The 
ophthalmic active compounds were used for the prevalidation of the HC construct as well as 
for other drug permeability studies. 
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Table 3-3: Relevant ophthalmic drugs used to prevalidate the HC construct in KRB at pH 7.4 
Substance 
Chemical 
formula 
Molecular 
weight 
[g·mol-1] 
*Log P 
Concentration
-Activity 
Supplier 
3H-aciclovir C8H11N5O3 225.20 -1.03 
1.0 µCi·mL-1 
American 
Radiolabeled 
Chemicals, St. Louis, 
USA 
3H-bimatoprost C25H37NO4 415.57 2.63 
3H-
dexamethasone 
C22H29FO5 392.46 1.68  
Timolol maleate C13H24N4O3S 316.42 1.34 75.0 µg·mL-1 
Biotrend, Cologne, 
Germany 
*Obtained from http://www.chemicalize.org (data accessed on 12.07.2016) 
 
3.1.2.3 Other relevant substances 
The substances listed in Table 3-4 were used to evaluate the permeability properties of the 
HC construct. 
Table 3-4: Summary of substances dissolved in KRB at pH 7.4 for in vitro ocular drug absorption 
Substance 
Chemical 
formula 
Molecular 
weight 
[g·mol-1] 
*Log P 
Concentration
-Activity 
Supplier 
3H-caffeine C8H10N4O2 194.19 -0.55 1.0 µCi·mL-1 
American 
Radiolabeled 
Chemicals, St. Louis, 
USA 
3H-propranolol 
hydrochloride 
C16H21NO2·HCl 295.80 2.58 
0.5 µCi·mL-1;      
10 µg·mL-1 
GE Healthcare, 
Buckinghamshire, 
UK 
Benzalkonium 
chloride  
C25H46ClN 396.092 1.9 
1000 µg·mL-1 
Sigma-Aldrich, 
Steinheim, Germany 
Methylparaben C8H8O3 152.15 1.67 
Thiomersal  C9H10HgO2S 382.83 2.35 200 µg·mL-1 
Rhodamine 123 C21H17ClN2O3 380.82 4.01 1.9 µg·mL-1 
14C-mannitol C6H14O6 182.17 -3.73 
1.0 µCi·mL-1 
3H-estriol C18H24O3 288.38 2.67 
Hartman Analytic, 
Braunschweig, 
Germany 
3H-methotrexate 
disodium  
C20H22N8Na2O5 498.40 -0.24 
3H-metoprolol C15H25NO3 270.00 1.76 
14C-nicotine C10H14N2 162.24 1.16 
14C-urea CH4N2O 60.06 -1.36 
*Obtained from http://www.chemicalize.org (data accessed on 12.07.2016), except for benzalkonium 
chloride (Shokri et al., 2001) 
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3.1.3. Cell culture medium and equipment 
The cell culture medium used for cultivating the HCK and HCE-T cells and the HC construct 
was keratinocyte growth medium (KGM): the keratinocyte basal medium (KBM™) (Lonza, 
St.Louis, USA) supplemented with SingleQuots™ (Lonza, St.Louis, USA) and 1 mL of 250 
mM CaCl2 96% extra pure powder anhydrous (Fisher Scientific, Geel, Belgium). The 
prepared KGM was stored at +4°C, wrapped in aluminum foil to protect it from light. The 
materials, further substances and pieces of equipment, which were used are mentioned in 
the following sections. 
3.1.4. Preparation of solutions for cell cultures 
Soybean trypsin inhibitor solution: About 100 mg of soybean trypsin inhibitor (Invitrogen 
Corporation, Scotland, UK) was dissolved in 100 mL PBS. The solution was sterile filtered 
and stored at -20°C. 
KGM-freezing solution: 5 mL of KGM was placed into 15 mL centrifuge tube and mixed with 
2 mL of sterilized dimethyl sulfoxide (DMSO) (Sigma-Aldrich, Steinheim, Germany) and 3 mL 
of fetal bovine serum (FBS) (Biochrom AG, Berlin, Germany). This mixture was stored until 
use at -18°C until used for the experiments.  
Collagen solution from Sigma-Aldrich (2.40 mg·mL-1): Type I rat tail collagen (Sigma-Aldrich, 
Steinheim, Germany) was weighed and placed into a 50 mL centrifuge tube. The collagen 
was mixed with the appropriate amount of sterile-filtered 0.05% acetic acid (Sigma-Aldrich, 
Steinheim) until reaching a concentration of 2.40 mg·mL-1. It was dissolved through slight 
rotational movement overnight at room temperature and, subsequently, it was stored at 4°C.  
Solution of 10x MEM, L-glutamine (12.9 mM) and NaHCO3 (16.1 mg·mL-1): 22 mL of 10x 
MEM with Earle’s salts (Biochrom AG, Berlin, Germany), 2 mL L-glutamine solution 200 mM 
(Sigma-Aldrich, Steinheim, Germany ) and 7 mL of 71.2 mg·mL-1 NaHCO3 (Merck, 
Darmstadt, Germany) were transferred into a 50 mL centrifuge tube. The solution was 
carefully mixed, sterile filtered and aliquoted into 2 mL Eppendorf tubes. The solution was 
stored at -18°C. 
3.1.5. Preparation of buffer solutions  
Krebs-Ringer bicarbonate-buffer (KRB) was prepared with 1.10 mM MgCl2·6H2O (Merck, 
Darmstadt, Germany), 1.25 mM CaCl2·6H2O (Sigma-Aldrich, Taufkirchen, Germany), 114.00 
mM NaCl (Merck, Darmstadt, Germany), 5.00 mM KCl (Merck, Darmstadt, Germany), 1.65 
mM Na2HPO4·2H2O, 0.30 mM NaH2PO4·2H2O (Merck, Darmstadt, Germany), 20.00 mM 
NaHCO3, 25.00 mM (D)-glucose anhydrous (Merck, Darmstadt, Germany) and 10.00 mM 
HEPES (Biochrom AG, Berlin, Germany). The solution was adjusted to a final pH of 7.4 
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(unless otherwise mentioned in the text) with H3PO4 (Merck, Darmstadt, Germany) or NaOH 
(Merck, Darmstadt, Germany). 
The citrate buffer at pH 4.5, the acetate buffer at pH 5.5 and the borate buffer at pH 8.0 were 
prepared at 10 mM following the specification according to USP 29. The pH of the buffer 
solutions was adjusted with NaOH. Citric acid monohydrate (C6H8O7) and boric acid (H3BO3) 
were obtained from Sigma-Aldrich (Steinheim, Germany). Sodium acetate (C2H3NaO2) was 
purchased from Merck (Darmstadt, Germany). 
Hanks balance salt solution (HBSS) at pH 6.5 contained 0.812 mM MgSO4 (Sigma-Aldrich, 
Steinheim, Germany), 0.952 mM CaCl2·6H2O, 126.62 mM NaCl, 5.36 mM KCl, 0.385 mM 
Na2HPO4·2H2O, 0.441 mM K2HPO4·3H2O (Merck, Darmstadt, Germany), 25 mM (D)-glucose 
anhydrous and 10 mM MES (Carl Roth, Karlsruhe, Germany). 
HBSS at pH 7.4 was prepared with 0.812 mM MgSO4, 0.952 mM CaCl2·6H2O, 126.62 mM 
NaCl, 5.36 mM KCl, 0.385 mM Na2HPO4·2H2O, 0.441 mM K2HPO4·3H2O, 25 mM (D)-
glucose anhydrous and 10 mM HEPES.  
sofZia® at pH 7.9 contained 113.21 mM H3BO3, 18.82 mM NaCl, 4.02 mM KCl, 0.06 mM 
ZnCl2, 49.53 mM 2-Amino-1-methyl-1-propanol, which were acquired from Sigma-Aldrich 
(Steinheim, Germany) and 1.13 mM MgCl2·6H2O, 1.28 mM CaCl2·6H2O, 10 mM PEG-400, 
76.85 mM sorbitol, which were purchased from Merck (Darmstadt, Germany). The original 
composition from Chowhan et al., 2010 was adapted for the current investigation.  
3.2. Methods 
3.2.1. Cultivation of corneal cells: HCE-T and HCK cell lines 
3.2.1.1 Cell culture method provided by TUBS for the HCE-T cell line 
All reagents and cell culture media were prewarmed in a water-bath at 37 °C. The HCE-T 
cells were initially cultivated with KGM at 37°C, 5% CO2 and at a relative humidity of 100%. 
They were transferred in 25 cm² cell culture flasks (TPP, Trasadingen, Switzerland) and 
cultivated until reaching confluence. The cell culture medium was changed three times a 
week. Before starting the subcultivation of cells, an inverted phase contrast microscope was 
used to monitor the cell confluence and to confirm the absence of microbial contamination. 
Afterwards, the cell culture medium was removed from the cell culture flask and the cell 
monolayers were immediately rinsed carefully twice with 7 mL calcium and magnesium free 
PBS (Biochrom AG, Berlin, Germany). After rinsing, 1.5 mL of EDTA 2.0% in calcium and 
magnesium free PBS (MP Biomedicals, Illkirch, France) was added to the cells and equally 
distributed. The cell culture flask was incubated at 37 °C for 2 min. The EDTA solution was 
removed and the cells were immediately incubated with 2.0 mL of UV-inactivated trypsin-
EDTA (0.05% - 0.022%) (PAA Laboratories, Cölbe, Germany) for 8 min at 37°C. The 
Materials and Methods 
27 
enzymatic reaction was stopped by adding 2.0 mL of soybean trypsin inhibitor. The cell 
suspension was pipetted up and down, quickly transferred into a 15 mL centrifuge tube and 
centrifuged for 2 min at 3,694 rpm. Thereafter, the supernatant was removed and cells were 
resuspended in 3.0 mL of KGM by pipetting up and down. 100 µL of the cell suspension was 
mixed with 900 µL of 0.5% trypan blue in physiological saline (Biochrom AG, Berlin, 
Germany) and was counted as well as assessed with regard to cell vitality using a Fuchs-
Rosenthal cell chamber (Brand, Wertheim, Germany). 150,000 HCE-T cells were seeded in 
a 25 cm² cell culture flask containing 7.0 mL KGM. 
According to the methods provided by TUBS, a Z2 Coulter Counter (Beckman Coulter, 
Krefeld, Germany) should be used within the scope of the cell harvesting. As this device was 
not available at ACB, a Fuchs-Rosenthal cell chamber was used instead. 
3.2.1.2 Cell culture method provided by TUBS for the HCK cell line 
All reagents and cell culture media were prewarmed in a water-bath at 37 °C. The HCK cells 
were initially cultivated with KGM at 37 °C, 5% CO2 and at a relative humidity of 100%. The 
cells were placed in 25 cm² cell culture flasks and cultivated until reaching confluence. The 
cell culture medium was changed three times a week. Before starting the trypsinization of 
cells, an inverted phase contrast microscope was used to monitor the cell confluence and to 
confirm the absence of microbial contamination. Afterwards, the cell culture medium was 
removed from the cell culture flask and the cell monolayers were immediately carefully rinsed 
twice with 7 mL PBS solution. After rinsing, 2.0 mL of UV-inactivated trypsin-EDTA was 
added to the cells and equally distributed. The cell culture flask was placed into the incubator 
for 4 min. The enzymatic reaction was stopped by adding 2.0 mL of soybean trypsin inhibitor. 
The cell suspension was pipetted up and down, quickly transferred in 15 mL centrifuge tube 
and centrifuged for 2 min at 3,694 rpm. Thereafter, the supernatant was removed and cells 
were resuspended in 3.0 mL KGM by pipetting up and down. 100 µL of the cell suspension 
was mixed with 900 µL of 0.5% trypan blue solution and the cells were counted using a 
Fuchs-Rosenthal cell chamber. 150,000 HCK cells were seeded in a 25 cm² cell culture flask 
containing 7.0 mL KGM. 
3.2.1.3 Cell culture method for the HCE-T cell line after the transfer phase 
The following amounts and parameters were adapted to cultivate the cells at ACB (see 
section 3.2.1.1). The cell monolayers were carefully rinsed twice with 15 mL PBS. UV-
inactivated trypsin-EDTA (0.05% - 0.022%) was replaced by trypsin-EDTA (0.05% - 0.022%) 
(Biochrom AG, Berlin, Germany). The amount of 3.5 mL of EDTA 2.0% in PBS, 3.5 mL 
trypsin-EDTA and 3.5 mL soybean trypsin inhibitor were used. The speed of centrifugation 
was reduced from 3,694 rpm to 2,900 rpm. The HCE-T cells were seeded at a density of 
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between 200,000 and 250,000 cells in 75 cm² cell culture flasks (TPP, Trasadingen, 
Switzerland) and cultivated with 15 mL KGM. 
3.2.1.4 Cell culture method for the HCK cell line after the transfer phase 
The following amounts and parameters were adapted to cultivate the cells at ACB (see 
section 3.2.1.2). The cell monolayers were carefully rinsed twice with 15 mL PBS solution. 
UV-inactivated trypsin-EDTA was replaced by trypsin-EDTA. 3.5 mL of trypsin-EDTA and 3.5 
mL soybean trypsin inhibitor were used. The centrifugation speed was reduced from 3,694 
rpm to 2,900 rpm. Enzymatic digestion was reduced from 4 min to 2 min. The HCK cells 
were seeded at a density of between 60,000 and 100,000 cells in 75 cm². 
3.2.2. Cryopreservation 
One day before freezing the cells the freezing container was filled up to the mark with 
isopropanol (Merck, Darmstadt, Germany) and stored at -20°C. The freezing solution was 
diluted in cold KGM (50:50) and cooled at 4 °C for 10 min. The cold freezing solution was 
kept in the refrigerator all the time (at approximately 4 °C). Following subcultivation, cells 
were centrifuged (2 min at 2,900 rpm) and resuspended in cold freezing medium-KGM 
(50:50) to receive approximately 700,000 to 1,000,000 cells·mL-1. 1 mL of the cell 
suspension was added to a labeled cryovial. The cryovials were transferred into the freezing 
container (a plastic box containing isopropanol to achieve a cooling rate of -1 °C min-1), and 
were then stored at -80 °C for 24 hours. Finally, the cryovials were transferred into a tank 
containing liquid nitrogen at -196°C. 
3.2.3. Thawing of cell lines 
A cryovial was taken out of the liquid nitrogen tank and thawed by holding it in the hand until 
a small crystal was left under laminar air flow and sterile conditions. The cell suspension was 
transferred into a centrifuge tube prefilled with 15 mL cold culture medium. The cell 
suspension was centrifuged for 2 min at 2,900 rpm. The supernatant was discharged and the 
pellet resuspended with 5 mL prewarmed KGM. The suspension was transferred into 25 cm² 
cell culture flask containing 7 mL KGM. The cells were incubated at 37 °C and 5% CO2. After 
two days, the cell culture media was replaced. 
3.2.4. Cultivation of the HC construct 
In vitro stromal equivalent (day 1): First, 2,782 µL of a solution of type I rat tail collagen 
(approximately 2.4 mg·mL-1 in 0.05% acetic acid) was diluted with 1,185 µL of 0.05% acetic 
acid (final concentration of collagen 1.7 mg·mL-1). Second, the HCK cells were subcultivated; 
about 1,120,000 cells were resuspended in 835 µl fresh KGM. Then, 799 µL of a solution of 
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10x MEM, L-glutamine (12.9 mM) and NaHCO3 (16.1 mg·mL-1) was added and mixed 
several times. This cell suspension was then mixed with the collagen solution. The final cell 
suspension was mixed by gently pipetting up and down until reaching homogenization. 400 
µL of this cell containing collagen solution was scattered on polycarbonate Transwell® inserts 
with a pore diameter of 0.4 µm or 3.0 µm and a filter surface of 1.12 cm² (Corning Inc., New 
York, USA) resulting in approximately 80,000 cells·well-1. After ca.10 min (time of gel 
solidification), 1.5 mL of KGM was added to the basolateral side of the Transwell® inserts. 
Then, they were incubated at 37 °C and 5% CO2 for 1 hour in order to complete the 
solidification of the gel. 
Human in vitro corneal epithelium (day 1): The HCE-T cells were subcultivated and about 
1,400,000 cells were resuspended in 5,600 µL of new KGM. 400 µL of the cell suspension 
(about 100,000 cells) was carefully poured onto the stromal equivalent. The HC construct 
was incubated at 37 °C and 5% CO2. The KGM was changed as follows: The KGM was 
removed and 0.5 mL of KGM was added to the apical side and 1.5 mL of KGM to the 
basolateral side of the Transwell® inserts under the liquid-covered conditions (LCC). The 
KGM was replaced on day 4, 6 and 7. 
ALI (Air-liquid interface) (day 7): To promote the epithelial multilayer formation, cells were 
exposed to ALI conditions by reducing the KGM level until the cellular surface was no longer 
medium. For this purpose, a metal plate was placed under the Transwell® inserts. 2.0 mL of 
KGM was added to the basolateral side and the KGM was changed on a daily basis from day 
7 until the day of the transport experiment. The TEER were measured during cultivation with 
an electrical voltohmmeter, which was equipped with a chopstick electrode (see 3.2.5). The 
TEER of the HC construct were calculated according to Equation 3-1. The experiments were 
conducted on day 9, 10 and day 11. 
3.2.5. In vitro permeability studies and transepithelial electrical resistance (TEER) 
measurements 
Transcorneal permeability studies and TEER measurements were performed to evaluate the 
barrier function of the reconstructed corneal barrier during and at the end of the cultivation 
phase and to investigate the effect of formulation factors (pH, EDTA, calcium and 
preservatives) on the barrier function of the HC construct. 
The TEER values provided instant information on the differentiation state of the epithelium 
during the cultivation phase as well as before, during and after permeation experiments. The 
TEER values were determined in cell culture medium (TEER in medium) with an electrical 
voltohmmeter (EVOM) (World Precision Instrument, Sarasota, USA), which was equipped 
with a chopstick electrode (STX-3).  
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The permeability studies were started by measuring the initial TEER of HC construct. 
Afterwards, the HC construct was rinsed with KRB to remove the cell culture medium. The 
donor solutions (drug substances in KRB, see Tables 3-2 and 3-4) were applied to the apical 
compartments; fresh KRB (pH 7.4) was filled into the acceptor compartments. Subsequently, 
the cells were equilibrated at 37 °C and 5% CO2 for a maximum of 60 min. Following the 
preincubation time, the TEER values were monitored to investigate the effect of the different 
substances (effect of the buffer solutions and different concentrations of preservatives). After 
this preincubation time, the transport experiment was started in order to calculate the Papp 
value by taking samples from the donor and acceptor compartments. For this purpose, 10 μL 
(fluorescence measurements) and 100 µL (scintillation and HPLC measurements) from the 
apical side were drawn to determine the initial concentration of the donor solution. At 60, 90, 
150, 210, 270, 330 and 390 min, samples of 100 µL were taken from the acceptor 
compartments and were immediately replaced by fresh prewarmed KRB. The TEER values 
were also measured during transport studies in order to evaluate the effect of the applied 
solutions (unless otherwise mentioned in the text). The cell models were incubated at 37 °C 
and 5% CO2. All experiments were performed in triplicate and repeated twice (unless 
otherwise mentioned in the text). At the end of the transport experiment, the TEER of the HC 
construct were again measured and calculated according to Equation 3-1. 
Equation 3-1: 
  ARRRTEER ffcAc  )(  [Ohm·cm²] 
Rc(A) Electrical resistance of the stromal layer and stratified epithelium covering the area A 
[Ohm·cm2] 
Rc+f Electrical resistance of the stromal layer and stratified epithelium including the filter 
[Ohm] 
Rf Electrical resistance of the Transwell
® inserts without the stromal layer and stratified 
epithelium [Ohm] 
A Area of the filter insert [cm2] 
 
The TEER values achieved with the different transport solutions during permeation studies or 
incubation were normalized to the initial mean value measured in cell culture medium. These 
values are expressed as TEER [%] as described in Equation 3-2. 
 
Equation 3-2: 
1000[%] 
MediumAverage
xtime
TEER
TEER
TEER  
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The TEERMedium is the initial value of the cell culture medium, the TEERxtime describes the 
values measured at specific points in time (e.g. 10, 20, 30, 60, etc.). The influence or 
modification of the TEER values (IF [%]) was further calculated as described in Equation 3-3. 
These values were statistically analyzed and compared with the control values obtained with 
KRB after the preincubation time of 60 min and at the end of the permeability assays after 
390 min. 
Equation 3-3: 
[%][%]100[%] TEERIF   
At the end of the drug absorption studies, the Papp values achieved with the different 
substances were calculated according to Equation 3-4, 
Equation 3-4: 
][
11 1.
0



 scmV
Amt
Q
P Dapp  
where Q/t is the permeation rate (steady state transport rate) obtained from the profile of the 
transported amount of substrate versus time, calculated by the linear regression of time and 
concentration. A represents the exposed area of the stratified epithelium (1.12 cm2 on 
Transwell® inserts). m0 is the initial mass of test compound in the donor compartment, and VD 
is the buffer volume of the donor compartment [cm³]. 
3.2.6. Determination of pH 
The pH values of the buffer solutions were measured with the pH meter PerpHecT Meter 
Orion model 330 (Orion Research, Boston, USA). This instrument was calibrated with a two-
point curve bracketing the expected pH values. 
3.2.7. Determination of osmolality 
The osmolality measurement of the buffer solutions was performed using an OSMOMAT® 
030 (Gonotec, Berlin, Germany). The instrument was calibrated with distilled water and a 
calibration standard of 300 mOsmol·kg-1 was used (Gonotec, Berlin, Germany). 
3.2.8. Evaluation of preservatives 
First, the TEER values were measured (TEER in medium). The cell culture medium was 
removed and the HC construct was rinsed with KRB to remove the cell culture medium. 500 
µL of the donor solution was applied to the donor compartments; fresh KRB (pH 7.4) was 
filled into the acceptor compartments. Subsequently, the cells were incubated at 37 °C and 
5% CO2. The TEER values were measured every 10 min for 30 min in order to investigate 
the effect of preservatives at different concentrations. After this time, the TEER values were 
continuously measured after 60, 90, 150, 210, 270, 330, and 390 min. 
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3.2.9. Quantification of samples 
3.2.9.1 Quantification of samples using fluorescence spectroscopy 
The components of the fluorescence system consisted of a Wallac VictorTM Multilabel 
Counter fluorescence plate reader (PerkinElmer Wallac, Freiburg, Germany) equipped with a 
photomultiplier detector and excitation and emission filters of 485 nm and 535 nm for sodium 
fluorescein, rhodamine 123 and fluorescein isothiocyanate dextran. The output signal was 
monitored and processed using the Wallac 1420 Multilabel Counter software. A fluorescence 
plate reader (Tecan, Männerdorf, Switzerland) was also used for rhodamine B. These 
samples were measured by the Department of Dermatology and Venereology of the 
University Hospital Hamburg-Eppendorf (UKE) using excitation and emission filters of 535 
nm and 590. In order to avoid shortcomings, the concentration of each transport solution with 
Na-FLU at different pH values was determined by running individual calibration curves, which 
resulted in a correlation coefficient of at least 0.995. The employed analytical methods 
correspond to the acceptance criteria recommended by the applicable guidelines (ICH, 2005; 
FDA Guidance For Industry, 2001).  
3.2.9.2 Quantification of samples using liquid scintillation counting 
The radiolabeled samples were measured with a Wallac 1450 Microbeta Trilux TM scintillation 
counter (PerkinElmer Wallac, Freiburg, Germany) after the addition of the scintillation 
cocktail OptiPhase SuperMix (PerkinElmer, Waltham, USA). The calibration curve was in the 
range of the evaluated concentrations with a correlation coefficient of ≥ 0.995 and met the 
acceptance criteria recommended by the applicable guidelines (ICH, 2005; FDA Guidance 
For Industry, 2001). 
3.2.9.3 Quantification of samples using HPLC 
Timolol maleate: The HPLC system used was a Waters Alliance 2487 (Waters, Milford, MA, 
USA), which was equipped with a quaternary pump, an autosampler and a dual absorbance 
detector. The output signal was monitored and processed using the EmpowerTM 2 software. 
The absorption was monitored at 295 nm. The chromatographic column used was a Waters 
Symmetry TM C8, 150 mm x 3.9 mm, 5.0 m. An isocratic method was used. The mobile 
phase contained 12.5% (v/v) acetonitrile (Merck, Darmstadt, Germany) and 87.5% (v/v) H2O 
with 0.1% triethylamine (Sigma-Aldrich, Steinheim, Germany) and was adjusted to a pH of 
2.9 using anhydrous acetic acid. The flow rate was 1.2 mL·min-1. The column temperature 
was set at 40 °C. The autosampler was maintained at 20 °C and the injection volume was  
20 L. The calibration curve was in the range of 0.515 µg·mL-1 – 98.689 µg·mL-1 with a 
correlation coefficient ≥ 0.995. 
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Benzalkonium chloride: The HPLC system used was an Agilent 1100 series (Agilent 
Technology, Hewlett Packard, Waldbronn, Germany), which was equipped with a binary 
pump, an autosampler and an absorbance detector. The output signal was monitored and 
processed using the ChemeStation software. The absorption was monitored at 210 nm. The 
chromatographic column used was a Waters Spherisorb CN, 150 mm x 4.6 mm, 5.0 m or 
Phenomenex 150 mm x 4.6 mm, 3.0 m. The mobile phase contained a gradient mixture of 
0.02 M potassium dihydrogen phosphate buffer (Merck, Darmstadt, Germany) pH 5.5 (eluent 
A) and acetonitrile (eluent B). The gradient method used consisted of decreasing the 
concentration of eluent A from 6:4 (A - B) to 3:7 until 7 min. This level was maintained for 2 
min and then again increased to 6:4 (A - B) until 11 min. The flow rate was 1.2 mL·min-1 with 
a retention time of 5 min. The column temperature was set at 20 °C. The autosampler was 
maintained at 20 °C and the injection volume was 20 L. The calibration curve was in the 
range of 10.21 µg·mL-1 – 198.6 µg·mL-1 with R² ≥ 0.995. 
Thiomersal: The HPLC system used was an Agilent 1100 series (Agilent Technology, 
Hewlett Packard, Waldbronn, Germany), which was equipped with a binary pump, an 
autosampler and an absorbance detector. The output signal was monitored and processed 
using the ChemeStation software. The absorption was monitored at 222 nm. The 
chromatographic column used was an X Terra, 150 mm x 4.6 mm, 5.0 m. An isocratic 
method was used. The mobile phase contained 78.0% (v/v) of 0.02 M potassium dihydrogen 
phosphate buffer pH 5.5 and 22.0% (v/v) acetonitrile. The flow rate was 1.0 mL·min-1 with a 
retention time of 4 min. The column temperature was set at 20 °C. The autosampler was 
maintained at 20 °C and the injection volume was 20 L. The calibration curve was in the 
range of 1.00 µg·mL-1 – 200.96 µg·mL-1 with R² ≥ 0.995. 
Methylparaben: The HPLC system used was an Agilent 1100 series (Agilent Technology, 
Hewlett Packard, Waldbronn, Germany), which was equipped with a binary pump, an 
autosampler and an absorbance detector. The output signal was monitored and processed 
using the ChemeStation software. The absorption was monitored at 215 nm. The 
chromatographic column used was a Luna, 150 mm x 4.6 mm, 3.0 m. The mobile phase 
was 65.0% (v/v) of 0.02 M potassium dihydrogen phosphate buffer (pH 5.5) and 35.0% (v/v) 
acetonitrile. The flow rate was 1.0 mL·min-1 with a retention time of 5 min. The column 
temperature was set at 20 °C. The autosampler was maintained at 20 °C and the injection 
volume was 20 L. The calibration curve was in the range of 0.195 µg·mL-1 – 305.3 µg·mL-1 
with R² ≥ 0.995. 
Propranolol: The HPLC system used was an Agilent 1200 series (Agilent Technology, 
Hewlett Packard, Waldbronn, Germany), which was equipped with a binary pump, an 
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autosampler and an absorbance detector (Waters, Milford, MA, USA). The output signal was 
monitored and processed using the Empower 2 software. The absorption was monitored at 
215 nm. The chromatographic column used was a Bischoff prontosil RP8, 53 mm x 4.0 mm, 
5.0 m. The mobile phase consisted of 75.0% (v/v) of 10 mM sodium dihydrogen phosphate 
(Merck, Darmstadt, Germany) adjusted to a pH of 3.5 using H3PO4 and 25.0% (v/v) 
acetonitrile. The flow rate was 1.0 mL·min-1 with a retention time of 3 min. The column 
temperature was set at 40 °C. The autosampler was maintained at 20 °C and the injection 
volume was 20 L. The calibration curve was in the range of 0.019 µg·mL-1 – 9.89 µg·mL-1 
with R² ≥ 0.995. 
3.2.1. Data evaluation and statistics 
Statistical calculations of TEER and Papp values were performed using the MS Excel 2010 
spreadsheet package and Data Analysis, Technical Graphics Origin version 8.6 (Microcal 
(TM) Software, Inc, Northampton, USA). One-Way ANOVA test was performed followed by 
Mann Whitney test. The data were considered as significantly different at p-values *p<0.05, 
**p<0.01, ***p<0.001. 
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4. Results and discussion 
4.1. Transferability of methods, quality and prevalidation of the Hemicornea model 
4.1.1. Transfer of cell culture conditions and quality of the Hemicornea model 
The use of a corneal cell culture model for in vitro drug absorption studies must meet several 
requirements in order to be validated as an alternative system to animal cornea. This so-
called prevalidation protocol consists of three main phases; i) protocol refinement, ii) protocol 
transfer and, iii) protocol performance (Curren et al., 1995). The first phase, including 
development of the methods for constructing (3D) human Hemicornea model (Hemicornea, 
HC) or Hemicornea construct used and protocols for conducting drug absorption studies, 
was performed by Matthias Hahne at TUBS (Hahne and Reichl, 2011). The present chapter 
describes the protocol transfer and performance for the prevalidation of the HC construct 
done at ACB. Subsequently, the data was evaluated by Matthias Hahne at TUBS and the 
results were summarized in Hahne et al., 2012. This work was funded by the German 
Federal Ministry for Education and Research (grant no. 0315504C). 
 
The HC construct employed in this investigation consists of immortalized HCK cells 
embedded into a collagen stromal matrix (Zorn-Kruppa et al., 2005) cast into Transwell® 
inserts and immortalized HCE-T cells (Araki-Sasaki et al., 1995) seeded onto the collagen 
matrix (see 3.2.4). The HCE-T cell line is until today most commonly used to build corneal 
models due to its capacity to display morphological characteristic similar to those of the 
human cornea (Toropainen et al., 2001; Becker et al., 2007; Seeber et al., 2008; Reichl et 
al., 2011), whereas co-cultivation with HCK cells provides the HC construct with more in vivo 
properties since they influence the morphology of the corneal epithelium (Orwin and Hubel, 
2000). The first step to develop an in vitro corneal model is the cultivation of different cell 
types. For the current investigation, HCK and HCE-T cells were first cultivated in 25 cm² and 
then in 75 cm² culture flasks in a 5% CO2 atmosphere at 37 °C until the confluence of cell 
monolayers. This required minor modifications in the seeding density of cells in order to 
reach confluence once a week. The light microscopic examination of HCK cells revealed that 
this cell type exhibited a spindle-like and flattened morphological shape as reported by Zorn-
Kruppa et al., 2005, whereas HCE-T cells showed a cobblestone-like appearance. This 
morphological shape has previously been described by Araki-Sasaki et al., 1995.  
 
The HC construct was cultivated under LCC until day 7 (see Figure 4-1), which was found to 
be an optimal day to expose the epithelial confluent monolayer to the ALI conditions (Hahne 
and Reichl, 2011) and to simulate in vivo conditions (Chang et al., 2000). The TEER values 
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declined sharply between day 4 and 7 probably due to nutrient depletion in the growth 
medium. After the culture medium was renewed and the HC construct was exposed to ALI 
conditions, the transepithelial electrical resistances (TEER) increased abruptly within 24 
hours and only modestly between day 9 and 11. Thereafter, a gradual decrease in the TEER 
values was observed (data not included). TEER values between 300 - 600 Ohm·cm2 have 
been suggested to reflect sufficient tightness of the epithelial cell layers for drug absorption 
studies (Steimer et al., 2005; Becker, 2006; Hahne and Reichl, 2011). The TEER values 
obtained in the present study achieved compliance with the acceptance limits and thus, it can 
be concluded that the transfer of methods for constructing the HC construct was successfully 
performed at ACB. 
 
Figure 4-1: TEER (mean ± SD) reached under LCC until day 7 and after the HC construct was 
exposed to ALI conditions in a serum-free KGM (n = 6) 
 
In accordance with the description provided in section 3.2.5, the transport studies were 
carried out with sodium fluorescein (Na-FLU), which is a hydrophilic permeation marker. The 
estimation of the TEER and permeation coefficients (Papp) values for the HC construct was 
performed as described in section 3.2.5. For the purpose of evaluating the acceptance 
criteria for the transfer phase previously defined Papp of Na-FLU < 1·10-6 cm·s-1 and TEER 
values ≥ 400 Ohm·cm² (Hahne and Reichl, 2011), the Papp values of Na-FLU were plotted 
against the TEER values obtained after the preincubation time (see Figure 4-2). The Papp 
data obtained with Na-FLU for the HC construct shows that at a minimum TEER value of 400 
Ohm·cm² Papp values below the defined acceptance criteria (quality criterion) are achieved 
(vertical dotted line, Figure 4-2). In summary, the values obtained with Na-FLU are an 
indicator for a successful transferability of the protocols for drug absorption studies and fulfill 
the acceptance criteria established already in TUBS. 
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Figure 4-2:  TEER and Papp values obtained with Na-FLU for the HC construct resulting in n=39 (6 
independent experiments) during the transfer phase. The vertical dotted line 
represents the minimum TEER value obtained for the HC construct. 
4.1.2. Prevalidation of the HC construct 
After the successful transfer of the cultivation and permeation protocols and the compliance 
with acceptance criteria was achieved, the intralaboratory and interlaboratory reproducibility 
of the HC construct was evaluated. For this purpose, the permeation of some molecules with 
different molecular properties was investigated (e.g. fluorescein isothiocyanate dextran (FD-
4), a hydrophilic macromolecule and rhodamine B, a lipophilic substance) (Figure 4-3). The 
same permeation markers together with Na-FLU were used by all involved laboratories. The 
Papp values for the different permeation markers versus the TEER values obtained were then 
compared to those measured in the other laboratories (Figure 4-3). The TEER values 
obtained at TUBS were between 380 and 780 Ohm·cm², the HC constructs showed TEER 
values between 200 and 1500 Ohm·cm² at the Department of Dermatology and Venereology 
of the University Hospital Hamburg-Eppendorf (UKE) and the HC constructs cultivated at 
ACB had TEER values between 580 and 1600 Ohm·cm². The source of variability observed 
for the reported TEER values may be due to differences in the methodology employed to 
determine TEER values and/or the levels of expression of zona occludens in the HCE-T cells 
grown in each laboratory. 
To evaluate the transferability and to define a common acceptance criterion for the HC 
construct, the TEER - Papp correlation was evaluated based on the best-fit line. In order to 
determine the minimum TEER value to be used as a quality criterion of the HC construct a 
vertical line was drawn in the intersection point of the regression with the horizontal line 
corresponding to the suggested Papp value for the human cornea. This value corresponds to 
the arithmetic mean of the Papp measured for the rabbit and porcine cornea (Hahne and 
Results and Discussion 
38 
Reichl, 2011). The intersection point for Na-FLU lies at 440 Ohm·cm² and for FD-4 at 500 
Ohm·cm². 
No correlation between TEER and Papp value was found for the lipophilic permeation marker 
rhodamine B (Figure 4-3). This is due to the fact that the transcorneal diffusion of the 
lipophilic substance depends to a considerably smaller extent on the paracellular pathway, 
which is reflected the TEER value (Prausnitz and Noonan, 1998). All together, these results 
confirmed the quality criterion (acceptance limits) defined during the transfer phase at ACB 
(a minimum of 400 Ohm·cm² is required). 
 
 
Figure 4-3: Representation of the correlation between TEER and Papp values for Na-FLU, FD-4 
and rhodamine B during the prevalidation of the HC construct, resulting in n=85 (14 
independent experiments) for Na-FLU; n=92 (16 independent experiments) for FD-4, 
n=66 (8 independent experiments) for rhodamine B. The minimum TEER value 
defined as a quality criterion for the HC construct is depicted in the graphics Na-FLU  
and FD-4. This value is represented by the vertical line in both graphics and was 
obtained from the intersection of the best-fit line (decreasing line) and the horizontal 
line, which is the average Papp value for isolated rabbit and porcine cornea (adapted 
from Hahne et al., 2012). 
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The broad range of different Papp values of selected markers and the TEER values generated 
during cultivation and diffusion transport provide a great opportunity to correlate the Papp 
values of Na-FLU, FD-4 and rhodamine B with the respective TEER values in order to 
establish only one acceptance criterion for the evaluation of results as is represented in 
Figure 4-3. 
 
In order to evaluate the reproducibility of the HC construct in each laboratory involved and its 
applicability for drug absorption, four relevant ophthalmic active compounds (aciclovir, 
bimatoprost, dexamethasone and timolol maleate) were selected and further tested in 
permeation studies. HC batches displaying TEER values ≥ 440 Ohm·cm² were taken for the 
evaluation of the intralaboratory and interlaboratory reproducibility. A summary of the mean 
Papp calculated for the permeation markers and these substances in all the laboratories is 
presented in Table 4-1. For comparison, the Papp values obtained for excised rabbit and 
porcine cornea by Matthias Hahne at TUBS are also shown.  
 
Table 4-1: Summary (mean ± SD) of the Papp of all substances for the HC construct observed in 
the participating laboratories and comparison of these values with the mean Papp of all 
HC as well as with those of rabbit and porcine cornea. *Experiments were only 
conducted at TUBS (adapted from Hahne et al., 2012). 
Permeation 
marker/ 
Active drug 
Papp 10-6 ± SD [cm·s-1] 
Mean HC 
TUBS 
Mean HC 
ACB 
Mean HC 
UKE 
Mean of all 
HC 
*Rabbit 
cornea 
*Porcine 
cornea 
Na-FLU 0.19 ± 0.05 0.33 ± 0.06 0.27 ± 0.08 0.24 ± 0.08 0.40 ± 0.11 0.18 ± 0.15 
FD-4 0.05 ± 0.01 0.04 ± 0.01 0.03 ± 0.01 0.04 ± 0.01 0.09 ± 0.05 0.017± 0.04 
Rhodamine-
B 
9.65 ± 1.02 7.35 ± 0.54 6.89 ± 0.76 8.40 ± 1.50 13.5 ± 2.11 5.43 ± 1.26 
Aciclovir 2.87 ± 0.51 1.91 ± 0.28 1.69 ± 0.41 2.20 ± 0.68 4.04 ± 0.98 2.03 ± 0.58 
Bimato-
prost 
2.20 ± 0.44 2.90 ± 0.98 5.12 ± 1.02 3.44 ± 1.51 3.63 ± 1.01 1.47 ± 0.45 
Dexametha-
sone 
5.40 ± 0.46 5.91 ± 1.27 6.26 ± 0.39 5.83 ± 0.87 7.68 ± 0.87 1.51 ± 0.12 
Timolol 
maleate 
7.78 ± 0.74 7.99 ± 0.30 7.18 ± 0.60 7.63 ± 0.67 22.5 ± 3.95 7.13 ± 1.79 
 
The analysis of the intralaboratory and interlaboratory reproducibility was performed by 
Hahne et al. using an equivalence test in which 95% confidence levels were calculated for 
the Papp value of each individual HC batch (Hahne et al., 2012). The equivalence was 
confirmed by comparing these confidence levels with the predefined acceptance criteria for 
excised rabbit cornea (Figure 4-4). The acceptance limits were determined using the Papp 
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values obtained with excised rabbit cornea, which were employed as reference values since 
they are commonly used in similar investigations. These experiments were performed at the 
TUBS laboratory. The permeation marker FD-4 was employed in order to ensure that future 
batches meet the predefined acceptance limits and since it showed the greatest variability of 
the mean Papp values (see Table 4-1 and Figure 4-4). The three 95% confidence levels for 
FD-4 were obtained independently for every single batch of rabbit corneal tissue (Figure 4-4) 
(Hahne et al., 2012). In addition, the largest deviation of these confidence levels (84.2%) 
compared to the mean value was specified as the relative variance (Hahne et al., 2012).  
This relative variance served to define the acceptance limits for HC batches. Within the 
scope of this prevalidation study, all studied 73 HC batches were in agreement with the 
acceptance limits defined for the intralaboratory reproducibility. However, with regard to the 
interlaboratory reproducibility, the HC batches varied slightly between the laboratories; but 
only 1 out of 73 sets of experiments did not meet the acceptance criteria. 
 
Figure 4-4: Schematic representation of the procedure for the equivalence test conducted at 
TUBS to evaluate the intralaboratory and interlaboratory reproducibility of the HC 
construct. The highest relative variability was 84.2% and was calculated based on the 
average values of all rabbit experiments performed at TUBS (adapted from Hahne et 
al., 2012). 
4.1.3. Summary of transferability of methods, quality and prevalidation of the HC 
construct 
The development of cornea models for studying in vitro drug absorption involves several 
phases before they can be finally validated as an alternative to in vitro and in vivo studies 
with animal cornea. This chapter describes the last two phases of the prevalidation process 
(protocol transfer and protocol performance) for constructing the HC model and for 
conducting drug absorption studies, which were carried out at ACB. The protocol refinement, 
which is the first stage in the prevalidation of a test model was already reported and mainly 
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performed by Matthias Hahne at TUBS (Hahne and Reichl, 2011). While the refinement of 
protocols is performed in one laboratory, the transfer and performance processes must be 
conducted in at least two different laboratories to ensure the model’s transferability and 
reproducibility. Within the framework of the present investigation TUBS, ACB and UKE were 
involved in the prevalidation process.  
A prevalidation process is assessed according to predetermined acceptance criteria that are 
defined in relation to studies based on excised cornea either from rabbit or porcine. Following 
the successful prevalidation, the HC model undergoes the validation process in order to be 
approved by the corresponding authorities, which ensure its worldwide applicability. 
The results demonstrated that the methods for developing the HC construct were 
successfully transferred. The TEER values of the HC construct are consistent with the 
formation of tight epithelial cell layers, which is a mandatory requirement that corneal models 
have to fulfill in order to be suitable for drug permeation studies (Reichl, 2008). The TEER 
values were in accordance with the acceptance TEER value defined by Matthias Hahne at 
TUBS.  
The HC batches with acceptable TEER values were then employed in permeability studies 
using standard permeation markers including Na-FLU. The Papp values obtained for Na-FLU 
were within the previously defined acceptance permeation limit of the HC model (Hahne and 
Reichl, 2011). 
In order to evaluate the intralaboratory and interlaboratory reproducibility, the Papp values for 
the different HC batches were calculated for seven substances with different 
physicochemical properties; the values obtained were then compared within the scope of an 
equivalence test as described in Hahne et al., 2012. While the HC construct showed 100% 
intralaboratory reproducibility, the interlaboratory reproducibility decreased slightly to 98.6% 
(1 out of 73 HC batches did not fulfill the accepted criteria). Despite this small decrease in 
the reproducibility between laboratories, the HC construct still complies with the acceptance 
criteria defined during the prevalidation phase. 
Based on this, within the scope of the present study, it has been observed that the 
permeability of the HC construct to substances is similar to that of excised corneal tissue, 
which suggests that the HC construct possesses an acceptable level of intra and 
interlaboratory reproducibility. 
In conclusion, the present investigation resulted in the successful protocol transfer and 
protocol performance process for constructing a cornea model for conducting drug 
absorption studies.  
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4.2. Comparative analysis of transcorneal drug absorption 
4.2.1. Differentiation capacity of the HC construct depending on the 
physicochemical properties of substances 
The transcorneal permeation rate of an ocular drug is an important parameter, which needs 
to be evaluated in the development phase of ophthalmic formulations. The permeation of 
drugs through the corneal barrier is influenced by their physicochemical properties (Järvinen 
et al., 1995). In vivo and ex vivo experiments with rabbit cornea are frequently conducted 
within the scope of such studies. However, several disadvantages have been reported with 
regard to these studies, such as the high variability of permeability data between 
laboratories, the high costs for keeping laboratory animals as well as ethical concerns 
(Kruszewski et al., 1997; Kawazu et al., 1998; Reichl et al., 2004). Therefore, in vitro corneal 
models have been developed to solve these issues. In order to demonstrate that the 
permeation of substances through the HC construct is also influenced by their 
physicochemical properties, as has already been reported for native corneal tissue, the 
permeability of the evaluated HC construct to 18 substances was correlated with their 
lipophilicity (referred to as log P) and molecular weight (MW). Furthermore, the Papp values of 
these substances were also used to determine the degree of comparability between the 
permeability of the HC construct and the permeability of excised rabbit and human cornea. 
Papp values of ex vivo animal cornea were obtained from literature. 
 
For a detailed evaluation of the permeability of the prevalidated HC construct, in particular, 
two aspects relevant for drug development (i.e. improvement of ocular bioavailability) were 
investigated: i) the ability of different substances to permeate the corneal barrier without 
excipients and ii) the permeability of the cornea model to diverse ophthalmic drugs as 
compared with that of excised tissue. To cover a wider range of physicochemical properties, 
highly hydrophilic paracellular markers (Na-FLU and mannitol) and lipophilic markers 
(rhodamine B) were used (Kawazu et al., 1998; Hahne and Reichl, 2011).  
The Table 4-2 provides an overview of the Papp of all substances obtained with the HC 
construct as well as their respective MW and log P values. 
Table 4-2: Mean Papp values ± SD of all substances achieved with the HC construct, as well as 
details on their MWs and log P. The letter n represents the number of independently 
conducted experiments. 
Substance 
Papp 10-6 ± SD 
[cm·s-1] 
Molecular weight 
[g·mol-1] 
*Log P n 
FD-4 0.044  0.02 4400 -1.52 12 
Na-FLU 0.29  0.08 376.27 -2.0 32 
Mannitol 0.38  0.08 182.17 -3.73 19 
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Substance 
Papp 10-6 ± SD 
[cm·s-1] 
Molecular weight 
[g·mol-1] 
*Log P n 
Methotrexate disodium 1.97  0.47 498.40 -0.24 6 
Aciclovir 2.07  0.35 225.20 -1.03 12 
Bimatoprost 2.95  1.04 415.57 2.63 12 
Urea 2.81  0.50 60.06 -1.36 6 
Dexamethasone 7.38  1.83 392.46 1.68 12 
Timolol maleate 10.30  0.42 316.42 1.34 12 
Metoprolol 10.05  0.57 270.00 1.76 6 
Propranolol hydrochloride 12.23  1.40 295.80 2.58 33 
Rhodamine B 12.42  2.11 479.02 1.78 12 
Caffeine 7.25  0.67 194.19 -0.55 6 
Nicotine 10.82  1.30 162.24 1.16 6 
Estriol 10.38  2.25 288.38 2.67 3 
Benzalkonium chloride 7.33  0.98 396.02 1.90 6 
Methylparaben 10.76  1.49 152.15 1,67 6 
Thiomersal 5.68  0.83 382.83 2.35 6 
*Obtained from ChemSpider chemical databank (http://www.chemicalize.org, accessed at 
12.07.2016), except for Na-FLU, FD-4 (Sakai et al., 1997) and benzalkonium chloride (Shokri et al., 
2001) 
 
The absorption rate of a drug for transcorneal transport appears to dependent on the 
octanol-water partition coefficient, hereinafter referred to as log P (Schoenwald and Huang, 
1983; Wang et al., 1991; Sasaki et al., 1995a). The Papp values for the different substances 
were calculated as described in section 3.2.5 and plotted against the respective log P as 
listed in Table 4-2 (Figure 4-5). This graphic shows that the permeability of the HC construct 
sigmoidally increased for substances with increased log P values. The data were fitted to a 
sigmoidal curve with a R² of 0.85 for all substances. An identical relationship was also 
described for excised rabbit cornea with β-blockers where a R² of 0.84 was calculated (Wang 
et al., 1991). According to the sigmoidal correlation, the R² found for the HC construct was 
thus in line with the value reported by Wang et al. This indicates that the barrier properties of 
the HC construct are largely equivalent to that of excised rabbit tissue. Furthermore, Figure 
4-5 shows that for substances with log P values below -0.24, with the exception of caffeine 
the permeability of the HC construct is minor influenced by their hydrophilic properties (log P 
values). However, for substances with log P values above 0.08, a higher influence of log P 
values on the permeability of the HC construct and the variability of Papp values can be 
observed. 
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Figure 4-5: Permeability of the HC construct as a function of log P of the permeated substances. 
Each symbol represents the mean  SD of three to six independent experiments 
carried out for each substance. 
 
 
Figure 4-6: Permeability of the HC construct as a function of molecular weight of permeation 
markers. Each symbol represents the mean  SD of three to six independent 
experiments carried out for each substance. 
 
Another parameter is the MW as described by Prausnitz and Noonan, 1998. In Figure 4-6 the 
MW of 17 substances are plotted against the corresponding Papp values. The macromolecule 
FD-4 was not included in this analysis since 94% of the tested substances have a MW, which 
is not higher than 500 g·mol-1. The graphic shows that no correlation exists between the 
permeability of the HC construct and the MW of permeation markers ranging from 60 to 500 
g·mol-1. This result is in accordance with previously reported data for isolated rabbit cornea 
(Prausnitz and Noonan, 1998). Prausnitz and Noonan have demonstrated in their 
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comprehensive study that the permeability of rabbit cornea is not influenced by the molecular 
size of drugs with MW mentioned above.  
4.2.2. Comparison of the permeability of the HC construct with those of ex vivo 
rabbit and human cornea based on the Papp values 
The section above describes that the HC construct was assessed with regard to its capability 
to discriminate between poorly or highly permeable substances. For successful use of an 
alternative cornea model, another important aspect, which has to be taken into account is the 
extent to, which its permeability is comparable to well-established excised corneal models. 
Therefore, in order to investigate the suitability of the HC construct for drug absorption 
studies, HC batches exhibiting TEER values larger than 400 Ohm (minimum TEER value 
accepted for permeability assay as previously defined during the transfer phase, 4.1.1) were 
considered. The Papp values for the HC construct were directly compared with the Papp values 
of excised rabbit and human cornea available from the literature (Figure 4-7 and Figure 4-8). 
It is worth noting that excised rabbit corneas are most commonly used for drug permeation 
studies (Mannermaa et al., 2006; Xiang et al., 2009; Reichl et al., 2011). 
 
 
Figure 4-7: Papp values of substances obtained for the HC construct (n = 6-39) compared with 
those for the excised rabbit cornea. The numbers denote the references where the values 
were extracted, as follows: (1) Nakamura et al., 2007; Hahne et al., 2012; (2) Becker, 2006; 
Hahne et al., 2012; (3) Reichl, 2008; Suhonen et al., 1998; (4) Becker, 2006; (5) Suresh et al., 
2010; Hahne et al., 2012; (6) Hahne et al., 2012; (7) Klyce, 1975; (8) Civiale et al., 2004; Hahne 
et al., 2012; (9) Huang et al., 1983; Ahmed et al., 1987; Shih and Lee, 1990; Wang et al., 1991; 
Becker, 2006; Hahne et al., 2012; (10) Huang et al., 1983; Xiang et al., 2009); (11) Hahne et al., 
2012 
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Figure 4-8: Papp values of substances obtained for the HC construct (n = 6 - 39) compared with 
those for the excised human cornea. The numbers denote the references where the 
values were extracted, as follows: (1-2, 5) Becker, 2006; (3) Woodward et al., 2001; (4) 
Reichl et al., 2005; Becker, 2006. When the error bar is not shown, the SD is smaller than the 
size of the symbol. 
 
For the purpose of comparison between HC and excised rabbit cornea, six permeation 
markers, four ophthalmic drugs, two β-blockers were used and a correlation coefficient (R²) 
of 0.85 was calculated (Figure 4-7). Interestingly, the Papp values for the hydrophilic 
permeation markers (FD-4, Na-FLU, mannitol and acyclovir) obtained with excised rabbit 
cornea (Majumdar et al., 2008; Suresh et al., 2010) and the HC construct were comparable. 
In contrast, larger differences between the Papp values reported and those measured in this 
work were found for urea and metoprolol. The urea Papp value for the HC construct turned out 
to be five-fold higher than the value reported by Klyce (Klyce, 1975), whereas, for metoprolol, 
it was about two-fold lower than the mean value obtained from the literature (Huang et al., 
1983; Xiang et al., 2009). These discrepancies may arise from differences in the corneal 
layers of excised rabbit cornea and those of in vitro model based on human cornea. For 
instance, the hydrophilic stroma of the rabbit cornea is remarkably thinner than the 
reconstructed stroma of the HC construct (Chan et al., 1983; Ojeda et al., 2001; Baydoun, 
2008). Thus it can be expected that rabbit cornea displays a higher permeability to the 
lipophilic compounds than HC and human cornea. This can be readily observed from Figure 
4-7 and Figure 4-8. Moreover, another factor that might contribute to the variability is the high 
degree of intraspecie-specific variations reported for rabbit (Wang et al., 1991; Majumdar et 
al., 2008; Suresh et al., 2010; Adelli et al., 2015). Furthermore, the correlation between the 
data available from the literature on excised human cornea with the data obtained with the 
HC constructs is shown in Figure 4-8. The R² of 0.99 indicates a good correlation between 
the permeability of the HC construct and that of native human cornea. 
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The comparison of the permeation data obtained with the HC construct and those collected 
from the literature for excised human and rabbit cornea demonstrates that the Papp values 
correlated well between the models as is also confirmed by the calculated R² values. 
The current investigation also shows that the HC construct exhibits barrier properties similar 
to those of excised rabbit and human cornea with regard to hydrophilic substances such as 
FD-4, Na-FLU, mannitol and aciclovir. This indicates that the permeability of the HC 
construct is the same to that of excised rabbit and human corneal tissue regarding 
hydrophilic substances. 
Regarding lipophilic substances such as dexamethasone, timolol and rhodamine B, the Papp 
values of the HC construct and excised rabbit cornea were almost similar. Nevertheless, the 
Papp values obtained with metoprolol and propranolol differed between the models. An 
explication for such discrepancy is the structural difference of the stromal cell layers, in 
particular with regard to the thickness, between both corneal models as well as the high 
interlaboratory variability of the Papp reported in the literature. Despite of these differences, it 
was noted that the Papp values obtained with these two lipophilic substances for the HC 
construct were lower than the data reported for excised rabbit cornea. This indicates that the 
HC construct possesses a lower permeability to lipophilic substances than rabbit cornea. In 
contrast, the comparison of the Papp values obtained with propranolol and timolol showed that 
the values of the HC construct and excised human cornea were identical. This indicates that 
the thickness of the hydrophilic stroma of the HC construct is similar to that of human cornea. 
Unfortunately, a Papp value for metoprolol has yet not been reported for excised human 
cornea due to which a comparison to the values achieved with the HC construct is not 
possible. Thus, the HC construct has an equal permeability to lipophilic substances than 
excised human cornea. 
4.2.3. Summary of the comparative analysis of transcorneal drug absorption 
This chapter deals with the investigation of the physicochemical properties of substances on 
the permeation through the HC construct. Furthermore, the evaluation of the grade of 
comparability between the barrier properties of the HC construct and that of isolated rabbit 
and human cornea is described. 
Eighteen different substances covering a wide range of octanol-water partition coefficients 
and molecular weights were used to evaluate thoroughly the permeability properties of the 
construct. Subsequently, the Papp values obtained with the HC construct were compared with 
the values available in the literature on excised rabbit and human cornea in order to assess 
the capability of the HC construct to show similar levels of permeability as the 
aforementioned excised corneal tissue.  
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The log P - Papp relationship for the different substances tested with the HC construct 
indicated that the lipophilicity of the substances is an important variable, which determines 
the permeation properties through the corneal barrier.  
With regard to the lipophilicity of substances, the Papp correlates with the log P. In addition, it 
was demonstrated that the permeability of the HC construct increased when the lipophilicity 
increase according to a sigmoidal relationship. It has been previously reported that the 
permeability of isolated rabbit cornea increases sigmoidally with the log P (Wang et al., 1991; 
Suhonen et al., 1991; Suhonen et al., 1998).  
Considering the barrier properties of the HC construct, it is predicted that hydrophilic 
substances cross the corneal epithelium through the pores formed by tight junctions 
(paracellular pathway). This means that this pathway also limits the diffusion transport of 
substances depending on their MWs. Nevertheless, this assumption is only applicable to 
substances with large MWs (Hämäläinen et al., 1997). In contrast, the transcorneal 
permeation of small substances is not influenced by their MWs (Prausnitz and Noonan, 
1998). This observation is in good agreement with the data obtained in the current work. 
 
In summary, the log P - Papp and the MW - Papp correlations demonstrate that, like ex vivo 
corneal tissue, the permeability properties of the HC construct are rather influenced by the 
lipophilicity of small substances but not their MWs. 
 
Eleven of the eighteen substances evaluated with the HC construct have previously been 
tested with excised rabbit cornea. Despite the fact that the HC construct used in this 
investigation originates from human tissue, the comparison of its permeability with that of 
excised rabbit cornea (information available from the literature) showed a relatively high 
degree of correlation (R² = 0.85) with regard to these eleven substances. Furthermore, the 
slope of the regression line was 1.29. This value indicates that the permeability of excised 
rabbit cornea is in general 30% higher than that of the HC construct.  
The comparison of the permeability characteristics of both corneal models indicated that, for 
hydrophilic substances (e.g. FD-4, Na-FLU, mannitol and acyclovir), the permeability of the 
HC construct was similar to that of excised rabbit cornea, whereas the permeability observed 
for lipophilic substances (bimatoprost, dexamethasone and rhodamine B), the permeability of 
the HC construct was close to the values published for excised rabbit cornea, whereas for 
metoprolol, the permeability of the HC construct was two-fold higher than the value found for 
excised rabbit cornea. The thickness of rabbit cornea, in particular, that of the hydrophilic 
stroma, is smaller than that of human cornea and thus the different Papp values obtained for 
some lipophilic markers might be a consequence of the different elongated diffusion 
distances of both corneal models (Chastain, 2003; Hahne and Reichl, 2011). This indicates 
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that the HC construct has a lower permeability to lipophilic substances than excised rabbit 
cornea. 
 
Five of the eighteen substances evaluated with the HC construct have previously been 
tested with excised human cornea. As expected based on the origin of the HC construct, the 
comparison of the Papp values obtained with the HC construct with the ones reported for 
excised human cornea resulted in a linear relationship (R2 = 0.99) for all 5 substances. This 
correlation was stronger than the one obtained for rabbit excised cornea. In addition, the 
resulting slope of the regression line was 0.94. The value suggests that the permeability of 
the HC construct is nearly equivalent to that of excised human cornea. However, the 
correlation is only based on five substances meaning a limited significance. Thus, further 
comparative permeation studies on ophthalmic drugs and model substances need to be 
conducted on excised human tissue in order to confirm the assumption mentioned above. 
In short, the findings obtained within the scope of the current study suggest that the barrier 
properties of the HC construct are comparable to those of ex vivo human and rabbit cornea 
and that its development is sufficiently advanced to be safely considered for entering into the 
next steps toward its validation. This includes the evaluation of formulation factors, i.e. the 
optimization of buffer compositions of the ophthalmic solutions that will be described in the 
next chapters. 
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4.3. Effect of formulation parameters and excipients on the barrier function of the 
HC construct 
4.3.1. Effect of pH ranging from 4.5 to 8.0 on the permeability of the HC construct 
The pH of ophthalmic solutions plays an important role for the chemical stability of active 
compounds, drug bioavailability, as well as the associated ocular comfort or adverse 
reactions (Small et al., 1997a; Small et al., 1997b; Ahuja et al., 2006). In this chapter, the 
effect of different buffer solutions frequently used in ophthalmic preparations, such as citrate, 
acetate and borate buffer and buffer solutions used in the cell cultivation such as PBS, HBSS 
and KRB (at different pH) were evaluated using the HC model based on the TEER values 
and the permeation of two hydrophilic permeation markers (Na-FLU and 14C-mannitol, 
hereafter referred to as mannitol). These measured values were compared with those of 
KRB at pH 7.4, which served as control. 
4.3.1.1 Influence of buffers: citrate pH 4.5, acetate pH 5.5 and borate pH 8.0 
The effect of three ophthalmic buffer solutions (citrate buffer at pH 4.5, acetate buffer at pH 
5.5 and borate buffer at pH 8.0) on the HC construct was evaluated. These solutions 
contained either the hydrophilic substance Na-FLU or mannitol, which served as transport 
solutions. The effect was evaluated by measuring the TEER (Figure 4-9) in KGM culture 
medium (black bars) as starting point. The TEER values achieved with each of the buffer 
solution were then measured after a preincubation time of 60 min before starting permeation 
experiments (gray bars) and at the end of the experiments after 390 min (pallid gray bars).  
 
The Figure 4-9 clearly shows changes in the TEER values overtime caused by the different 
buffer solutions applied to the HC construct. However, only the citrate (pH 4.5) and borate 
buffer (pH 8.0) containing 10 µg·mL-1 of Na-FLU significantly affected the TEER values of the 
HC construct in comparison to KRB pH 7.4; the citrate buffer after 60 min and 390 min (end 
of the experiments) and the borate buffer only after 390 min. With respect to the effect of the 
buffer solutions containing 1.0 µCi·mL-1 of mannitol, the citrate buffer led to a slight decrease 
in the TEER values by 14% and the acetate buffer reduced the TEER values by 22% after 60 
min of incubation. Both buffer solutions steadily reduced the TEER values of the HC 
construct to approximately 60% at the end of the experiments. Nevertheless, the observed 
reduction in the TEER values was not statistically significant when they were compared to 
the values achieved following the treatment with KRB at pH 7.4 (control solution). 
The alterations caused by the citrate buffer at pH 4.5 containing Na-FLU can be explained by 
the fact that this buffer possibly leads to a depletion of the calcium ions and consequently a 
reduction in the TEER of the HC construct. This theory is supported by the fact that citrate 
buffer is a chelating agent (Akers, 2010) and calcium ions are required for the normal 
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functioning of the epithelial barrier membrane, which need an unspecified amount of calcium 
ions (Kaur and Smitha, 2002; Zheng and Cantley, 2007). The low pH value of the citrate 
buffer solution could be another reason for a possible damage caused in the superficial 
epithelial cells of the HC construct resulting in a decrease of barrier function. Therefore, the 
effect produced by the citrate buffer at pH 4.5 containing Na-FLU could be associated with its 
acidic pH and its capacity to form complexes with calcium.  
Interestingly, the citrate buffer at pH 4.5 containing mannitol did not significantly affect the 
TEER values of the HC construct. This suggests that the assumption that the TEER value 
reduction has been caused by the acidic pH of this buffer and the possible depletion of 
calcium in the cells is questionable. However, since it was noted that citrate buffer with 
mannitol also led to a steady decrease in the TEER values throughout the duration of the 
experiments, the chelating properties and low acidic pH of this buffer are still the most 
probable reasons of the TEER values reduction. The indication that the citrate buffer 
containing mannitol did not cause a significant reduction of the TEER values could be 
explained by the fact that some excipients such as mannitol could have a protective effect on 
the HC construct. This assumption is supported by an observation recently made by 
Mohamed et al., who noted that mannitol reduced the effect of preservatives, such as 
benzalkonium chloride, on the TEER values of the corneal epithelium of rabbits (Mohamed et 
al., 2016). In addition, a similar protective effect of mannitol against cytotoxic influence of 
benzalkonium chloride was also observed with regard to an in vitro corneal model based on 
the HCE-T cell line, which has also been used in the current investigation (Nagai et al., 
2011). 
In contrast, the borate buffer with 10 µg·mL-1 of Na-FLU produced a lower reduction of the 
TEER values. However, the effect of borate buffer on the corneal epithelium is controversially 
discussed in the literature. Some investigations suggested that this buffer produces 
alterations in the tight junctions while others did not report any morphological change of the 
corneal epithelium (Gorbet et al., 2010; Lehmann et al., 2010).  
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Figure 4-9: TEER values that the HC construct reached with citrate buffer at pH 4.5, acetate buffer 
at pH 5.5, KRB at pH 7.4 and borate buffer at pH 8.0 containing Na-FLU as well as 
mannitol. For the statistical analysis, the TEER values obtained with the buffer 
solutions were normalized to the mean value of the TEER in KGM (black bar) and 
compared to the data achieved with KRB at pH 7.4 after 60 min (gray bar) and 390 
min (pallid gray bar), which served as control values. Each bar represents the mean  
SD of five to six independent experiments. 
 
Besides the TEER measurements, the effect of citrate, acetate and borate buffer on the 
permeability of the HC construct was investigated using Na-FLU (Figure 4-10) and mannitol 
(Figure 4-11). Na-FLU is a hydrophilic permeation marker whose chemical form and log P is 
pH-dependent (Sjöback et al., 1995), whereas mannitol is hydrophilic permeation marker, 
which is not influenced by changes in pH values. The Papp values of Na-FLU rose 
significantly under acid pH conditions (citrate and acetate buffer). A similar effect was 
observed when the pH of the solution was above 7.4 (borate buffer). Compared to the Papp 
values of KRB at pH 7.4, the Papp values of Na-FLU increased 37-fold for citrate, 4.9-fold for 
acetate and 5.8-fold for borate buffer. The strong enhancing effect observed for the citrate 
buffer on the permeability of the HC construct to Na-FLU was probably a consequence of the 
acid pH of the buffer solution, which made Na-FLU more lipophilic. Another reason, which 
could contribute to this effect, is the reduction of the TEER values of the HC construct 
(Figure 4-9).  
The effect of the acetate and borate buffer on the permeability of the HC construct to Na-FLU 
could only be explained by a steady decrease in the TEER values and the fact that the acidic 
conditions increase the lipophilicity of Na-FLU. These results are consistent with reports on 
experiments with excised rabbit cornea showing that alterations in the pH of the buffer 
solutions affect the lipophilicity of pilocarpine prodrugs, which consequently changes the 
permeability of excised rabbit cornea to these substances (Suhonen et al., 1998). In contrast, 
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the calculated Papp values of mannitol in citrate, acetate and borate buffers were equivalent to 
the Papp value of mannitol in KRB at pH 7.4. Thus, the Papp of mannitol was not affected by 
these buffer solutions. These results are also in good agreement with Papp values of mannitol 
observed for excised rabbit cornea when the pH of the buffer solution was decreased from 
7.65 to 5.0 (Suhonen et al., 1998). 
 
Figure 4-10: Influence of citrate buffer at pH 4.5, acetate buffer at pH 5.5 and borate buffer at pH 
8.0 on the permeation of Na-FLU through the HC construct. For the statistical analysis, 
the Papp values were compared to the data obtained with KRB at pH 7.4 (control 
values). Each bar displays the mean  SD of five to six independent experiments. 
 
 
Figure 4-11: Influence of citrate buffer at pH 4.5, acetate buffer at pH 5.5 and borate buffer at pH 
8.0 on permeation of mannitol through the HC construct. For the statistical analysis, 
the Papp values were compared to the data obtained with KRB at pH 7.4 (control 
values). Each bar displays the mean  SD of five to six independent experiments. 
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4.3.1.2 Influence of KRB at pH 5.0, 6.0, 7.4 and 8.0  
The buffer systems found in the human body are, for instance, the bicarbonate, phosphate 
and protein buffers. The Krebs-Ringer bicarbonate-buffer (KRB) is a mixed solution of 
bicarbonate and phosphate (see section 3.1.5), which can be supplemented with serum 
albumin or glucose. Thus, KRB is the solution, which is most commonly used within the 
scope of permeation studies since it provides a buffer capacity that is sufficiently strong 
(Becker et al., 2007; Hakkarainen et al., 2010; Hahne and Reichl, 2011). This part of the 
work focused on the investigation of the pH effect of KRB on the barrier function of the HC 
construct without altering the composition of the transport solution. The pH values 
investigated were 5.0, 6.0, 7.4 (control values) and 8.0 as is demonstrated from Figure 4-12 
to Figure 4-14.  
As described above, the black bars represent the TEER values of the HC construct in culture 
medium before the buffer solution was applied to apical side, the gray bars represent the 
TEER values after the preincubation time and the light gray bars show the TEER values after 
390 min (end of the experiments). Neither KRB at pH 5.0, 6.0 and 8.0 with Na-FLU, nor KRB 
at the same pH containing mannitol significantly altered the TEER values of the HC construct 
after 60 min of incubation and at the end of the experiment. This indicated that the TEER 
values of the HC construct were not considerably altered by KRB at a pH between 5.0 and 
8.0 (see Figure 4-12). 
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Figure 4-12: TEER values of the HC construct reached with KRB buffer at pH 5.0, 6.0, 7.4 and 8.0. 
For the statistical analysis, the TEER values obtained with the buffer solutions were 
normalized to the mean value of the TEER in KGM (black bar) and compared to the 
data achieved with KRB at pH 7.4 after 60 min (gray bar) and 390 min (pallid gray 
bar), which served as control values. Each bar represents the mean  SD of five to six 
independent experiments. 
 
The evaluation of the Papp indicated that KRB at pH 5.0 increased the Papp of Na-FLU about 
12-fold. At pH 6.0, the Papp of Na-FLU was only 1.7-fold higher but not significantly different 
compared to KRB pH 7.4 (see Figure 4-13). Therefore, no significant alterations in the Papp 
values were observed. Moreover, when using KRB with a pH of 8.0, the Papp of Na-FLU was 
not modified and was almost equal to the Papp of Na-FLU in KRB at pH 7.4. Since no 
significant alterations were observed with regard to the TEER values of the HC construct 
(see Figure 4-12), the change in the permeation of Na-FLU can be attributed to the increased 
log P of Na-FLU when the pH of KRB was decreased from pH 7.4 to 6.0 and 5.0, 
respectively. The log P of Na-FLU in KRB at different pH was not determined in this study, 
but there is sufficient evidence, which demonstrates that the lipophilicity of ionizable 
substances increase in a dependent-manner when the pH of the buffer solution is modified 
(Cherng-Chyi and Lidgate, 1986; Suhonen et al., 1998; Anand and Mitra, 2002; Ahuja et al., 
2006). 
As already observed with regard to ophthalmic buffers, the permeation of mannitol was not 
affected by pH values in the same range. All Papp values determined were equivalent to the 
Papp value of mannitol in KRB at pH 7.4 (see Figure 4-14). This demonstrates that the corneal 
permeability of the HC construct is not changed by non-ionic compounds such as mannitol at 
pH values 5.0 to 8.0. 
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Figure 4-13: Influence of KRB at pH 5.0, 6.0 and 8.0 on the permeation of Na-FLU through the HC 
construct. For the statistical analysis, the Papp values obtained with KRB at pH 5.0, 6.0 
and 8.0 were compared to the data obtained with KRB at pH 7.4. Each bar represents 
the mean  SD of five to six independent experiments. 
 
 
Figure 4-14: Influence of KRB at pH 5.0, 6.0 and 8.0 on the permeation of mannitol through the HC 
construct. For the statistical analysis, the Papp values obtained with KRB at pH 5.0, 6.0 
and 8.0 were compared to the data obtained with KRB at pH 7.4. Each bar represents 
the mean  SD of five to six independent experiments. 
4.3.1.3 Influence of HBSS at pH 6.5, 7.4 and PBS at pH 7.4  
The Hanks’-balanced salt solution (HBSS) has also been employed to conduct transport 
experiments. The main function of HBSS is to maintain the cell physiology and tonicity. This 
solution supplies cells with a balanced proportion of ions and energy.  
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The composition of HBSS permits to conduct permeability assays with different ionic 
concentrations compared to KRB and to investigate its influence on the barrier properties of 
the HC model. In addition, the effect of HBSS was evaluated at two different pH values, i.e. 
6.5 and 7.4 (Figure 4-15 - Figure 4-17), using Na-FLU (10 µg·mL-1) and mannitol (1.0 
µCi·mL-1), respectively.  
The evaluation of the results indicated that HBSS at pH 6.5, 7.4 and PBS at pH 7.4 
containing Na-FLU or mannitol did not have a negative effect on the TEER values after 60 
min of incubation and at the end of the transport experiment compared with those obtained 
with KRB at pH 7.4, which served as control. 
 
Figure 4-15: TEER values of the HC construct reached with HBSS at pH 6.5, 7.4, KRB at pH 7.4 
and PBS at pH 7.4. For the statistical analysis, the TEER values obtained with the 
buffer solutions were normalized to the mean value of the TEER in KGM (black bar) 
and compared to the data achieved with KRB at pH 7.4 after 60 min (gray bar) and 
390 min (pallid gray bar), which served as control values. Each bar represents the 
mean  SD of five to six independent experiments. 
 
In comparison of the effect of HBSS (pH 6.5 and 7.4) and PBS (pH 7.4) on the in vitro 
transcorneal permeation of Na-FLU, the transport rate of Na-FLU in HBSS at pH 7.4 was 
approximately two times higher than the one detected for the marker substance in KRB at pH 
7.4 (Figure 4-16). Furthermore, the Papp of Na-FLU in HBSS at pH 6.5 was increased 6.86-
fold compared to the mean Papp value of the reference value. The transport rate of Na-FLU in 
PBS was two-fold higher than the transport rate of Na-FLU in KRB at pH 7.4 (see Figure 
4-16). Surprisingly, the measurements of the TEER values after 60 min and 390 min 
demonstrated the integrity of the in vitro corneal epithelium and no significant differences 
between HBSS, PBS and KRB. 
The increase of the Papp values of Na-FLU in HBSS (pH 6.5) could be explained by the fact 
that the lipophilicity of Na-FLU increased when the pH of the HBSS was decreased from 7.4 
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to 6.5. The smaller but significantly effect of HBSS (pH7.4) and PBS (pH 7.4) could be due to 
different ionic strength of the buffer in comparison to KRB (pH 7.4), which increased the 
permeability of the HC construct to the cationic form of Na-FLU. The calculation of the ionic 
strength indicated that the ionic strength of HBSS and PBS at pH 7.4 was similar but 
significantly lower than that of KRB pH 7.4. The conclusion is based on the fact that diffusion 
potential experiments conducted by Rojanasakul and Robinson in 1989 using isolated rabbit. 
They previously demonstrated that the ionic strength of a buffer solution can influence the 
permeability of the corneal epithelium to ionic substances. They reported that the decrease 
of the ionic strength of the buffer solution resulted in an increase in the membrane selectivity 
to cations. In addition, the increase in the cation selectivity of the corneal epithelium led to an 
increase in the absolute permeability to cationic substances, and vice versa (Rojanasakul 
and Robinson, 1989). In contrast, the lipophilicity of mannitol (neutral molecule) was not 
affected by the pH of the buffer solutions. Therefore, the permeation of mannitol through the 
HC construct remained unchanged by HBSS at pH 6.5 compared to KRB at pH 7.4, as is 
represented in Figure 4-17. Moreover, within the scope of the current study, it was also noted 
that the ionic strength of HBSS, PBS at pH 7.4 did not influence the corneal permeability of 
the HC construct to mannitol in comparison to the data achieved with KRB at pH 7.4. Thus, it 
can be suggested that the ionic strength of buffer solutions has no effect on the membrane 
permselectivity to non-ionic substance such as mannitol.  
 
Figure 4-16: Influence of HBSS at pH 6.5, 7.4, KRB at pH 7.4 and PBS at pH 7.4 on the permeation 
of Na-FLU through the HC construct. For the statistical analysis, the Papp values 
obtained with HBSS at pH 6.5 and 7.4 and PBS at pH 7.4 were compared to the data 
obtained with KRB at pH 7.4 (control values). Each bar shows the mean  SD of five 
to six independent experiments. 
  
Results and Discussion 
59 
 
Figure 4-17: Influence of HBSS at pH 6.5, 7.4, KRB at pH 7.4 and PBS at pH 7.4 on the permeation 
of mannitol through the HC construct. For the statistical analysis, the Papp values 
obtained with HBSS at pH 6.5 and 7.4 and PBS at pH 7.4 were compared to the data 
obtained with KRB at pH 7.4(control values). Each bar shows the mean  SD of five to 
six independent experiments. 
4.3.2. Influence of osmolality  
This section deals with the influence of non-isotonic solutions on the in vitro permeation of 
the hydrophilic substance Na-FLU through the HC construct. The osmolality of ophthalmic 
preparations is evaluated in the preclinical phase because hypotonic or hypertonic solutions 
produce ocular discomfort and its administration can be painful for the patient (Schrage et al., 
2004).  
Within the scope of the present study, different osmolalities were obtained by modifying the 
concentrations of NaCl in the KRB (178, 252, 346 and 432 mOsmol·kg-1) and used to assess 
the applicability of the present corneal model for preclinical evaluation and formulation 
design. The effect of the different osmolalities on the barrier properties of the HC construct 
and on the permeation of Na-FLU is illustrated in Figure 4-18 and Figure 4-19. 
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Figure 4-18: TEER values that the HC construct reached with different osmolalities ranging from 
178 to 432 mOsmol. For the statistical analysis, the TEER values obtained with KRB 
with different osmolalities were normalized to the mean value of the TEER in KGM 
(black bar) and compared to the data achieved with KRB at 301 mOsmol (control 
values) after 60 min (gray bar) and 390 min (pallid gray bar) Each bar represents the 
mean  SD of five to six independent experiments. 
 
The TEER values were monitored before the donor solution was applied to the apical side 
(KGM medium, black bars). After 60 min as well as at the end of the permeation studies (390 
min) the TEER values of the HC construct were measured again to compare the effect of the 
different osmolalities. After 60 min, no significant alterations of the TEER values were 
observed for the above-mentioned range of osmolalities. Nevertheless, the most 
hypoosmotic and hyperosmotic buffer had an impact on the TEER values of the HC 
construct, causing a significant increase or reduction of the TEER values after 390 min of 
transport experiments.  
The Papp values of Na-FLU obtained with KRB (178, 252, 346 and 432 mOsmol·kg-1) were 
compared with the Papp values of Na-FLU achieved with KRB at 301 mOsmol·kg-1 (see 
Figure 4-19). It can be noted that all Papp values of Na-FLU were almost equal in the range of 
the osmolality evaluated. Thus, the observed changes in the TEER values of the HC 
construct did not cause alterations of the Na-FLU transport. Nevertheless, it has been 
reported that the deviation of osmolalities from their physiological conditions can lead to 
alterations in the transport of substances through the corneal epithelium as demonstrated for 
pilocarpine. The transcorneal permeation of pilocarpine was decreased 1.28-fold when the 
osmolality of the vehicle was 600 mOsmol·kg-1. In contrast, pilocarpine’s transcorneal 
permeation increased 1.29-fold when the osmolality was 80 mOsmol·kg-1 (Scholz et al., 
2002). For the HC construct only a modest increase in the permeation of Na-FLU was 
observed when the osmolality of KRB was increased to 432 mOsmol·kg-1, which can be 
associated with a slight reduction in the TEER values observed during the course of the 
Results and Discussion 
61 
permeation experiments. Nevertheless, KRB at 432 mOsmol·kg-1 did not cause a significant 
change in the corneal permeability of the HC construct to Na-FLU compared with KRB 301 
mOsmol·kg-1 control values 
 
Figure 4-19: Influence of different osmolalities ranging from 178 to 432 mOsmol on the in vitro 
permeation of Na-FLU through the HC construct. For the statistical analysis, the Papp 
values obtained with KRB at 178, 252, 346 and 432 mOsmol were compared to the 
data obtained with KRB at 301 mOsmol (control values). Each bar displays the mean 
 SD of five to six independent experiments. 
4.3.3. Influence of EDTA and calcium 
Ethylenediaminetetraacetic acid (EDTA) is a stabilizer and antioxidant agent used to 
maintain the stability of ophthalmic medications. Furthermore, this substance is known for its 
ability to enhance the properties of preservatives in ophthalmic products. EDTA is frequently 
found in eye drops in concentrations ranging from 0.01 to 0.1% (Furrer et al., 2002). 
Epithelial barriers are formed by zona occludens and other associated proteins, which 
contribute to the formation of tight junctions. Among others, tight junctions control the 
paracellular transport of substances and stabilize cell junctions. The divalent ion calcium is 
known to assist in the formation of tight junctions (Westphal, 2009). Taking both into 
consideration, the effect of EDTA was evaluated on the HC construct for concentrations 
ranging from 0.005% to 0.1%, which is the maximum concentration used in ophthalmic 
preparations. The EDTA donor solutions were prepared in KRB with Na-FLU (10 µg·mL-1) 
without calcium and magnesium. The effect of EDTA was compared with the values obtained 
for KRB (1.25 mM calcium with Na-FLU), hereinafter referred to as 0.0% EDTA, after 60 min 
and 390 min again, as illustrated in Figure 4-20. 
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Figure 4-20: TEER values that the HC construct reached with different EDTA concentrations. For 
the statistical analysis, the TEER values obtained with different EDTA concentrations 
were normalized to the mean value of the TEER in KGM (black bar) and compared to 
the data achieved with KRB without EDTA (referred as 0.0% EDTA) after 60 min (gray 
bar) and 390 min (pallid gray bar), which served as control values. Each bar 
represents the mean  SD of five to six independent experiments. 
 
The effect of EDTA on the TEER values of the HC construct was concentration-dependent. It 
was noted that the TEER values of the HC construct were not affected when it was exposed 
to 0.005% EDTA, neither after 60 min nor at the end of the permeation experiments (390 
min). In contrast, 0.04% EDTA reduced the TEER values by more than 50% of the initial 
TEER mean value (black bars) after 60 min of application. This effect was even stronger at 
concentrations of 0.06% and 0.1%. These values deteriorated even more at the end of 
transport experiments.  
Similar results have been previously described for EDTA experiments using excised corneal 
tissue. In excised rabbit cornea 0.05% EDTA caused morphological alterations in the corneal 
epithelium after 180 min of incubation. Moreover, the treatment of rabbit cornea with 0.04% 
and 0.4% EDTA resulted in a decrease of the TEER values after the first 60 min of 
application (Rojanasakul et al., 1990). These results are consistent with those obtained for 
the HC construct. Moreover, in vitro cytotoxicity studies using corneal epithelial cell cultures 
(human origin) indicated that the toxic effect of EDTA is dependent on the exposure time and 
the concentration used (Saarinen-Savolainen et al., 1998). 
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Figure 4-21: Permeated amount of Na-FLU with different concentrations of EDTA through the HC 
construct for a period of 390 min. For the statistical analysis, the calculated Papp values 
obtained with different concentrations of EDTA were compared to the data obtained 
with KRB without EDTA referred to as 0.0% EDTA (control values). Each point 
represents the mean  SD of five to six independent experiments. 
 
This disruption of the epithelial barrier correlates with an increase in the cumulative transport 
of Na-FLU by 27-fold for 0.1%, 12-fold for 0.06%, 7-fold for 0.04% and 2-fold for 0.005%, as 
shown in Figure 4-21. With regard to the calculated Papp through the HC construct, Na-FLU 
transport solutions with different concentrations of EDTA showed the same rank order of the 
cumulative transport described above for 0.1% > 0.06% > 0.04%. 
The permeation of hydrophilic substances would preferably take place via the paracellular 
pathway. Thus, the increase in the permeated amount of Na-FLU, which was measured on 
the receptor side indicated that a loosening of the epithelial barrier occurred due to the 
depletion of calcium. The current data are in good agreement with the effect of EDTA 
previously reported by other investigation groups, which conducted experiments with isolated 
rabbit cornea. They showed that 0.5% EDTA increased the corneal permeability of isolated 
rabbit cornea to the hydrophilic substances, such as FD-4, about 3-fold (Nakamura et al., 
2007) and about 15-fold (Sasaki et al., 1995b). 
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Figure 4-22: TEER values of the HC construct reached with KRB at 0.0, 1.25, 2.5 and 3.75 mM. 
For the statistical analysis, the TEER values obtained with KRB at different calcium 
concentrations were normalized to the mean value of the TEER in KGM (black bar) 
and compared to the data achieved with KRB at 1.25 mM (control values) after 60 min 
(gray bar) and 390 min (pallid gray bar). Each bar represents the mean  SD of five to 
six independent experiments. 
 
Calcium plays an important role regarding the tightness of epithelial barriers (Tang and 
Goodenough, 2003). Thus, calcium levels of 0.0, 1.25, 2.50 and 3.75 mM in the transport 
solution (KRB) were evaluated in the same way as done for EDTA. Concentrations higher 
than 3.75 mM calcium (e.g. 5 and 10 mM) led to the precipitation of KRB. The lack of calcium 
in the donor solution did not affect the TEER values of the HC construct during the course of 
permeability assay. The increasing of the calcium concentration to 1.25, 2.50 and 3.75 mM in 
the transport solution did neither cause a change in the TEER values nor an alteration in the 
permeated amounts of Na-FLU through the HC construct (see Figure 4-22 and Figure 4-23). 
The recorded TEER values were above 500 Ohm·cm². The fact that there was no change in 
the TEER values could be explained by the stromal equivalent of the HC construct being 
cultivated with 0.5 mM of CaCl2, which is the concentration of calcium in KGM culture 
medium. In addition, the stromal equivalent provides the in vitro corneal epithelium with 
nutrients, which help to maintain the calcium homeostasis during permeability assays. This 
indicates that the solution 0.0 mM calcium was not completely calcium-free because the 
stromal equivalent was probably saturated with calcium. 
Regarding calcium incubation of corneal tissue the effect on the corneal permeability has not 
yet been investigated within the scope of ex vivo studies with rabbit cornea. Thus, the data 
achieved with the HC construct cannot be compared to those obtained with ex vivo corneal 
tissue or with other in vitro corneal models. 
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Regarding calcium, the effect on the corneal permeability has not yet been investigated 
within the scope of ex vivo studies with rabbit cornea. Thus, the data achieved with the HC 
construct cannot be compared to those obtained with ex vivo corneal tissue or with other in 
vitro corneal models. 
 
Figure 4-23:  Permeated amount of Na-FLU with different concentrations of calcium through the HC 
construct for a period of 390 min. For the statistical analysis, the calculated Papp values 
with different concentrations of calcium were compared to the data obtained with             
1.25 mM calcium (control values). Each point symbolizes the mean  SD of five to six 
independent experiments. 
4.3.4. Summary of the evaluation of the effect of formulation parameters and 
excipients on the barrier function of the HC construct 
In this section, formulation parameters such as pH, osmolality and a number of ophthalmic 
adjuvants or excipients (i.e. EDTA and calcium), which are crucial to improve the stability and 
bioavailability of ocular drugs were investigated using the HC construct. The aim was to 
demonstrate HC's applicability in preclinical absorption studies during the phase of drug 
development. The changes in the corneal permeability induced by these formulation 
parameters and excipients were investigated by measuring the TEER values of the HC 
construct over time and by evaluating the permeability of the HC construct to Na-FLU and 
mannitol 
4.3.4.1 Evaluation of buffer solutions in the range of pH 4.5 to 8.0 
The results of the present investigation have shown the behavior of the barrier properties of 
the HC construct to different buffer solutions, covering a wide range of pH (4.5 to 8.0) in 
which ophthalmic solutions are commonly formulated. The buffer solutions evaluated in this 
study were the following: citrate buffer (pH 4.5), acetate buffer (pH 5.5), borate buffer (pH 
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8.0), HBSS (pH 6.5 and 7.4), PBS (pH 7.4) and KRB (pH 5.0, 6.0, 8.0) and KRB (pH 7.4); the 
values obtained with the latter were used as reference values.  
The changes in the TEER values demonstrated that ophthalmic buffers with Na-FLU and 
mannitol, such as acetate buffer (pH 5.5), borate buffer (pH 8.0), HBSS at pH 6.5 and 7.4, 
PBS at pH 7.4 and KRB (pH 5.0, 6.0, 8.0) only cause minor alterations in the TEER values of 
the HC construct during the course of the experiments. Moreover, the application of citrate 
buffer (pH 4.5) with mannitol to the HC construct for the same time did not significantly affect 
the TEER values. In contrast, the incubation with the same citrate buffer (pH 4.5) containing 
Na-FLU resulted in a substantial reduction in the TEER values after 60 min, and an even 
higher decrease after 390 min.  
Until today, there is no evidence, which confirms that the pH of the buffer solutions, in 
particular, citrate buffer at pH 4.5 causes any reduction in the TEER values obtained with 
isolated rabbit cornea or in vitro corneal models. Despite of the lack of evidence, it can be 
suggested that, on the one hand, the effect of citrate buffer with Na-FLU on the HC construct 
is due to the calcium chelator properties of this buffer or its low pH, which can affect the 
corneal integrity of the HC construct. On the other hand, these assumptions might be 
questionable considering that citrate buffer with mannitol did not cause any significant 
change in the TEER values. However, the results obtained with citrate buffer containing 
mannitol suggests that to some extent mannitol has a protective effect on the HC construct 
against citrate buffer at pH 4.5. This observation is supported by the toxicological studies 
previously conducted by Mohamed et al. and Nagai et al. with either isolated rabbit cornea or 
an in vitro corneal model based on the HCE-T line used in the current study. These 
investigations have shown that the presence of mannitol in ophthalmic agents can reduce the 
damaging effect of preservatives, such as benzalkonium chloride, on the superficial corneal 
epithelium of ex vivo rabbit cornea and the epithelium of the cultured corneal model, 
respectively (Mohamed et al., 2016; Nagai et al., 2011).  
Furthermore, in the current study, minor changes were seen in the TEER values following 
the application of the other above-mentioned buffer solutions containing either Na-FLU or 
mannitol. This suggests that an optimal equimolar concentration of bicarbonate and 
phosphate in the buffer system similar to those found in the human body or lacrimal fluid 
provides the HC construct with the adequate conditions to protect itself against low acidic 
solutions. 
In order to investigate how the pH of the buffer solution changes the permeability of the HC 
construct, two different hydrophilic permeation markers, Na-FLU, an ionizable substance, 
and mannitol, a non-ionizable compound, were used within the scope of the current 
investigation. The data obtained indicate that the permeability of the HC construct to Na-FLU 
can be increased without altering its TEER values when the pH of the buffer solution is 
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reduced from 8.0 to 5.0. This suggests that the lipophilicity of Na-FLU increases when the pH 
of the buffer solution is decreased. In addition, citrate buffer at pH 4.5 also led to both an 
increase in the corneal permeability to Na-FLU and a significant decrease in TEER values of 
the HC construct, which correlated with the highest Papp value achieved with buffer solutions 
containing Na-FLU.  
Except for citrate buffer containing Na-FLU, the current findings are in line with permeability 
experiments previously conducted by other groups with ex vivo animal tissue. These 
experiments demonstrated that the corneal permeability of isolated rabbit cornea to ionizable 
hydrophilic substances, such as ketorolac, pilocarpine, diclofenac, amino acids ester 
prodrugs (e.g. L-Valyl ester of aciclovir), is increased when the pH of the buffer solution was 
decreased from 7.65 to 5.0 (Cherng-Chyi and Lidgate, 1986; Suhonen et al., 1998; Anand 
and Mitra, 2002; Ahuja et al., 2006). They demonstrated that the lipophilic characteristics of 
these substances changed when the pH of the buffer solutions were altered, which however 
did not affect the integrity of the corneal barrier. Consequently, it can be concluded that an 
increasing of the lipophilicity of hydrophilic substances by changing the pH of the buffer 
solutions results in an increase of their permeation rates through the corneal epithelium, 
which is the major barrier to transport of drugs through the cornea.  
In addition, in the present study, it was seen that PBS and HBSS at pH 7.4 increased the 
corneal permeability of the HC construct to Na FLU compared to that observed with KRB at 
pH 7.4. Thus, the change in the corneal permeability to Na-FLU is a result of the different 
ionic strength of the buffer solutions. Moreover, the calculation of the ionic strength of these 
solutions indicated that the ionic strength of PBS and HBSS is similar but it is significantly 
lower than that of KRB. Thus, the data indicates that a lower ionic strength of the buffer 
solution could lead to an increase in the corneal permeability of the HC construct to Na-FLU 
considering that the predominant form of Na-FLU at neutral pH is the cation form as has 
been reported by Doughty in 2010. Therefore, these results are in agreement with the 
findings of Rojanasakul and Robinson who have demonstrated that a decrease in the ionic 
strength of the bath solution leads to an increase in the membrane permeability of isolated 
rabbit cornea to cationic substances, and vice versa (Rojanasakul and Robinson, 1989).  
Furthermore, within the scope of the present study, it was observed that none of the 
evaluated buffer solutions with a pH in the range from 4.5 to 8.0 changed the corneal 
permeability of the HC construct to mannitol. Several previously performed permeability 
studies with ex vivo rabbit tissue also demonstrated that the corneal permeability of isolated 
rabbit cornea to non-ionizable hydrophilic permeation markers, such as mannitol or glycerol, 
was not significantly affected when the pH of the buffer solution was decreased from 7.65 to 
5.0 since neither the lipophilicity of mannitol nor the corneal integrity was altered (Suhonen et 
al., 1998; Fu and Lidgate, 1986; Ahuja et al., 2006). In addition, there is no evidence 
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indicates that the ionic strength of a transport solution can alter the corneal permeability to 
non-ionizable hydrophilic substance such as mannitol.  
Thus, the results obtained in the present study are in good agreement with the data collected 
from the literature with regard to isolated rabbit cornea. 
 
In conclusion, the above-mentioned findings demonstrate that buffer solutions at pH values 
ranging from 5.0 to 8.0 are relatively harmless to the superficial epithelial cells of the HC 
construct since minor modifications have been noted with regard to the TEER values. In 
addition, the pH of the buffer solution can change the permeability of the HC construct to 
ionizable permeation markers (e.g. Na-FLU) but not to non-ionizable hydrophilic permeation 
markers (e.g. mannitol), which has also been previously reported for the isolated rabbit 
cornea. These findings support the conclusion that the HC construct is an in vitro corneal 
model, which can be used in the development of new ophthalmic solutions.  
4.3.4.2 Influence of osmolality 
This part of the current study was to investigate the effect of non-isotonic solutions on the 
corneal integrity of the HC construct and also to assess whether these solutions can produce 
an increase of the corneal permeability to the hydrophilic permeation marker Na-FLU. The 
effect of the osmolality was evaluated using KRB containing Na-FLU in the range of 178 to 
432 mOsmol·kg-1. The data obtained with KRB containing Na-FLU at 301 mOsmol·kg-1 
served as control values.  
The findings of the current study with the HC construct demonstrated that only KRB at 178 
mOsmol·kg-1 led to an increase in the TEER values at the end of the transport experiments. 
In contrast, when the HC construct was exposed to KRB at 432 mOsmol·kg-1, the TEER 
values significantly decreased after 390 min. Until today, there is no evidence, which 
confirms that the exposure of isolated rabbit cornea to non-isotonic solutions results in 
changes in the TEER values.  
The analysis of the permeation rates of Na-FLU with the different osmolalities demonstrated 
that none of the non-isotonic solutions has been able to change the corneal permeability of 
the HC construct to Na-FLU. Previously conducted permeability studies with rabbit corneal 
epithelial cells demonstrated that non-isotonic solution at 80 mOsmol·kg-1 and                             
600 mOsmol·kg-1 changed the corneal permeability of the in vitro corneal model used 
(Scholz et al., 2002). However, these osmolalities were out of the scope of the current study 
since no ophthalmic medication formulated with the mentioned osmolalities was found. 
In conclusion, the application of non-isotonic ophthalmic solutions causes lacrimation, which 
accelerates the drug elimination process and consequently reduces the ocular bioavailability 
(Urtti, 2006). These factors play an important role in vivo. However, the in vitro HC construct 
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is not able to mimic these factors, which may be the reason why non-isotonic solutions have 
no effect on the corneal permeability of the HC construct. 
4.3.4.3 Influence of EDTA and calcium 
Ethylenediaminetetraacetic acid (EDTA) is a calcium chelating agent, which is frequently 
used in ophthalmic medications to improve the antimicrobial action of preservatives (Furrer et 
al., 2002; Heydari et al., 2013). Nevertheless, it has been reported that EDTA can affect the 
corneal integrity and change the corneal permeability to drugs (Grass et al., 1985). Thus, one 
of the aims of the present study was to evaluate the effect of EDTA on the barrier properties 
of the HC construct. For this reason, EDTA concentrations ranging from 0.005% to 0.1% 
were dissolved in KRB containing Na-FLU (without calcium). The data obtained with KRB 
containing Na-FLU (without EDTA) served as reference values and the solution was defined 
as 0.0% EDTA. Furthermore, this KRB solution also contained 1.25 mM calcium, which is the 
extracellular concentration in mammalian cells.  
In addition, the effect of calcium was also investigated at different concentrations within the 
scope of permeation studies, using KRB containing Na-FLU and calcium at concentrations 
ranging from 0.0, 1.25, 2.50 and 3.75 mM. Concentrations higher than 3.75 mM calcium (e.g. 
5 and 10 mM) were not investigated since it was found that they led to the precipitation of 
KRB. The data obtained with KRB containing Na-FLU (1.25 mM calcium) served as 
reference values.  
The findings of the current study indicate that the application of 0.005% EDTA to the HC 
construct has not caused any alteration in the TEER values during the entire course of the 
experiments. In contrast, 0.04% EDTA decreased the TEER values after 390 min. Moreover, 
when the HC construct was exposed to 0.06% and 0.1% EDTA, the reduction in the TEER 
values was even stronger after 60 min and 390 min than the reduction noted for 0.04% 
EDTA. This demonstrates that effect of EDTA on the HC construct is concentration and time-
dependent. Moreover, it has also been demonstrated that the reduction in the TEER values 
correlated with a substantial increase in the corneal permeability of the HC construct to Na-
FLU compared with the values obtained with KRB without EDTA.  
The effect of EDTA noted with regard to the barrier function of the HC construct is in good 
agreement with that reported in the literature for isolated rabbit cornea. Rojanasakul et al. 
demonstrated that 0.05% EDTA damaged the superficial corneal epithelium after 180 min of 
application. In addition, they found that 0.05% and 0.5% EDTA led to a steady decrease in 
the TEER values, which started after the first 45 min of application and lasted until the end of 
the investigation (180 min) (Rojanasakul et al., 1990). Furthermore, Saarinen-Savolainen et 
al. demonstrated that high concentrations of EDTA (e.g. 0.04%) significantly reduced the 
percentage of living cells of the cultured human corneal epithelial cells after 60 min of 
application (Saarinen-Savolainen et al., 1998). Moreover, Nakamura and co-workers 
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demonstrated that 0.5% EDTA increased the corneal permeability of isolated rabbit cornea to 
hydrophilic permeation marker, such as FD-4, which correlated with a substantial reduction in 
the TEER values during the entire course of the experiments (Sasaki et al., 1995b; 
Nakamura et al., 2007). Moreover, it has been proposed that the effect of EDTA on the 
barrier function of the corneal epithelium is caused by calcium depletion on the cells that 
induces the disruption of the actin filaments and, as a consequence, a disruption of the tight 
junctions. The cytotoxic properties of EDTA have also been specified as a possible reason 
for its effect on the barrier function of the corneal epithelium (Rojanasakul and Robinson, 
1991; Sasaki et al., 1995b; Nakamura et al., 2007).  
 
Regarding the influence of the calcium concentrations during permeability assays, none of 
the tested calcium concentrations had an effect on the TEER values or the corneal 
permeability of the HC construct to Na-FLU. The present study is the first to investigate the 
effect of calcium during transport experiments, and, thus, there is no evidence available on 
isolated rabbit cornea to confirm the results obtained with the HC construct. In order to 
demonstrate that the results achieved within the scope of the present investigation are valid, 
the same experiments should be conducted with isolated rabbit cornea. 
On the basis of the current results it can be concluded that EDTA affects the in vitro corneal 
integrity in a concentration and time-dependent manner and that it can also increase the 
corneal permeability of the HC construct to the hydrophilic permeation markers, such as Na-
FLU, in a way that is similar to that previously reported for ex vivo experiment with isolated 
rabbit cornea. In addition, it was found that transport solutions without calcium or with 
calcium concentrations higher than 1.25 mM neither affect the TEER values nor the corneal 
permeability of the HC construct to Na-FLU. 
Other kinds of excipients frequently found in ophthalmic medications are preservatives such 
as benzalkonium chloride, cetrimide and Purite®, among others. The effect of these 
substances on the barrier properties of the HC construct will be described in the next 
chapter.  
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4.4. Preservative effects on the HC construct 
This section describes the influence of adjuvants, such as preservatives, which could 
besides their primary function also modify the in vitro epithelial barrier, facilitate or affect the 
permeation of drugs through the HC construct. Preservatives are commonly found in 
pharmaceutical preparations, such as ophthalmic solutions, and contact lens solutions. 
However, their use can cause adverse reactions that may lead to alterations of the ocular 
bioavailability. Thus, the impact of the most relevant opthalmic preservatives on the barrier 
properties of the HC construct and their influence in permeability assays were investigated.  
4.4.1. Evaluation of preservatives using the HC construct 
This investigation examined the influence of frequently used preservatives on the barrier 
properties of the HC construct. For this purpose, the changes of the TEER values were used 
again to determine the effects on the HC construct.  
The effect of the preservatives was evaluated as described in section 3.2.8. In brief, for each 
preservative, 500 µL of a donor solution containing the respective preservative at different 
concentrations was added to the apical side of the HC construct. The, TEER values were 
then checked at different time points. The TEER values were evaluated to define an 
acceptance limit for the tolerance level of the HC construct for the preservatives. This 
acceptance limit was established in accordance with the quality criterion previously obtained 
during the transfer phase of the prevalidation of the HC construct (see section 4.1.1). Based 
on these requirements, the HC construct can tolerate a preservative concentration when both 
this concentration does not lead to a reduction of TEER values below 400 Ohm·cm² and the 
reduction of the TEER values does not exceed 50% compared to the initial TEER values.  
The TEER values of preservative-free KRB served as negative control and 1.0% sodium 
dodecyl sulfate (SDS) solution served as positive control. The effect of the preservatives on 
the TEER of the HC construct is shown from Figure 4-24 to Figure 4-30. 
4.4.1.1 Benzalkonium chloride 
The preservative benzalkonium chloride (BAC) is a quaternary ammonium salt, which is 
active against fungi, gram-positive and gram-negative bacteria. BAC is found in ophthalmic 
preparations in concentrations from 0.004% to 0.02% (Ryan et al., 2011). The effect of BAC 
on TEER was investigated for a concentration range from 0.0005% to 0.1% (see Figure 
4-24).  
For preservative-free KRB, which served as a negative control within the first 10 min a 
decrease of TEER values was detected, which is attributed to the experimental approach. 
After this initial decrease the TEER values stabilized in the range of 500-600 Ohm·cm² for 
the rest of the experiment. Furthermore, it can be seen that all concentrations of BAC 
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reduced the TEER values already after 10 min of application. The extent of this effect was 
dependent on the concentration of BAC. A stronger decrease of the TEER values than that 
caused by KRB was interpreted as a possible damage of the epithelial barrier of the HC 
construct. After 10 min, the TEER values observed for 0.0005% and 0.001% BAC increased 
steadily to above 450 Ohm·cm² until 60 min. Thereafter, the TEER values for BAC 0.0005% 
remained constant, while the TEER values for BAC 0.001% began to decrease slowly to 
about 321 Ohm·cm² until the end of the experiments. Higher BAC concentrations than 
0.001% had a strong impact on the TEER values already after 10 min of application. These 
TEER values remained below 100 Ohm·cm² throughout the rest of the experiments.  
 
 
Figure 4-24: Mean ± SD of TEER values of the HC construct in function of time obtained after 
incubation with several concentrations of BAC compared to preservative-free KRB 
 
Some previous studies have been described on the effect of BAC on corneal epithelium. In 
vivo studies with rabbits showed that 0.05% BAC led to a reduction of the TEER values from 
600 Ohm·cm² to about 350 Ohm·cm² after only 5 s of application. In contrast, the TEER 
values of rabbit cornea treated with physiologic saline remained unchanged (control). 
Furthermore, the histopathological evaluation using electron microscopy showed that 0.05% 
BAC damaged the superficial corneal epithelial cells and the junctions between cells, which 
indicated the loss of tight junctions (Uematsu et al., 2007). A similar in vivo study also 
disclosed that BAC concentrations higher than 0.002% caused a significant reduction of the 
TEER values after 1 min of administration, whereas concentrations lower than 0.002% did 
not significantly reduce the TEER values in comparison to the control values generated by 
the application of HBSS during the same time (Kusano et al., 2010). Furthermore, an ex vivo 
study carried out with isolated rabbit cornea by Nakamura et al., 2007 has demonstrated that 
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BAC concentrations of 0.002%, 0.01% and 0.05% concentrations are able to cause a 
reduction of the TEER values to about 45% (0.002%), 85% (0.01%) and 90% after 80 min of 
application. Within the scope of the further examination of the TEER values, the same group 
also noted that the epithelial resistances continued to decrease gradually over 160 min. 
Thus, these data are in good agreement with those obtained for the HC construct. In 
addition, Kusano et al. observed that the application of 0.005%, 0.01% and 0.02% BAC for 
60 s reduced the percentage of living cells of in vitro cultivated rabbit corneal epithelial cells 
to about 30%, 70% and 80% in comparison to the control values (Kusano et al., 2010). In 
contrast, concentrations lower than or equal to 0.002% neither reduced the percentage of 
living cells nor the TEER values (Kusano et al., 2010). Furthermore, this group has been able 
to establish a linear correlation between TEER values and cell vitality. Moreover, in a series 
of in vitro experiments, Ayaki et al. reported cytotoxic effects for cultured human and rabbit 
corneal epithelial cells when these were exposed to ophthalmic solutions with BAC 
concentrations of 0.005%, 0.01% and 0.015% for 10 min, 20 min, 30 min, 60 min and 48 
hours. They concluded that BAC had a toxic effect on the cultured cells that was dependent 
on the concentration and the exposure time (Ayaki et al., 2008; Ayaki et al., 2010).  
The effect seen in the current investigation with regard to the different BAC concentrations 
on the HC construct is equivalent with those found for in vivo and isolated rabbit cornea. 
Furthermore, it can also be suggested that there is a strong correlation between the BAC 
concentration and the reduction in TEER values, which is probably due to the toxic effect of 
BAC on the reconstructed corneal epithelium as has also been observed within the scope of 
in vitro toxicological experiments. All these facts indicate that the HC construct has a level of 
sensitivity to BAC, which is comparable to that reported for rabbit cornea 
4.4.1.2 Cetrimide 
The preservative cetrimide (Ce) is also a quaternary ammonium salt like BAC. The difference 
between Ce and BAC and is that the latter is effective against gram-positive, gram-negative 
bacteria and has also wide spectrum against fungi. However, Ce is not active against all 
bacteria and fungi. The maximum concentration of Ce used in pharmaceutical eye drops is 
0.005% (Furrer et al., 2002; Bron et al., 1998).  
The effect of this preservative was investigated in the HC construct for a concentration of 
0.0005% and 0.005% (see Figure 4-25). The evaluation of the TEER values indicated that 
the barrier function of the HC construct exceeded the limit of 400 Ohm·cm² following the 
application of 0.0005% and 0.005% Ce and remained unaffected throughout the course of 
the experiments.  
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Figure 4-25: Mean ± SD of TEER values of the HC construct in function of time obtained after 
incubation with some concentrations of Ce compared to preservative-free KRB 
 
Unfortunately, no TEER data are yet available in the literature for Ce using in vivo, ex vivo or 
in vitro corneal models. Hence, the results obtained for Ce with the HC construct cannot 
directly be compared with the aforementioned corneal models. However, several research 
groups have used microscopic analyses to evaluate the effect of ophthalmic solutions or 
excipients, taking into account the corneal epithelial cell morphology (Furrer et al., 2000; 
Reichl et al., 2005; Kusano et al., 2010). Microscopic analyses are used to control the 
integrity of the superficial cells and the tight junctions between them. In this context confocal 
microscopy experiments on albino rabbits have demonstrated that 0.01% and 0.02% Ce 
instilled into the rabbit eyes, three drops daily for about three weeks, did not produce any 
morphological alteration in the corneal epithelium and stromal cell layers (Mahmoud, 2007; 
Mahmoud et al., 2011). Furthermore, Matsuda et al. have also demonstrated that high Ce 
concentrations are toxic to the corneal epithelial cells. In their experiments, they observed 
that the application of 0.05%, 0.5% and 1.0% Ce for 30 min reduced the percentage of living 
cells of cultured rabbit corneal epithelial cells (3D corneal model) to about 60%, 10% and 5% 
respectively (Matsuda et al., 2009).  
The above-mentioned evidence revealed that 0.01% Ce does not significantly change the 
morphology of rabbit cornea suggesting no influence on the barrier properties of the corneal 
epithelium. These findings are consistent with the results obtained within the scope of the 
current investigation. 
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4.4.1.3 Methylparaben 
The preservative methylparaben (MP) is a member of the parabens family. MP is an ester of 
p-hydroxybenzoic acid, which is effective against fungi but has only a limited activity against 
bacteria. This preservative is not frequently used in ophthalmic solutions. Nevertheless, it 
can be found in concentrations between 0.001% and 0.1% (Epstein et al., 2009; Furrer et al., 
2002). This concentration range was evaluated with the HC construct (see Figure 4-26). It 
can be noted that all concentrations of MP altered the TEER values of the HC construct after 
the first 10 min of application again. In addition, it can be seen that MP concentrations of 
0.001% and 0.05% caused roughly the same effect as preservative-free KRB after 20 min. In 
contrast, a stronger decrease of the TEER values was observed for the MP concentration of 
0.1%. After 30 min of application, the TEER values for 0.001% MP were still above 450 
Ohm·cm² and remained at this level until 390 min, whereas the TEER values for 0.05% MP 
began to decrease slightly to about 270 Ohm·cm² until the end of experiment. In contrast, 
0.1% MP led to a gradual decrease in the TEER values from 250 Ohm·cm² to about 200 
Ohm·cm² until 60 min of incubation. After this time they fell below 100 Ohm·cm² until 390 min 
of incubation. 
 
 
Figure 4-26: Mean ± SD of TEER values of the HC construct in function of time obtained after 
incubation with several concentrations of MP compared to preservative-free KRB 
 
Unfortunately, the effect of MP on the TEER values measured on isolated human or rabbit 
cornea has not yet been reported to date. Thus, a comparison between the TEER values of 
the different corneal models with regard to the preservative MP is not available. 
Nevertheless, one research group used confocal microscopy to evaluate the effect of MP on 
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corneal epithelial cell morphology following its topical application. They conducted in vivo 
animal experiments with rats and demonstrated that a daily dose of 0.005% MP instilled into 
the eyes of the test animals for one month led to significant morphological alterations in the 
corneoconjuntival epithelium (Becquet et al., 1998). In addition, further toxicological in vitro 
experiments have been conducted to evaluate the effect of MP on cultured human corneal 
epithelial cells. For instance, one in vitro study demonstrated that more than 50% of the cells 
survived after 60 min of incubation with 0.004% MP (Saarinen-Savolainen et al., 1998). 
Another in vitro study described that the treatment of cultured human corneal epithelial cells 
with 0.001%, 0.05% and 0.1% MP for 60 min resulted in the death of approximately 36%, 
67% and 77% of the cells (Epstein et al., 2009). Altogether, these studies indicate that MP at 
concentrations ranging from 0.004% to 0.1% significantly changes the superficial corneal 
epithelium. Thus, the results of the current investigation are in good agreement with those 
effects seen in in vivo and in vitro experiments.  
4.4.1.4 Thiomersal 
The preservative thiomersal (Thio) is an organomercury substance and is used as 
bacteriostatic and fungistatic agent in ophthalmic solutions in concentrations from 0.001% to 
0.02% (Furrer et al., 2002); 0.0025% is the most frequently used concentration (Epstein et 
al., 2009). The influence of Thio on the HC construct was investigated for a concentration 
range from 0.00005% to 0.02% (see Figure 4-27). The TEER values for Thio 0.00005%, 
0.0005% and 0.005% indicated that these concentrations induced the same effect as 
preservative-free KRB during the first 60 min of exposure. After 60 min, the TEER values for 
0.0005% and 0.005% began to exhibit a different trend. For KRB the TEER values increased 
slightly and remained constant, while for Thio 0.00005% a slight decrease in the TEER 
values from 550 Ohm·cm² to about 450 Ohm·cm² was observed until the end of the 
experiments. However, the TEER values for Thio 0.0005% and 0.005% constantly 
decreased until they reached a value of below 200 Ohm·cm² after 390 min of exposure.  
With respect to the highest Thio concentration tested (0.02%), a stronger effect was 
observed during the first 60 min of incubation in which the TEER values decreased even 
more than the values for Thio 0.005%. A steady decrease of the TEER values was observed 
after this time. The TEER values fell to approximately 100 Ohm·cm² until the end of the 
experiments. 
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Figure 4-27: Mean ± SD of TEER values of the HC construct in function of time obtained after 
incubation with several concentrations of Thio compared to preservative-free KRB 
 
The data obtained in the current investigation are in good agreement with those obtained by 
Burstein and Klyce in 1977. In their study they investigated the effect of Thio in the range 
from 0.00004% to 0.0004% on isolated rabbit cornea. For instance, 0.0004% Thio led to the 
detachment of approximately 50% of the superficial epithelial cells after 90 min of application. 
This change in the corneal epithelium correlated with a reduction of the transcorneal 
resistance. Furthermore, a decrease of the transcorneal resistance did not occur until 45 min 
of incubation, the point when the process of detachment of superficial epithelial cells started. 
At a concentration of 0.0001%, Thio affected to some extent the epithelial surface of the 
isolated rabbit cornea after 90 min of incubation. In contrast, 0.00004% Thio neither 
produced a morphological alteration of the superficial epithelial cell layers nor a change in 
the transcorneal resistance after 120 min of incubation (Burstein and Klyce, 1977). Moreover, 
it has been demonstrated in in vitro experiments that 0.0001%, 0.0005% and 0.01% Thio 
reduces the percentage of living human corneal epithelial cells to about 30%, 20% and 4% 
after 60 min of incubation (Epstein et al., 2009). These results suggest that Thio can affect 
the integrity of the corneal epithelium in concentrations ranging from 0.0004% to 0.01%. 
Thus, the data reported for ex vivo rabbit cornea and in vitro corneal models are consistent 
with the data obtained with the HC construct. 
4.4.1.5 Polyquaternium-1 
The preservative polyquaternium-1 (Polyquad® - PQ-1) is a polymeric quaternary ammonium 
salt with antimicrobial activity. The effect of PQ-1 on the HC construct was evaluated at 
concentrations ranging from 0.0000005% to 0.0005% (see Figure 4-28).  
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Figure 4-28: Mean ± SD of TEER values of the HC construct in function of time obtained after 
incubation with several concentrations of PQ-1 compared to preservative-free KRB 
 
After 30 min of application all concentrations of PQ-1 affected the TEER to an extent, which 
is roughly comparable to preservative-free KRB. Thereafter, PQ-1 0.0000005% increased 
the TEER values until 90 min, whereas PQ-1 0.00025% slightly decreased the TEER values 
until 60 min. Afterwards, the TEER values for these concentrations of PQ-1 were relatively 
stable until the end of the assays. In contrast, for PQ-1 0.0005%, the TEER values were only 
stable until 30 min. A steady decrease in the TEER values was observed after this time. The 
values decreased to approximately 450 Ohm·cm² until the end of the experiments. 
 
Although, in the current in vitro study, the maximum PQ-1 concentration evaluated was 
0.0005%, the current results are congruent with those obtained in vivo by other research 
groups. Within the scope of an in vivo study described in 1991, the authors first exposed 
rabbit cornea to ruthenium red (a diagnostic substance that is used to detect the disruption of 
tight junctions) and then the rabbit cornea was treated with 0.001% PQ-1 for 90 min and 180 
min. Transmission electron microscopy was used to examine the isolated rabbit cornea. The 
analysis showed that ruthenium red was found between the cells of the superficial epithelium 
indicating that 0.001% PQ-1 damaged the corneal tissue (López and Ubels, 1991). In 
addition, other groups indirectly evaluated the toxicity of 0.001% PQ-1 using in vitro cultured 
human corneal epithelial cells, which were exposed to a mixture that contained 0.001% PQ-1 
(Ammar et al., 2010; Paimela et al., 2012). Ammar et al. found that travoprost preserved with 
0.001% PQ-1 reduced the living cells to 80% after 25 min of incubation (Ammar et al., 2010). 
A similar investigation also showed that pure 0.001% PQ-1 reduced the percentage of living 
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cells to about 60% after 30 min of application (Paimela et al., 2012). These studies suggest 
that PQ-1 can cause a disruption of the superficial rabbit corneal epithelium in vivo and has a 
toxic effect, which leads to the death of about 30% of corneal epithelial cells in vitro.  
In the current investigation, 0.0005% PQ-1 decreased the TEER values of the HC construct 
after 30 min of application. Thus, it can be assumed that concentrations higher than 0.0005% 
PQ-1 have an even stronger effect on the TEER values. In addition, measuring the TEER 
values also demonstrates that PQ-1 concentrations lower than 0.001% (e.g. 0.0005%) can 
affect in vitro the integrity the barrier function of the HC construct. Furthermore, it can be also 
assumed that this alteration is due to the toxic effect of PQ-1 as previously proven in 
cytotoxicity studies in vitro. 
4.4.1.6 Purite® 
The preservative Purite® is a stabilized oxychloro complex with antibacterial, antifungal and 
antiviral activity (Kaur et al., 2009). Its effect on the HC construct was evaluated for 
concentrations ranging from 0.00005% to 0.005% (see Figure 4-29), the latter being the 
concentration used in ophthalmic solutions (Galanopoulos and Goldberg, 2009).  
As it was already observed within the scope of the evaluation of other preservatives, all 
tested concentrations of Purite® (0.00005%, 0.0005%, 0.001% and 0.005%) caused a 25% 
alteration of the TEER values of the HC construct, which was also noted for preservative-free 
KRB during the first 10 min of incubation. Interestingly, the TEER values increased slightly 
until 90 min of the experiments. After this time, the TEER values did not change significantly 
until the end of the tests. In addition, it can also be seen in Figure 4-29 that there is a 
relatively high variation in the average TEER values. This can be due to the different 
expression levels of zona occludens during the cultivation of the HC construct, which has 
influence on the corneal barrier function of the model. 
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Figure 4-29: Mean of TEER values ± SD of the HC construct in function of time obtained after 
incubation with several concentrations of Purite® compared to preservative-free KRB 
 
The influence of pure Purite® on TEER has not yet been investigated neither on native 
corneal tissue nor on cultured corneal cells. The present study is the first to evaluate this 
effect on the HC construct in in vitro experiments. Thus, the current data cannot be directly 
compared to the aforementioned corneal models. However, one group studied the influence 
of this preservative indirectly in vivo with artificial tears containing 0.005% Purite® (Way et al., 
2001). They used scanning electron microscopy to analyze the appearance of the rabbit 
corneal epithelium after the instillation of the artificial tears with 0.005% Purite® into the eyes 
of the test animals four times a day for one week. The results showed that 0.005% Purite® 
did not cause corneal epithelial damage and did not affect the epithelial tight junctions. In 
contrast, another in vivo experiment with rabbits revealed that the long-term administration of 
the eye drops brimonidine that are formulated with 0.005% Purite® (administered between 
once and twice on a daily basis for one month) into the eye can have a disruptive effect on 
the corneal epithelium (Noecker et al., 2004). The evidence indicates that the influence of 
Purite® on the corneal epithelium can potentially be associated with the duration of the 
treatment.  
In summary, the present work shows that Purite® (in concentrations ranging from 0.00005% 
to 0.005%) does not affect the barrier function of the HC construct during 390 min of 
application. Nevertheless, it cannot be ruled out that an exposure time longer than 390 min 
could lead to a dysfunction of tight junctions of the HC construct.  
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4.4.1.7 sofZia® 
An alternative preservative system, which has recently been introduced into the market, is 
the buffered preservative system called sofZia®. This buffer system has antibacterial and 
antifungal activities. The original composition developed by Chowhan et al., 2010, was 
adapted for the current investigation since HP-Guar is not part of sofZia® preservative system 
and propylene glycol leads to precipitation of the solution (see section 3.1.5).  
The results of this study are shown in Figure 4-30. It can be noted that the TEER values 
increased after 10 min of application. Interestingly, these values were stable almost until 90 
min, thereafter the TEER values decreased with a constant rate of approximately 300 
Ohm·cm² per hour until reaching a level of about 240 Ohm·cm² until 390 min of incubation.  
 
 
Figure 4-30:  Mean ± SD of TEER values of the HC construct in function of time obtained after 
incubation with sofZia® at pH 7.9 compared to preservative-free KRB at pH 7.4 
 
sofZia® has been recognized by the United States Pharmacopoeia as an alternative 
preservative system to be used in topical multidose medications and is also considered to be 
relatively harmless to the corneal surface in the way it is currently used, for instance, in the 
ophthalmic medication sofZia®-preserved travoprost (Ryan et al., 2011, Noecker, 2007). 
Nevertheless, the effect of pure sofZia® on the barrier function of the human or rabbit cornea 
has been poorly investigated until today. As a consequence, no precise TEER values that 
would indicate how the barrier function is affected by sofZia® have been reported to date. 
However, the effect of sofZia®-preserved travoprost has been evaluated in vivo with regard to 
the morphology of rabbit cornea. In 2006, Whitson et al. demonstrated that neither the 
application of one drop of travoprost with sofZia® over 3 min nor the application of 1 drop per 
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min for 3 min resulted in changes of the superficial corneal epithelium or the cell size of the 
cornea of the test rabbits (Whitson et al., 2006). In addition, in 2008, Kahook and Noecker 
evaluated the histopathological effect of sofZia®-preserved travoprost with the 
aforementioned corneal model in a study, which involved the administration of one dose per 
day for 30 days. In this in vivo experiment, they reported no significant damage to superficial 
cells and concluded that travoprost formulated with sofZia® had only a minimal toxic effect on 
the corneal surface (Kahook and Noecker, 2008). In contrast, in vivo studies with human 
participants involving the long-term application of travoprost with sofZia® for three months 
revealed that this ophthalmic medication caused the death of small groups of corneal 
epithelial cells. This effect on the corneal surface was directly attributed to the preservative 
system sofZia® and not to the active substance travoprost (Aihara et al., 2013). In addition, in 
vitro cytotoxic studies with sofZia® disclosed that this preservatives decreased the 
percentage of living cells of cultured human corneal epithelial cells to 30% after 25 min of 
incubation (Kahook et al., 2008). These reports suggest that sofZia® affects the integrity of 
the corneal barrier to a certain degree. 
The data achieved within the scope of current investigation demonstrate that sofZia® does 
not produce any changes in the HC construct during the first 90 min of application. This 
suggests that the tight junctions between the superficial cells of the HC construct have not 
been affected during this time that is similar to the observations made by Whitson et al. 
Nevertheless, a steady decrease of the TEER was measured after this time indicating that 
sofZia® affected the tight junctions of the HC construct. Thus, these findings confirm that 
sofZia® can induce alterations in the in vitro superficial corneal epithelium as also 
demonstrated in in vivo experiments with rabbits by Aihara et al. (Aihara et al., 2013). In 
addition, this alteration seen in the HC construct can be associated to the low toxic effect that 
sofZia® revealed on cultured human corneal epithelial cells as Kahook et al. observed in in 
vitro experiments (Kahook et al., 2008).  
In summary, it can be concluded that the results of the current investigation are consistent 
with those obtained in vivo. Moreover, it can also be assumed that the HC construct displays 
similar barrier properties as native rabbit tissue when sofZia® is applied for a short time. In 
addition, the reduction of the TEER values of the HC construct after 90 min was probably 
caused by the toxic effect sofZia® as previously described by Kahook et al. (Kahook et al., 
2008). 
4.4.2. Influence of preservatives in permeability assays 
In this section the permeability of the HC construct to the hydrophilic compound Na-FLU and 
the non-hydrophilic drug bimatoprost was evaluated under the influence of different 
preservative concentrations (0.0005% BAC; 0.001% MP, 0.00005% Thio, 0.0005% PQ-1, 
0.005% Purite® and sofZia®), which caused minor changes in the TEER values. The effect of 
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the preservatives on the permeability of the HC construct was evaluated considering the Papp 
values of Na-FLU and bimatoprost. Furthermore, the BAC concentration of 0.005% BAC, 
which is known to have a negative impact on the barrier function of the HC construct, was 
used as a positive control to demonstrate that a significant reduction in the TEER values of 
the HC construct results in an increase of corneal permeability to hydrophilic compounds. 
The donor solutions containing Na-FLU or bimatoprost as well as the different preservatives 
were prepared in KBR at pH 7.4, except for the preservative sofZia®, which is a buffer 
solution at pH 7.9. The resulting Papp values of Na-FLU and bimatoprost were compared with 
those obtained without preservatives. An enhancement factor (Ef) was calculated in order to 
assess the effect of these preservatives. The Ef was defined as the ratio between the Papp of 
the test substances with preservative and the Papp of the test substances without 
preservative. Finally, the results achieved with the HC construct were compared with those 
available in the literature in order to evaluate the degree of comparability between the barrier 
properties of the HC construct and that of native corneal tissue following the exposure to 
preservatives. 
4.4.2.1 Permeation of sodium fluorescein through the HC construct in presence and 
absence of preservatives 
The cumulative transport of Na-FLU in absence and presence of preservatives for 
ophthalmic use is illustrated in Figure 4-31 and Figure 4-32. 
 
Figure 4-31: Permeated amounts per unit area of sodium fluorescein (Na-FLU) from preservative-
free KRB and KRB containing benzalkonium chloride (BAC), methylparaben (MP) and 
thiomersal (Thio) versus time. Each point shows the mean  SD of five to six 
independent experiments. 
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The permeated amount of Na-FLU under influence of BAC 0.005% was 27-fold higher 
compared to preservative-free Na-FLU, whereas the permeated amount of Na-FLU in KRB 
with BAC 0.0005% was almost in the same range as the amount determined for 
preservative-free Na-FLU. The resulting Papp achieved with Na-FLU was significantly 
increased by 0.005% BAC, which was accompanied by a reduction of the TEER values of 
the HC construct. In contrast, the Papp obtained for Na-FLU was not significantly influenced in 
the presence of BAC 0.0005% and the TEER values remained constant at about 670 
Ohm·cm2 (see Table 4-3). Furthermore, MP 0.001% neither affected the permeability of the 
HC construct to Na-FLU nor the TEER values. Similar results were found for 0.00005% Thio. 
However, it was noted that the TEER values significantly decreased at the end of the 
transport experiment (see Figure 4-31 and Figure 4-32).  
The Papp and TEER values, which were obtained for Na-FLU in combination with various 
preservatives at different concentrations are summarized in Table 4-3. 
Table 4-3: Papp and TEER values (mean  SD) calculated for Na-FLU with and without 
preservatives 
Preservative 
[%(m/v)] 
Mean ± SD 
Enhancement 
Factor  
TEER [Ohm·cm²] Papp 10-7 
[cm·s-1] Medium 60 min 390 min 
preservative-free 711 ± 128 674 ± 254 653 ± 194 2.92 ± 0.85 --- 
0.005% BAC  1075 ± 131 77 ± 8 56 ± 11 76.94 ± 4.66 26.34 
0.0005% BAC  1014 ± 130 666 ± 101 679 ± 76 2.76 ± 0.36 0.94 
0.001% MP  827 ± 91 786 ± 79 732 ± 56 3.31 ± 1.36 1.13 
0.00005% Thio 974 ± 54 612 ± 52 256 ± 19 3.31 ± 0.20 1.13 
 
BAC is well known for its permeation enhancing properties. Moreover, its effect on the 
corneal permeability, in particular, with regard to hydrophilic substances has frequently been 
evaluated in vivo, ex vivo and in in vitro experiments with cultured corneal cells (Burstein, 
1984; Majundar et al., 2008; Mccarey and Edelhauser, 2007). In earlier in vivo studies, the 
influence of 0.0025%, 0.005%, 0.01%, 0.02% and 0.05% BAC on the permeability of human 
and rabbit cornea was evaluated based on the permeation of the hydrophilic substance 
fluorescein (Burstein, 1984). Burstein detected that 0.0025% BAC increased the permeation 
of fluorescein through rabbit cornea, whereas concentrations higher than 0.0025% BAC led 
even to a several-fold increase of the permeability of rabbit cornea to fluorescein. In contrast, 
the permeation of fluorescein through the human cornea was only significantly influenced by 
concentrations higher than or equal to 0.02% BAC (Burstein, 1984). Another in vivo study 
with rabbits was conducted by Ubels et al. They reported that the administration of 0.01% 
BAC into the eyes of the test animals, where the substance was left for only 5 min, led to an 
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approximately 13-fold increase of the corneal permeability to the hydrophilic substance 5,6-
carboxyfluorescein. Furthermore, the permeation enhancing effect of BAC has already been 
demonstrated in a series of ex vivo experiments with isolated rabbit cornea. In 1995, Sasaki 
et al., for instance, showed that BAC increased the permeability of isolated rabbit cornea to 
the hydrophilic paracellular markers FD-4 and FD-10 about 29 and 37-fold, respectively 
(Sasaki et al., 1995). Another study carried out by Nakamura et al. has also demonstrated 
that BAC 0.002%, 0.01%, 0.05% enhanced the permeability of the rabbit cornea to FD-4 6, 
12 and 27-fold, respectively (Nakamura et al., 2007). In fact, the authors have also reported 
that the increase of the corneal permeability to FD-4 correlated with a decrease of the TEER 
of the isolated rabbit cornea (Nakamura et al., 2007).  
Regarding culture-based corneal models it has previously been reported that BAC 
concentrations of 0.005% and 0.01% led to a significant increase of the in vitro permeability 
of cultured SIRC epithelial cells to phenylacetyl phenylephone HCl. This alteration in the 
permeability of the corneal model correlated with a reduction in the TEER (Goskonda et al., 
2000). 
In short, all these investigations indicate that BAC concentrations ranging from 0.002% to 
0.02% exhibit the same concentration-dependent permeation enhancing effect using in vivo 
and ex vivo corneal models as well as cultured corneal epithelial cells. Moreover, this effect 
has been attributed to BAC concentrations, which damage to the corneal barrier or cause a 
disruption of the tight junctions of the superficial corneal epithelium. In fact, the current 
investigation also demonstrates that 0.005% BAC leads to a several-fold increase in the 
corneal permeability of the HC construct to Na-FLU. Moreover, this change in the corneal 
permeability strongly correlated with a reduction of the barrier function (TEER) of the model. 
Furthermore, the present work also demonstrated that 0.0005% BAC neither causes a 
reduction in the barrier function nor changes in the corneal permeability of the HC construct 
to Na-FLU. Thus, the results of the current study are in line with those previously reported for 
in vivo or ex vivo rabbit cornea or culture-based corneal models. 
 
The effect of pure MP on the corneal permeability has not yet been investigated within the 
scope of in vivo or ex vivo studies with rabbit cornea. Only a small number of investigations, 
either in vivo studies with rabbits or in vitro cultured corneal models (see section 4.4.1.3), 
have focused on investigating the corneal integrity after the long-term administration of MP 
(0.005%) or demonstrating the toxic effect of MP. For this reason, the results obtained with 
the HC construct are not comparable to those achieved with the above-mentioned corneal 
models. The present study showed that 0.001% MP did not change the corneal permeability 
of the HC construct to Na-FLU. Thus, it can be suggested that the tight junctions of the HC 
construct are highly resistant to 0.001% MP. 
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In vivo experiments with rabbits conducted by Fister and Burstein in 1975 demonstrated that 
Thio 0.01% led to the desquamation of epithelial cells with ocular lesions (epithelial holes) 
after 6 h of application. Based on this observation, a significant modification of the corneal 
permeability at least to hydrophilic substances can be expected as has already been 
demonstrated by López Bernal and Ubels in 1991 in in vivo experiments with rabbits (López 
Bernal and Ubels, 1991). They have described that 0.001% and 0.004% Thio almost doubled 
the permeability of the corneal epithelium of rabbits to 5,6-carboxyfluorescein after 180 min. 
Following the permeation experiments, the rabbit cornea was isolated and stained with 
ruthenium red. Based on the morphological evaluation of the stained corneal tissue, the 
group was able to correlate the increase of corneal permeability with a damage of the 
superficial corneal epithelium since they found ruthenium red in the first layers of the 
superficial corneal epithelium (López Bernal and Ubels, 1991). Thus, Thio at concentrations 
higher than or equal to 0.001% can result in an alteration of the superficial corneal epithelium 
of rabbits.  
The current study also indicates that the barrier function of the HC construct is equivalent to 
native rabbit corneal tissue. This conclusion is based on the observation that similar Thio 
concentrations significantly affected the barrier function of the HC construct. Moreover, it was 
found that lower concentrations of Thio, e.g. 0.00005%, did not increase the corneal 
permeability of the HC construct to Na-FLU. This can be explained by the fact that 0.00005% 
Thio did not damage the barrier function of the HC construct significantly since the TEER 
values were not substantially altered. 
 
The individual effect of the preservatives PQ-1, Purite® and sofZia® on the permeation of Na-
FLU through the HC construct is represented in Figure 4-32. The results demonstrate that 
0.0005% PQ-1 increased the transported amount of Na-FLU 1.9-fold, whereas the 
transported amounts of Na-FLU in combination with 0.005% Purite® and sofZia® were similar 
to that of Na-FLU in preservative-free KRB. PQ-1 in concentration of 0.0005% led to 
alterations in the TEER values of the HC construct that was expressed in a reduction of 
approx. 40% after the preincubation time (60 min) and then a further reduction of 20% at the 
end of the permeation study (see Table 4-4). This alteration in the TEER values correlated 
well with an increase of the Papp of Na-FLU, which was significant higher in comparison with 
the Papp of Na-FLU without preservatives. No modification of the TEER values was observed 
for the preservative Purite® with Na-FLU in KRB. For the preservative sofZia® it can be 
pointed out that the TEER values of the HC construct were increased 15% after the 
preincubation time and gradually reduced to 50% until the end of the permeability study. 
However, TEER reduction didn't result in any alteration of the transport of Na-FLU through 
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the HC construct. The Papp and TEER values, which were obtained for Na-FLU in 
combination with 0.0005% PQ-1, 0.005% Purite® and sofZia® are summarized in Table 4-4. 
 
 
Figure 4-32: Permeated amounts per unit area of sodium fluorescein (Na-FLU) from preservative-
free KRB and KRB containing Polyquad® (PQ-1), Purite® and sofZia® versus time. 
Each point represents the mean  SD of five to six independent experiments. 
 
Table 4-4: Papp and TEER values (mean  SD) calculated for Na-FLU with and without 
preservatives 
Preservative 
[%(m/v)] 
Mean ± SD 
Enhancement 
Factor  
TEER [Ohm·cm²] Papp 10-7 
[cm·s-1] Medium 60 min 390 min 
preservative-free 1303 ± 335 861 ± 184 1016 ± 159 1.80 ± 0.30 --- 
0.0005% PQ-1 1480 ± 99 846 ± 141 524 ± 108 3.13 ± 0.78 1.83 
0.005% Purite®  1027 ± 216 853 ± 203 952 ± 253 1.50 ± 0.26 0.83 
sofZia®  1372 ± 129 1577 ± 238 692 ± 215 1.44 ± 0.25 0.80 
 
Even though PQ-1, Purite® and sofZia have been developed as potential alternatives to the 
older generation of preservatives, such as BAC, Ce or MP, their effect on the corneal 
permeability to ophthalmic drugs has been poorly or not at all investigated up to now. The 
current study is the first in vitro study to investigate the influence of the above-mentioned 
preservatives on the corneal permeability of the HC construct to the hydrophilic substance 
Na-FLU. The permeation of Na-FLU was evaluated on the basis of changes in the TEER that 
were measured in real time within the scope of transport experiments. However, since it is 
the first investigation, the TEER and permeability data cannot be directly compared with 
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those obtained in in vivo or ex vivo experiments with rabbit cornea or with cell culture-based 
corneal models. 
Regarding PQ-1, López Bernal and Ubels investigated the influence of 0.001% PQ-1 on the 
corneal permeability of rabbit eyes in vivo (López Bernal and Ubels, 1991). They found that 
0.001% PQ-1 increased the permeability of the rabbit cornea to 5,6-carboxyfluorescein a 
compound with similar physicochemical characteristics as Na-FLU, about 3-fold after 90 min 
and about 6-fold after 180 min in comparison to the permeability of untreated rabbit cornea. 
Likewise, this group found that the alteration in the corneal permeability was caused by the 
disruption of tight junctions.  
In the current study, it has been demonstrated that 0.0005% PQ-1 influences the corneal 
permeability of the HC construct to Na-FLU by a factor of approximately 1.8 after 390 min. 
This change in the corneal permeability has been associated with a dysfunction of the tight 
junctions between the superficial epithelial cells. The findings allow the assumption that 
0.001% PQ-1 affects the corneal permeability of the HC construct to Na-FLU to an extent, 
which is comparable to that observed by López Bernal and Ubels for rabbit corneal tissue. 
 
Unfortunately, to my knowledge, no data have yet been reported for Purite® regarding its 
influence on the permeability of native corneal tissue. In the present study, it has been noted 
that Purite® does not affect the corneal permeability of the HC construct to Na-FLU in 
comparison to that of the untreated HC construct.  
 
With regard to sofZia®, in 2007, Mccarey and Edelhauser investigated the effect of sofZia®-
preserved travoprost on the permeability of rabbit cornea in in vivo experiments. The data 
were compared with those collected on untreated animals in order to determine changes in 
the corneal permeability to 5,6-carboxyfluorescein (Mccarey and Edelhauser, 2007). They 
found that the rabbit cornea when being exposed to sofZia®-preserved travoprost for 3 min 
did not change its permeability to 5,6-carboxyfluorescein compared to that of the cornea of 
untreated animals. After the permeation experiments the rabbit cornea was isolated, stained 
with ruthenium red and analyzed under the transmission electron microscope. They noted 
that the cornea treated with sofZia®-preserved travoprost showed no significant alteration 
with regard to the tight junctions. This investigation indicates that the permeability of the 
rabbit cornea is not significantly affected when the cornea is exposed to sofZia® for only a 
short time.  
In the current investigation, it was observed that the TEER of the HC construct decreased 
steadily after 90 min of exposure to sofZia® with Na-FLU. Nevertheless, the permeability of 
the HC construct to Na-FLU was comparable to its permeability before the application of 
sofZia®. Thus, the current results are in good agreement with those previously reported for 
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native rabbit cornea. In addition, the data also indicate that sofZia® produced a dysfunction of 
the tight junctions of the HC construct, which was dependent on the time of exposure. 
However, the alteration seen in the barrier function did not exceed the limit TEER value of 
400 Ohm·cm² neither after 60 min nor 390 min. 
4.4.2.2 Permeation of bimatoprost through the HC construct in presence and absence 
of preservatives  
Bimatoprost was selected as a model drug to investigate the influence of the tolerated 
preservative concentrations (BAC 0.0005%, MP 0.001%, Thio 0.00005%, PQ-1 0.0005%, 
Purite® 0.005% and sofZia®) on the permeability of the HC construct. The effect caused by 
these preservative concentrations was evaluated by comparing the Papp values of 
bimatoprost in preservative-free and preservative containing KRB. 
The cumulative transport of bimatoprost from KRB containing different preservative 
concentrations is represented in Figure 4-33 and Figure 4-34. The illustrations show that the 
transported amounts of bimatoprost did not differ significantly between the experiments 
carried out in the absence or in the presence of preservatives. Moreover, the comparison of 
the Papp values of bimatoprost expressed as enhancement factor indicated that none of these 
preservative concentrations were capable to alter the permeability of the HC construct to 
bimatoprost (see Table 4-5 right column).  
Donor solutions containing bimatoprost and 0.00005% Thio, 0.0.005% PQ-1 or sofZia®, 
respectively, altered the TEER values to some extent. However, none of these alterations 
affected the permeability of HC construct to bimatoprost. This can be explained by the fact 
that the passive transcellular drug diffusion through the HC construct is fewer dependent on 
the TEER values than observed for hydrophilic compounds, as was demonstrated during the 
prevalidation phase of the HC model (Hahne et al., 2012). 
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Figure 4-33: Permeated amounts per unit area of bimatoprost from preservative-free KRB and KRB 
containing benzalkonium chloride (BAC), methylparaben (MP) and thiomersal (Thio) 
versus time. Each point shows the mean  SD of five to six independent experiments. 
 
 
Figure 4-34: Permeated amounts per unit area of bimatoprost from preservative-free KRB and KRB 
containing Polyquad® (PQ-1), Purite® and sofZia® versus time. Each point shows the 
mean  SD of five to six independent experiments. 
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Table 4-5: Papp and TEER values (mean  SD) calculated for bimatoprost and enhancement 
factors of various concentrations of different preservatives 
Preservative 
[%(m/v)] 
Mean ± SD 
Enhancement 
Factor 
TEER [Ohm·cm²] Papp 10-7 
[cm·s-1] Medium 60 min 390 min  
preservative-free 1102 ± 288 838 ± 100 1061 ± 245 39.45 ± 10.42 --- 
0.0005% BAC 860 ± 63 706 ± 96 735 ± 31 39.35 ± 3.09 1.00 
0.001% MP 885 ± 156 610 ± 93 689 ± 107 37.75 ± 1.56 0.96 
0.00005% Thio 883 ± 65 610 ± 56 280 ± 32 39.77 ± 3.59 1.00 
preservative-free 917 ± 95 846 ± 117 856 ± 106 24.16 ± 1.59 --- 
0.0005% PQ-1 1214 ± 155 626 ± 78 330 ± 62 24.62 ± 1.04 1.01 
0.005% Purite® 1101 ± 118 946 ± 118 1032 ± 113 24.87 ± 0.70 1.02 
sofZia® 1023 ± 178 1264 ± 311 592 ± 223 23.34 ± 2.94 0.97 
 
Prostaglandins analogs such as travoprost, latanoprost, tafluprost (prostanoids) and 
bimatoprost (prostamide) are used for the treatment of glaucoma. The majority of the 
commercially available ophthalmic solutions contain preservatives. As already mentioned 
above, preservatives like BAC additionally work as permeation enhancers, which can 
increase the concentration of an ophthalmic drug in the aqueous humor, in particular of 
hydrophilic substances (Majumdar et al., 2008; Mccarey and Edelhauser, 2007). The effect 
of BAC on the transcorneal permeation of lipophilic drugs, such as bimatoprost, timolol 
maleate and dexamethasone, has already been investigated. Chang et al. demonstrated in in 
vivo and in vitro experiments using rabbit cornea and primary cultures of rabbit corneal 
epithelial cells (pRCE) that increasing of BAC concentration from 0.005% to 0.02% 
significantly influenced the permeation rate of bimatoprost (0.03%) through in vivo as well as 
ex vivo corneal tissue (Chang et al., 2012). Furthermore, Saettone and co-workers reported 
that 0.02% BAC increased the permeation rate of timolol maleate through excised rabbit 
cornea 2.6-fold (Saettone et al., 1996). Another group described that 0.01% BAC increased 
the permeability of ex vivo rabbit cornea to the lipophilic drug dexamethasone 3-fold (Camber 
and Edman, 1987). All these reports indicate that BAC concentrations of 0.01% and higher 
can change the permeability of rabbit cornea to lipophilic drugs.  
The current study has demonstrated that 0.0005% BAC neither causes a significant change 
in the TEER values nor increases the permeability of the HC construct to bimatoprost. 
Furthermore, it has also been shown that BAC concentrations higher than 0.0005% (e.g. 
0.005%) can affect the barrier function of the HC construct. Therefore, based on the 
collected evidence, it can be expected that BAC concentrations higher than or equal to 
0.005% (e.g. 0.01%) also affect the permeability of the HC construct to bimatoprost.  
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Besides the current study with the HC construct, no other investigation has yet been 
conducted to evaluate the effect of pure MP, Thio, PQ-1, Purite® and sofZia® on the corneal 
permeability to bimatoprost. Hence, the data obtained with the HC construct for bimatoprost 
in the presence of the preservatives cannot directly be compared with results achieved with 
in vivo, ex vivo rabbit cornea or cultured corneal cells. 
4.4.3. Summary of preservative effects on the HC construct  
The majority of the commercially available ophthalmic solutions are formulated with 
preservatives to prevent microbial contamination. In the light of the fact that some 
preservatives have been reported to cause epithelial damage (Ahmad and Chishti, 1992; 
Epstein et al., 2009; Ayaki and Iwasawa, 2010) and increase the ocular bioavailability of 
drugs by influencing the corneal permeability, the first aim of this chapter was to investigate 
the effect of preservatives on the epithelial integrity of the HC construct by measuring the 
transepithelial electrical resistance. The second aim of this chapter was to evaluate the effect 
of preservatives on the permeability of the HC construct expressed as permeation 
coefficients of sodium fluorescein as a hydrophilic marker substance and bimatoprost (non-
hydrophilic) as a model drug. The data obtained with the HC construct were compared with 
those from in vivo, ex vivo and in vitro experiments available in the literature. 
 
The present in vitro study has demonstrated that the effect of preservatives (BAC, Ce, Thio, 
MP, PQ-1, Purite® and sofZia®) on the barrier function of the HC construct basically depends 
on the concentration and the exposure time. Furthermore, it was found that in particular the 
effect of BAC, Thio, MP and PQ-1 on the epithelial integrity of the HC construct is intensified 
by increasing the concentration used. For instance, BAC concentrations higher than or equal 
to 0.005% resulted in TEER value reduction after the first 10 min of application. In contrast, 
0.001% BAC required 90 min to cause a substantial reduction of TEER. Moreover, BAC 
concentrations lower than 0.001% (e.g. 0.0005%) had no effect on the barrier properties of 
the HC construct. In previously published studies it has been found that similar or identical 
concentrations of BAC and Thio led to a concentration and time-dependent reduction of 
TEER values of ex vivo rabbit cornea (Chetoni et al., 2003; Nakamura et al., 2007; Burstein 
and Klyce, 1977). Furthermore, the data obtained in this study are in line with results of 
previous in vivo investigations that evaluated the effect of PQ-1 and MP on rabbit corneal 
epithelium. It was observed in the present study that PQ-1 concentrations lower than 
0.0005% had no effect on TEER of the HC construct. In contrast, 0.0005% PQ-1 affected the 
TEER of the HC construct even after 30 min of application. This implies that 0.001% PQ-1, 
the commonly used concentration in ophthalmic drugs, can accelerate the TEER reduction of 
the HC construct. This assumption is supported by the data reported by Mohamed et al., who 
found in in vivo experiments that the application of ophthalmic solutions containing 0.001% 
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PQ-1 into rabbit eyes caused TEER reduction of about 20% after 1 min of exposure 
(Mohamed et al., 2006). Moreover, it was observed in the present study that 0.1% MP 
decreased the TEER rapidly after the first 10 min of incubation, whereas only a slight but 
steady TEER value reduction was noted for 0.005% MP after 30 min of application. 
Furthermore, 0.001% MP did not change the barrier properties of the HC construct. 
Unfortunately, it was not possible to directly compare the data obtained with the HC construct 
with those of animal cornea since the effect of MP on the TEER of rabbit cornea has not yet 
been reported. Nevertheless, a suitable and frequently used approach to demonstrate the 
effect of substances on the corneal surface is the morphological examination by means of 
microscopic analysis. For example, Becquet et al. used this approach to demonstrate that 
0.005% MP produces morphological alterations in the corneal epithelium of rats (Becquet et 
al., 1997).  
With regard to the other preservatives (Ce, Purite® and sofZia®), the effect on the TEER 
values of native corneal tissue has not been investigated so far. In contrast, the effect of 
these preservatives on the structure of superficial epithelium of rabbit cornea has already 
been evaluated by other groups in in vivo experiments (Way et al., 2001; Mahmoud, 2007; 
Mahmoud et al., 2011; Whitson et al., 2006; Kahook and Noecker, 2008). These 
morphological studies have proven that Ce and Purite® concentrations lower than or equal to 
0.02% (Ce) and 0.005% (Purite®) as well as the short-term application of sofZia®-preserved 
ophthalmic solutions are relatively harmless to rabbit corneal epithelium; a conclusion, which 
corresponds to the results obtained with the HC construct.  
Furthermore, it can be suggested that the alterations of the barrier function of the HC 
construct caused by the preservatives were due to their cytotoxic potential. This assumption 
is supported by the results of several cytotoxicity studies reported by other groups (Kusano 
et al., 2010; Nakamura et al., 2007; Ayaki et al., 2007; Matsuda et al., 2009, Saarinen-
Savolainen et al., 1998; Epstein et al., 2009; Tripathi et al., 1992; Ammar et al., 2010; Ammar 
et al., 2011; Paimela et al., 2012; Zheng et al., 2015). These investigations have 
demonstrated that the reduction of the percentage of living corneal epithelial cells can be 
attributed to the cytotoxic properties of preservatives, the tested concentrations as well as 
the exposure time.  
Regarding the effect of preservatives on the transcorneal permeation of substances, the 
present study proved that only preservative concentrations, which affected the tightness of 
the HC model within the first 30 min of exposure (e.g. BAC (0.005%) and PQ-1 (0.0005%)) 
also caused a significant increase of the permeability of the HC construct to hydrophilic 
substances (Na-FLU). This effect has already been observed for rabbit cornea in in vivo and 
ex vivo experiments, when corneal tissue was exposed to concentrations higher than or 
equal to 0.001% BAC or concentrations higher than 0.0005% PQ-1 (Sasaki et al., 1995; 
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Nakamura et al., 2007; López Bernal and Ubels, 1991; Burstein, 1984). In contrast, 0.0005% 
PQ-1 or diluted BAC concentrations (e.g. 0.0005%) did not alter the permeability of the HC 
construct to bimatoprost. Permeability experiments with lipophilic substances in the presence 
of preservative concentrations, which significantly affected the tightness of the HC construct 
were not carried out. Nevertheless, it has been previously demonstrated that 0.002% BAC 
changed the permeability of rabbit cornea in vivo and pRCE cells in vitro to bimatoprost 
(Chang et al., 2012). Other groups also detected that BAC concentrations ranging from 
0.01% to 0.025% increase the permeability of ex vivo rabbit cornea to lipophilic substances, 
such as dexamethasone and timolol maleate (Camber and Edman, 1987; Ashton et al., 
1991).  
In short, all evidence reported in the relevant literature and results obtained within the scope 
of this study suggest that the HC construct behaves in a manner, which is comparable to that 
already reported for in vivo and ex vivo rabbit cornea with regard to the effect of 
preservatives on the permeability properties of the corneal epithelium.  
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5. Final discussion 
5.1.1. Transferability of methods, quality and prevalidation of the HC construct 
During the development of new or reformulated ophthalmic drug delivery systems, in vitro 
corneal cell culture models are used as an alternative to excised animal or human cornea 
within the scope of drug permeability studies. The human Hemicornea model (Hemicornea, 
HC or Hemicornea construct) has been developed by Reichl and co-workers for the purpose 
of performing such studies (Hahne and Reichl, 2011). This HC construct was the subject of 
the current investigation.  
The HC construct has to fulfill certain criteria before it can be accepted by authorities. The 
prevalidation of the HC construct is one of these criteria. The prevalidation step involves 
three main phases: i) protocol refinement, ii) protocol transfer and, iii) protocol performance 
(Curren et al., 1995). The first phase, including the development of the protocols for 
constructing the HC construct and methods for performing drug permeability studies, was 
already carried out by Hahne and Reichl (Hahne and Reichl, 2011). Thus, the current 
chapter deals with the evaluation of the protocol transfer and the performance for the 
prevalidation of the HC construct carried out at ACB.  
In the current study, it was possible to produce several batches of the HC construct with a 
similar range of TEER, which were stable over an extended period of time (cultivation 
protocol) and a similar range of permeability to the hydrophilic substance Na-FLU that 
demonstrates the reproducibility of the barrier function of the HC construct. In addition, 
acceptance criteria were defined at ACB based on the barrier properties of the HC construct. 
Thus, in order to ensure that the HC construct possesses sufficient strong barrier properties 
to be suitable for drug permeability studies, the TEER should be ≥ 400 Ohm·cm² and the Papp 
achieved with Na-FLU should be < 1·10-6 cm·s-1. However, there are currently no generally 
applicable criteria, which could be used as a basis to assess the suitability of an in vitro 
human corneal model for such studies. This is the first study of this kind, which has been 
conducted to define such criteria. Nevertheless, these criteria can be compared with those 
previously reported for others cultivated epithelial cells, such as bronchial and or intestinal 
cells (Caco-2). The latter is an alternative in vitro model, which has already been accepted by 
validation authorities as a substitute for human intestinal permeability studies (Larregieu and 
Benet, 2013.) Thus, it has been reported that a minimum TEER value of approximately 250 
Ohm·cm² confirms the differentiation state of the epithelial barrier and should be adequate to 
achieve Papp values in the order of 10-7 cm·s-1 for the hydrophilic permeation marker sodium 
fluorescein (Ehrhardt et al., 2002; Verstraelen and Reichl, 2013).  
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In the current study, the TEER and Papp values (Na-FLU) obtained by all participating 
laboratories (TUBS, UKE and ACB) were plotted to specify a general acceptance criteria for 
the HC construct for its use in drug permeability studies. The data suggest that a minimum 
TEER value of 440 Ohm·cm² is required to confirm the barrier properties of the reconstructed 
corneal epithelium (Hahne et al., 2012). Thus, the current study indicates that the 
acceptance criteria are of vital importance in order to ensure the high quality of the HC 
construct at all times. In addition, they are critical parameters to ensure that the HC construct 
complies with the quality standards of drug permeability studies. 
 
Drug permeability studies are frequently performed using isolated animal cornea, in particular 
of rabbit origin. However, in general the variability of the results obtained from animals is high 
(Becker et al., 2008; Anand and Mitra, 2002). Therefore, another objective of this 
investigation was to demonstrate that the reproducibility of data can be improved by 
standardizing the methods for cultivating the HC construct and the protocols to perform drug 
permeability studies. The analysis of the variances of Papp values obtained with different 
substances and HC batches cultivated at the three laboratories reveals that the 
intralaboratory reproducibility of the HC construct is higher than that of isolated rabbit cornea. 
However, even though the interlaboratory reproducibility is acceptable, it could be further 
improved. Until today, there are neither regulatory guidelines nor acceptance criteria for the 
validation of in vitro alternative methods for corneal permeability studies. However, the data 
obtained with the HC construct can be compared with the Caco-2 cell model. In accordance 
with the biopharmaceutical classification system and FDA recommendations, the in vitro 
cultured Caco-2 cells can be employed for the screening of new drugs since the permeability 
data are comparable to those of in vivo or ex vivo human or animal (in particular from pig) 
intestinal tissue (FDA Guidance For Industry, 2015; Volpe, 2008a). The Caco-2 cell model 
has high intralaboratory reproducibility but a low interlaboratory reproducibility since the 
protocols used by the laboratories are not well standardized. Furthermore, uncharacterized 
samples of Caco-2 cells from different origins are often used (Volpe, 2008b; Volpe et al., 
2007). In addition, it has been recommended that an in vitro model with good intralaboratory 
reproducibility should have a coefficient of variation not higher than 50% and the ratio of the 
average Papp values has to be in the range of 0.5 to 2.0 in order to ensure good 
interlaboratory variability (Zucco et al., 2005; Prieto et al., 2010). The standardized culture 
methods and protocols to conduct drug permeability studies that are presented in the current 
study are in line with the observations made when using the Caco-2 cell model since it has 
been demonstrated that there is a correlation between the use of standardized protocols and 
the good intra-interlaboratory reproducibility of the permeability data obtained with the HC 
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construct. In addition, the above recommended range of values for other validation studies is 
also in agreement with the data obtained within the scope of the current study. 
 
According to FDA Guidance For Industry an alternative in vitro cell model has to fulfill certain 
criteria to be accepted as a substitute for animal experiments in order to evaluate the 
permeation of substances through epithelial membranes. One of these criteria is that the 
vitro model has to be able to differentiate between low and high permeability rates of 
substances. Another criterion is the comparability of data between different sets of 
experiments (FDA Guidance For Industry, 2015). The permeation data achieved with the HC 
construct within the scope of the current investigation demonstrate that the HC is able to 
discriminate between substances depending on their physicochemical properties. Moreover, 
the reproducibility of data obtained with different HC batches is high. This suggests that the 
HC construct also complies with the recommendations included in the FDA Guidance For 
Industry. 
The current work provides specifications and acceptance criteria for the development and 
implementation of well standardized methods for the cultivation of an in vitro HC construct as 
well as protocols for conducting drug permeability experiments. Furthermore, the successful 
transfer of culture protocols, the high intralaboratory and the sufficiently high interlaboratory 
reproducibility demonstrate that the prevalidation of the model has been successful. Against 
this background, it can be concluded that the current work provides the necessary 
information to consider the HC construct as an alternative model for regulatory biowaiver 
applications. 
5.1.2. Comparative analysis of transcorneal drug absorption 
In the last 20 years, in vitro ocular models have emerged as substitutes for in vivo or ex vivo 
animal experiments to evaluate the transport of substances through the ocular barriers 
(Hornof et al., 1995; Reichl et al., 2011). Regarding topically applied drugs, the cornea has 
been identified as the main barrier substances have to pass in order to enter the aqueous 
humor (Huang et al., 1989; Järvinen et al., 1995). Thus, before new ophthalmic medications 
can be administered to humans, their transcorneal permeation needs to be evaluated. The 
permeability properties of the human cornea are attributed to its different cellular layers 
(epithelium, stroma, and endothelium). It has been demonstrated that the corneal 
endothelium does not have much influence on the corneal permeability to hydrophilic or 
lipophilic substances. In contrast, the hydrophilic stromal tissue impairs the transport of 
substances with lipophilic characteristics and the multilayered epithelium is the main barrier 
to hydrophilic substances (Huang et al., 1989; Prausnitz and Noonan, 1998). Against the 
background of these previous findings, an in vitro corneal tissue (HC construct) of human 
origin has been reconstructed (Hahne and Reichl, 2011) with an equivalent stromal cell layer, 
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which contains immortalized human keratocytes (Zorn-Kruppa et al., 2005) and an equivalent 
multilayered corneal epithelium using an immortalized human corneal epithelial cell line 
(Araki-Sasaki et al., 1995).  
Due to the lack of predefined specifications and acceptance criteria for the evaluation of the 
suitability of in vitro corneal models for drug permeability studies, the recommendations of an 
FDA Guidance For Industry should be followed, which concerns the investigation of the oral 
permeability of drugs through the intestinal epithelium using in vitro cell models, such as the 
Caco-2 and MDCK cell model (FDA Guidance For Industry, 2015). This guidance outlines 
the evaluation of the passive transport of 20 substances in order to define the permeability 
class of substances. Another requirement is that the in vitro cell culture model has to be able 
to differentiate between low and high permeable substances on the basis of their 
physicochemical characteristics. In addition, the permeability data obtained with the in vitro 
models should correlate with the permeability values achieved for human tissue. 
Within the scope of the current study, the suitability of the HC construct as a substitute for 
animal experiments was investigated. For this purpose, the HC construct was used to 
evaluate the passive permeation of eighteen substances. It was seen that the permeability of 
the HC construct increased in a sigmoidal manner when the lipophilicity of substances 
increases. However, an influence of the molecular weight of substances in the range from 60 
to 480 g·mol-1 on permeation rate was not detected. These observations indicate that the 
permeability of the HC construct is influenced by the physicochemical properties of 
substances to the same extent as excised rabbit cornea (Wang et al., 1991; Suhonen et al., 
1991, 1996; Hämäläinen et al., 1997; Prausnitz and Noonan, 1998). Furthermore, the 
permeability data obtained for the eighteen substances prove that the HC construct is able to 
differentiate the permeation of substances based on their physicochemical properties, which 
is a criterion included in the above-mentioned FDA Guidance For Industry. Moreover, the 
current HC construct offers several advantages in comparison with previously developed in 
vitro corneal models for drug permeability studies, e.g. its components include an in vitro 
multilayered corneal epithelium and a stromal equivalent, which have barrier properties 
similar to those of the human cornea (Hahne and Reichl, 2011). Due to these components, 
the HC construct is able to distinguish between low and high permeable substances. Another 
advantage is that the HC construct can be easily cultured and the reproducibility of its barrier 
properties between the individual batches is remarkably high. In addition, the tightness of the 
reconstructed corneal epithelium is in the range of that reported for in vivo rabbit cornea 
(Uematsu et al., 2007; Kusano et al., 2010) as well as for ex vivo rabbit and human cornea 
(Nakamura et al., 2007; Kikuchi et al., 2005; Becker et al., 2008). In contrast, other in vitro 
corneal models only consist of a reconstructed epithelium that is based on, for example, 
SIRC or CEPI cell lines, which exhibit low permeation barriers to highly hydrophilic and 
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lipophilic substances, such as mannitol and testosterone, in comparison to excised bovine 
cornea (Reichl, 2008). Similar results have also been reported for the reconstituted human 
corneal epithelium from Skinethic laboratories and the Epiocular model from MatTek 
Corporation (Reichl, 2008). Moreover, the permeation data obtained with these corneal 
models indicate that they are not suitable for drug permeability studies since their epithelial 
tightness is out of the range reported for native corneal tissues (Kikuchi et al., 2005; 
Nakamura et al., 2007; Uematsu et al., 2007; Reichl, 2008, Becker et al., 2008; Kusano et 
al., 2010). Besides the HC construct used for the present investigation, the Clonetics human 
corneal epithelium (cHCE) from Cambrex is another in vitro corneal model, which is probably 
suitable for drug permeability studies. The cHCE model possesses a tight epithelial barrier 
and has similar permeability properties with regard to hydrophilic and lipophilic substances 
as those reported for isolated native tissue (Becker et al., 2008; Xiang et al., 2009). Despite 
of the above described advantages of the HC construct in comparison to other models, the 
main disadvantage of the HC construct is that the TEER values only remain stable for a short 
period of time of about 3 days (from day 10 to day 13). After this time, the TEER level 
decreased rapidly. To test the hypothesis that the superficial cells do not receive enough 
nutrients, 50 µL of KGM were applied to the apical surface of the HC construct. 
Nevertheless, the TEER continued to decrease constantly after the aforementioned time 
period. Therefore, the factors, which lead to a decrease of the TEER of the HC construct are 
not clear. Further studies need to be conducted in order to improve the long-term stability of 
the barrier properties of the HC construct. 
 
In addition, the passive diffusion of substances with different physicochemical properties 
obtained with the HC construct has been correlated with relevant data previously reported for 
ex vivo rabbit and human cornea in order to evaluate the equivalence between the 
permeability of the HC construct and native tissue. The correlation coefficient obtained from 
the linear regression indicates that the permeability properties of the HC construct and ex 
vivo rabbit cornea are in the same range. However, the slope factor (1.29) indicates that the 
permeability of ex vivo rabbit cornea is generally higher than that of the HC construct. 
Furthermore, the results show that the permeation of hydrophilic substances, such as Na-
FLU, mannitol or acyclovir is nearly identical to that reported for ex vivo rabbit tissue, 
indicating that the permeability characteristics of the corneal epithelium are similar. However, 
the higher the lipophilicity of substances is (e.g. dexamethasone, metoprolol, rhodamine B), 
the larger are the differences between the models. This can be explained by the 
morphological differences between them, in particular thickness and structure of the 
hydrophilic stroma. Other reasons may also be that the tissue quality and the methodologies 
used to evaluate the permeation of substances differed between laboratories. Furthermore, it 
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has to be mentioned that different expression levels of drug-metabolizing enzymes (e.g. 
cytochrome P450 (Kölln and Reichl, 2016a, 2016b)) and transport proteins, such as P-
glycoprotein (P-gp or MDR1), lung resistance-related protein (LRP), breast cancer resistance 
protein (BCRP) and multidrug resistance associated proteins (MRP) (Becker et al., 2007; 
Dey et al., 2003) have been reported for human cell culture models in comparison to animal 
cornea. These proteins can strongly influence the transport of substances through the 
epithelium (Dey and Mitra, 2004). Several substances have been identified as MDR1 
substrates, such as daunorubicin (Shtil et al., 2000), steroids, e.g. dexamethasone and 
hydrocortisone (Ueda et al., 1992), and protease inhibitors, e.g. saquinavir (Huisman et al., 
2003) among others. The mRNA and functional expression of the MDR1 protein have been 
identified in ex vivo rabbit cornea (Dey et al., 2003; Verstraelen and Reichl, 2013) as well as 
in in vivo rabbit cornea (Dey and Mitra, 2004). In addition, a weak mRNA expression of 
BCRP has been found in ex vivo rabbit cornea (Verstraelen and Reichl, 2013). Moreover, 
Verstraelen and Reichl have recently investigated the mRNA and protein expression as well 
as the functionality of some transporter proteins (MDR1, BCRP) with the HC construct 
(Verstraelen and Reichl, 2013). They have found that the HC construct exhibits mRNA and 
functional expression of BCRP but not of MDR1. Moreover, identical results have been 
reported for cultured primary rabbit corneal epithelial cells (Dey et al., 2003; Kawazu et al., 
2003). All evidence indicates that the expression pattern is quite different for human and 
animal cornea and that some transport proteins could play an important role in the 
permeation of substances through the corneal barrier. Even though characterization 
experiments regarding transport proteins were out of scope of the current study, the 
comparison of the Papp rates obtained with the different substances showed that there was a 
difference in the permeability of the HC construct and ex vivo rabbit cornea. In further 
studies, transport experiments should be conducted with specific substrates and inhibitors in 
order to determine the functional expression of transport proteins, in particular SLC 
transporters, in the HC construct.  
The comparison of other cell culture models, such as Caco-2 cell model and cell-based skin 
models, with the respective native tissues has revealed that they differ with regard to the 
permeability values. In the case of the Caco-2 cell model, it has been demonstrated that the 
permeation rate of drug substances correlated well with the intestinal absorption in humans 
for substances, which diffuse passively (Artursson and Karlsson, 1991). Nevertheless, the 
permeability of the Caco-2 cell model can be lower or higher than that of the human intestinal 
epithelium to substances being substrates of active transport proteins (Artursson et al., 2001; 
Sun et al., 2002; Lennernäs, 2007). The authors concluded that these differences in the 
permeability are mainly caused by the differences in the expression levels of drug-
metabolizing enzymes and active transport proteins between the Caco-2 model and human 
Final Discussion and Conclusions 
101 
tissue. With regard to skin models, the permeability values reported for different drug 
substances have indicated that the permeability of in vitro skin models is significantly higher 
than that of ex vivo human skin. The different morphological structures, protein biding 
capacity, and the lack of lipids are the main reasons for this increased permeability of 
reconstructed skin models (Schäfer-Korting et al., 2008; Netzlaff et al., 2007). 
 
Comparing the permeability of the HC construct with that of ex vivo human cornea indicated 
a high degree of similarity. The Papp values of five substances were compared and the 
correlation coefficient obtained from the linear regression demonstrates that the data 
obtained with the HC construct correlate well with the data previously reported for ex vivo 
human cornea. Moreover, the slope factor (0.94) shows that the permeation rates of 
hydrophilic and lipophilic substances achieved with the HC construct is expected to be 
almost identical to those of human cornea. Thus, these results show that the data obtained 
with the HC construct correspond better to those obtained with ex vivo human cornea than 
those achieved with rabbit cornea. This can be explained by the fact that the morphological 
characteristics of the HC construct and the human cornea are equivalent. The main 
advantage of an in vitro cornea model, which is based on human cells and equivalent to the 
human cornea is that the transferability of experimental results is more reliable than that of 
animal models since the results vary considerably between the species used (Hahne and 
Reichl, 2011; Becker et al., 2008; Van Eyk et al., 2009). 
Despite of the good correlation between the permeability of the HC construct and data 
previously reported for ex vivo human cornea, it is premature to conclude that the HC 
construct can completely replace experiments using ex vivo animal tissue or ex vivo human 
tissue to investigate drug permeability. This is because the comparison of more than five 
substances with different physicochemical properties is required to determine whether the 
permeability of the HC construct and ex vivo human cornea is equivalent. Furthermore, the 
permeability data usually obtained with isolated human cornea have to be interpreted with 
caution for the following reasons: 1) human tissue used for experimental purposes is mostly 
not suitable for transplantation due to infectious diseases, e.g. hepatitis B (Reichl et al., 
2005) or cell degeneration, 2) the origin of the tissue is partly unknown, 3) human corneas 
are stored for an unknown period of time, which can affected the tissue quality. In addition, 
the transport proteins of the human cornea have been poorly investigated and the results 
reported to date by different research groups appear to be contradictory, which is probably 
due to the poor availability of suitable human tissue for such experiments (Becker et al., 
2007; Zhang et al., 2008; Xiang et al., 2009; Verstraelen and Reichl, 2013). From my point of 
view, more experiments need to be carried out with suitable human donor corneas in order to 
evaluate the transferability of data obtained with the HC construct to human situation. For 
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these reasons, experiments conducted with isolated corneas of animal origin, in particular of 
rabbits, remain to be best option to compare the results achieved with the HC construct in 
order to finally obtain a recognized in vitro corneal model that can be used by laboratories to 
investigate corneal drug absorption. In addition, formulation factors that influence the 
permeability of substances, such as pH, osmolality, or excipients (e.g. EDTA, preservatives) 
of ophthalmic formulations, also need to be further investigated and the results have to be 
compared with native tissue for the purpose of evaluating the suitability of the HC construct 
for drug permeability studies. The effect of these formulation factors is discussed in the 
following section. 
5.1.3. Effect of formulation parameters and excipients on the barrier function of 
the HC construct 
In order to determine the usefulness of the HC construct in the development of new 
formulations, the effect of different buffer solutions at different pH values ranging from pH 4.5 
to 8.0 (the solutions contained either Na-FLU or mannitol) and with osmolalities ranging from 
178 to 432 mOsmol·kg-1 (the solutions contained Na-FLU) on the epithelial integrity and 
corneal permeability of the HC construct was evaluated. 
Within the scope of the current study it was observed that buffer solutions at pH values 
ranging from 5.0 to 8.0 did not affect the tightness of the HC construct for a period of time of 
390 min. Furthermore, it was noted that these pH values changed the corneal permeability of 
the HC construct to the ionizable hydrophilic substance Na-FLU but not to the non-ionizable 
hydrophilic substance mannitol. In contrast, only the citrate buffer at pH 4.5 containing               
Na-FLU affected the integrity of the in vitro epithelium of the HC construct and increased the 
permeability to Na-FLU, whereas the same buffer solution containing mannitol affected the 
integrity of the HC construct to a lesser degree.  
This is the first in vitro study, which has investigated in detail the effect of pH of different 
buffer solutions on epithelial integrity by determining changes of TEER of the HC construct. 
Unfortunately, the TEER values cannot directly be compared with those reported for ex vivo 
rabbit cornea. Despite of this limitation, the data obtained within the scope of the present 
study are in accordance with previous studies, which investigated the effect of different pH 
values on ex vivo rabbit and goat cornea. Regarding ex vivo rabbit cornea, changes in the 
integrity of the superficial corneal epithelial cells were evaluated in permeability studies with 
hydrophilic substances, e.g. mannitol (non-ionizable substance), and lipophilic substances, 
e.g. progesterone dissolved in a glutathione bicarbonated buffer solution. The results of 
these experiments indicated that the integrity of ex vivo rabbit cornea is not affected at pH 
values in the range from 5.0 to 7.7 since the Papp values achieved with mannitol and 
progesterone were identical (Suhonen et al., 1998). Furthermore, Majumdar and co-workers 
evaluated the effect of different pH values on ex vivo goat cornea by measuring the 
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percentage of corneal hydration. The normal hydration level of the cornea lies between 75 
and 80% (Rathore and Majumdar, 2006). This research group associated changes in the 
corneal tissue with an increase of the corneal hydration level. They reported that an aqueous 
solution containing moxifloxacin formulated at pH ranging between 5.5 and 7.2 did not affect 
the corneal integrity since the level of corneal hydration did not exceed 80% (Pawar and 
Majumdar, 2006). In short, the evidence mentioned above suggests that the integrity of ex 
vivo animal cornea is not affected when the pH of the buffer solution is raised from 5.0 to 7.7. 
Thus, the data obtained in the current study demonstrates that the HC construct can tolerate 
a change in the pH range similar to that reported for ex vivo animal cornea. In addition, in the 
current study, it has been observed that the pH-related effect on the integrity of the in vitro 
epithelium of the HC construct is dependent on the composition of the buffer solution. Similar 
results have also been reported for other corneal cell culture models. Tsai et al. have 
demonstrated that neither the vitality nor the TEER of corneal epithelial cells are significantly 
affected by the application of the culture medium at pH 5.0 (without any supplement) to the 
surface of the cultured human corneal epithelial cells (HCE cell line) (Tsai et al., 2010). In 
addition, another toxicity study conducted with pRCE cells has shown that a combination of 
citrate-acetate buffer or citrate-borate buffer at pH equal to or lower than 5.0 has a stronger 
effect on the corneal integrity than the phosphate-buffered solution (Dale and James, 1991a). 
These results are in agreement with the observations made with the HC construct in the 
current investigation in which the most pronounced effect was noted following the application 
of the citrate buffer at pH 4.5 containing Na-FLU. In contrast, the citrate buffer at pH 4.5 
containing mannitol had a much lower impact. This can be explained by the fact that 
excipients such as mannitol reduce the toxic effect of preservatives (e.g. benzalkonium 
chloride) on the superficial corneal epithelium of ex vivo rabbit cornea and of the HCE-T 
epithelial cell model (Mohamed et al., 2016; Nagai et al., 2011).  
No specification that defines which pH level can be tolerated by the corneal tissue in ex vivo 
or in vitro studies has yet been established. In further studies, the experiments conducted in 
the current investigation should be complemented with toxicological experiments and the 
results should be compared to those obtained with ex vivo rabbit cornea in order to define a 
guideline, which contains acceptable pH thresholds at which ophthalmic medications should 
be formulated in order to avoid any significant modification to the superficial corneal 
epithelium. Moreover, the current study shows that the corneal permeability of the HC 
construct can be influenced by the pH and composition of the buffer solution used. Moreover, 
it has been demonstrated that changes in the corneal permeability of the HC construct are 
associated with the physicochemical properties of substances. In the case of the hydrophilic 
permeation marker Na-FLU, which is an ionizable substance, the permeability of the HC 
construct is increased when the pH of the buffer solution is reduced or its composition is 
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modified. In contrast, neither changes in the pH nor the composition of the buffer solution 
altered the permeability of the HC construct to mannitol. All evidence obtained from the 
literature indicates that the permeability properties of ex vivo rabbit cornea or other ex vivo 
animal cornea (e.g. sheep, goat) can be altered by changes in the pH and composition of 
buffer solutions if they affect the lipophilicity and the solubility of substances. Thus, it has 
been concluded that these changes in the corneal permeability of ex vivo rabbit cornea is 
dependent on the physicochemical properties of the evaluated substances (Cherng-Chyi and 
Lidgate, 1986; Fu and Lidgate, 1986; Rojanasakul and Robinson, 1989; Suhonen et al., 
1998; Anand and Mitra, 2002; Fuchsjäger-Mayrl et al., 2002; Ahuja et al., 2006). 
 
Regarding the effect of the osmolalities, only the non-isotonic solutions at 178 mOsmol·kg-1 
and 432 mOsmol·kg-1 altered the barrier properties of the HC construct after 390 min of 
incubation. Based on these experimental results it can be concluded that the long-term 
application of non-isotonic solutions leads to changes in the structures of the superficial 
corneal epithelium of the HC construct. Even though experiments with ex vivo rabbit cornea, 
which determine the effect of non-isotonic solutions on the TEER have not yet been carried 
out up to now, the data of the current investigation can be compared with those obtained in 
investigations with other in vitro corneal models. In this context, toxicological studies with 
non-isotonic solutions at osmolalities ranging from 100 to 1000 mOsmol·kg-1 were 
conducted with pRCE cells (Dale and James, 1991b). This group reported that pRCE cells 
are only able to tolerate non-isotonic solutions at osmolalities ranging from 100 to 600 
mOsmol·kg-1 after 64 min and 128 min of application. Thus, the effect seen in the HC 
construct is consistent with that reported in the literature. Moreover, the changes of the 
integrity (TEER) of the HC construct observed after 390 min did not affect its permeability to 
Na-FLU. It has been reported that only non-isotonic solutions at osmolalities lower than or 
equal to 83 mOsmol·kg-1 or higher than or equal to 582 mOsmol·kg-1 can influence the 
permeability of ex vivo rabbit cornea (Ashton et al., 1991). In further studies, the effect of 
highly non-isotonic solutions (e.g. 80, 100 and 600 mOsmol·kg-1) could be evaluated in order 
to determine whether the corneal permeability of the HC construct is also affected by these 
osmolalities as has previously been reported for ex vivo rabbit cornea. Moreover, it has been 
described that the instillation of hypertonic solutions into the eye intensifies the precorneal 
loss process (e.g. blinking, lacrimation and tear turnover) resulting in a reduction of the 
precorneal residence time of the drug and thereby decreases its ocular bioavailability 
(Podder et al., 1992; Carlfors et al., 1998). In contrast, it has been suggested that the 
application of hypotonic solutions does not cause lacrimation (Conrad et al., 1978), whereby 
the residence time of the drug on the precorneal surface is prolonged resulting in an increase 
of the drug permeation through the corneal barrier (Podder et al., 1992; Carlfors et al., 1998). 
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Other authors have proposed that non-isotonic solutions produce an osmotic gradient 
between the tear film and the surrounding tissue that enhances the permeation of the drug 
through the cornea (Malhotra and Majumdar, 2001). Thus, it can be suggested that these 
factors play an important role under in vivo but not in vitro conditions. In further studies, the 
experimental methodology needs to be refined in order to be able to imitate these important 
precorneal conditions, which influence in vivo the bioavailability of ocular drugs.  
5.1.4. Preservative effects on the HC construct 
Ophthalmic medications are usually formulated with preservatives and chelating agents in 
order to conserve their microbial quality during use. However, it has been reported that the 
administration of preserved ophthalmic medications into the eye results in alterations of the 
integrity and permeability of the corneal tissue (Baudouin et al., 2010). Thus, the current 
investigation evaluates the effect of preservatives and the chelating agent EDTA on the 
barrier function of the HC construct.  
Within the scope of the current study, it was found that EDTA and preservatives (BAC, MP, 
Thio, and PQ-1) change the permeability of the HC construct in a time-concentration 
dependent manner. The effect that has been observed for EDTA and BAC, MP, Thio, and 
PQ-1 is also related to their toxic properties. In contrast, the preservatives Ce, Purite®, 
sofZia® have not affected the permeability of the HC construct. The few data available in the 
literature demonstrate that the effect of MP, Thio, Ce and the alternative preservatives (PQ-
1, Purite®, sofZia®) on the native corneal epithelium has been poorly investigated. Thus, this 
study aims to provide additional information about the effect of these excipients, which needs 
to be considered during the development of new ophthalmic medications. In contrast, the 
effect of the foremost used preservative BAC and the ophthalmic excipient EDTA on the 
native tissue has been intensively investigated, thus it was possible to assess to which extent 
the data obtained with the HC construct are transferable to native tissue. For example, in 
vivo animal experiments demonstrated that BAC concentrations higher than or equal to 
0.005% led to a rapid TEER reduction of the rabbit cornea after 1 min of application. In 
contrast, BAC concentrations lower than or equal to 0.002% did not decrease the TEER 
recorded for in vivo rabbit cornea (Uematsu et al., 2007; Kusano et al., 2010).  
However, the in vivo effect of these BAC concentrations (0.001% and 0.002%) on the 
corneal surface is certainly questionable due the following reasons: Firstly, the ophthalmic 
solution is removed from the corneal surface after 2 to 4 min in humans (Malhotra and 
Majumdart, 2001; Urtti, 2006). Secondly, some ocular diseases require the application of the 
ophthalmic medication more than once per day within the scope of a long-term treatment, 
which could lead to the accumulation of BAC in the corneal epithelium and the anterior 
stroma (Green and Chapman, 1986; Noecker, 2001; Chen et al., 2014). In contrast, it has 
been reported for ex vivo rabbit cornea that 0.001% and 0.002% BAC reduced the TEER by 
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more than 50% following a time of between 60 and 80 min of application. In addition, the 
application of 0.01% and 0.02% BAC on the surface of ex vivo rabbit cornea resulted in a 
reduction of the TEER that was higher than that noted for 0.002% BAC (Chetoni et al., 2003; 
Nakamura et al., 2007). All these toxicological experiments have demonstrated that the 
reduction of the TEER in vivo and in vitro correlated with the cytotoxic effect of BAC. These 
observations indicate that concentrations higher than or equal to 0.001% BAC can affect the 
TEER of ex vivo rabbit cornea. Thus, the data obtained with the HC construct are in 
agreement with those previously reported for ex vivo rabbit cornea. In addition, toxicological 
experiments with pure corneal epithelial cell culture models have demonstrated that 0.001% 
and 0.0025% BAC reduces the percentage of living cells (HCE cells) to approximately 60% 
and 40% after 20 min of application. This effect was even higher after 60 min of application 
(Guzman-Aranguez et al., 2014). Burgalassi et al. have shown that 0.001% BAC decreases 
the percentage of living cells (HCE and RCE cells) to 15% after 15 min of application 
(Burgalassi et al., 2001). Other research group has also found that 0.0025% BAC decreases 
the percentage of living cells (HCE cells) to approximately 55% after 60 min of application 
(Epstein et al., 2009). Against this background, it can also be concluded that the effect of 
BAC on other in vitro epithelial cells is related to its cytotoxic properties, concentration as 
well as the exposure time. Moreover, the results of the current study demonstrate that BAC 
concentrations, which have not affected the tightness of the in vitro corneal epithelium have 
not changed the corneal permeability of the HC construct to neither hydrophilic nor lipophilic 
substances. In contrast, BAC concentrations, which have decreased the epithelial tightness 
have also led to a significant change in the corneal permeability of the HC construct to the 
hydrophilic substance Na-FLU. These data are in accordance with those obtained in 
previously described permeability studies, which assessed the effect of BAC on the 
permeability of ex vivo rabbit cornea to hydrophilic substances (López Bernal and Ubels, 
2001; Ubels et al., 2004; Nakamura et al., 2007; Majumdar et al., 2008). However, the effect 
of such concentrations of BAC or other preservatives, which cause a reduction in the 
tightness of the HC construct has not been evaluated for non-hydrophilic substances (e.g. 
bimatoprost). Despite of this limitation, permeability studies previously carried out with 
lipophilic drugs demonstrated that such BAC concentrations (e.g. 0.01 or 0.02%) increased 
the permeability of the native tissue to lipophilic drugs (Camber and Edman, 1987; Ashton et 
al., 1991; Maccarey and Edelhauser, 2007; Chang et al., 2012). Finally, the data obtained in 
the current study indicate that the HC construct is suitable to investigate the effect of 
ophthalmic excipients since they are comparable to those reported for ex vivo rabbit cornea. 
The effect of other kinds of excipients (e.g. cyclodextrins, mucoadhesive polymers) and 
ophthalmic formulations remains to be evaluated and compared to ex vivo native tissue 
within the scope of further studies. Moreover, the dynamic processes, which take place 
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under in vivo conditions, e.g. the blinking of the eye, the tear turnover and the dilution of the 
drug by the tear film, also need to be simulated under experimental conditions in order to 
ensure that the data obtained with the HC construct can be transferred to the situation in 
vivo. 
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6. Summary and outlook 
The present study focused on the method transfer and further characterization of an in vitro 
human Hemicornea model that has been developed by the Institut für Pharmazeutische 
Technologie, Technische Universität Braunschweig, Germany. The first step of the present 
investigation was to establish the HC construct at the biotech laboratory ACB by transferring 
standardized protocols that have been developed and provided by TUBS. The HC construct, 
which is based on two immortalized human corneal cell lines, is used as an alternative to in 
vivo methods employed for drug absorption studies. The successful protocol transfer was 
demonstrated on the basis of the barrier properties of the HC construct (TEER and Papp), 
which fulfilled acceptance criteria previously defined by TUBS. Furthermore, after successful 
transfer, additional quality criteria for further HC batches were defined at ACB and applied 
within the scope of this investigation. A minimum TEER value of 400 Ohm·cm² was required 
to achieve Papp values < 1·10-6 cm·s-1 for the hydrophilic permeation marker Na-FLU.  
In a second step, the intra- and interlaboratory reproducibility of the HC construct was 
assessed, which is critical requirement of in vitro alternative models in order to be accepted 
by the respective authorities. The prevalidation phase was conducted at three different 
laboratories (TUBS, ACB and UKE) by performing permeability experiments with Na-FLU, 
FD-4, rhodamine B and four ophthalmic drugs, namely aciclovir, bimatoprost, 
dexamethasone and timolol maleate. The resulting data demonstrated that the intra- and 
interlaboratory reproducibility of permeability experiments with the HC construct is distinctly 
higher than for experiments using ex vivo rabbit cornea. Additional in vitro permeability 
studies were conducted with substances having a wide range of different physicochemical 
properties and compared to those previously reported for native corneal tissue of rabbit and 
human origin. The data indicated that the permeability of the HC construct is quite similar to 
that of rabbit and nearly equivalent to that of human cornea.  
With regard to a widespread use of the HC construct in preclinical drug development, in a 
third step, the influence of formulation parameters, such as the pH, osmolality and excipients 
(e.g. EDTA and preservatives) on the barrier properties of the HC construct was also 
investigated. The results demonstrated that the barrier properties of the HC construct are not 
influenced in a wide range of pH and osmolality. Only extreme values of pH and osmolality 
resulted in alteration of barrier properties and permeability of the HC construct. Furthermore, 
results from experiments studying the influence of EDTA and preservatives showed that the 
impact of most excipients is both, concentration as well as time dependent, and in general 
based on the cytotoxic potential of these substances. However, comparison with reports from 
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the literature including similar studies on in vivo or ex vivo animal tissue disclosed that the 
results obtained with the HC construct are very similar to that of animal cornea. 
In conclusion, it can be stated that the HC construct can be successfully transferred in other 
laboratories. The HC construct can be used to predict the corneal permeability to ophthalmic 
drugs and to screen excipients and formulations for ophthalmic drugs. Despite some 
limitations, the HC construct is a promising in vitro model to reduce animal testing in 
development of ophthalmic drugs.  
Nevertheless, some points should be considered to improve the cultivation of HC construct 
and the significance of drug absorptions studies. In future investigations, the culture 
conditions of the HC construct have to be refined in order to increase the stability of its TEER 
level for a period of time longer than 11 days. In addition, excipients, such as preservatives, 
should be evaluated over an incubation time no longer than 5 or 10 min. Such short 
incubation time represents the common precorneal residence time of ophthalmic 
formulations and should result in more significant outcomes in drug development. Moreover, 
these studies can be complemented with toxicological experiments, i.e. WST-1 or LDH 
assays. Furthermore, drug permeability studies should be conducted under simulated in vivo 
physiological conditions (e.g. the use of tear fluid and the simulation of precorneal loss 
factors) in order to obtain more accurate information with regard to the ocular 
pharmacokinetics (absorption and desorption rates) and the bioavailability of ophthalmic 
drugs.  
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